0001193125-23-276108.txt : 20231113 0001193125-23-276108.hdr.sgml : 20231113 20231113163825 ACCESSION NUMBER: 0001193125-23-276108 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corner Growth Acquisition Corp. CENTRAL INDEX KEY: 0001829953 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39814 FILM NUMBER: 231399506 BUSINESS ADDRESS: STREET 1: 251 LYTTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650-543-8180 MAIL ADDRESS: STREET 1: 251 LYTTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 10-Q 1 d452213d10q.htm 10-Q 10-Q
Table of Contents
false0001829953Q3--12-31CA 0001829953 2023-09-30 0001829953 2022-12-31 0001829953 2022-01-01 2022-09-30 0001829953 2023-01-01 2023-09-30 0001829953 2023-07-01 2023-09-30 0001829953 2022-07-01 2022-09-30 0001829953 2022-04-01 2022-06-30 0001829953 2023-04-01 2023-06-30 0001829953 2023-01-01 2023-03-31 0001829953 2020-10-29 2020-12-31 0001829953 2022-01-01 2022-03-31 0001829953 2023-01-01 2023-01-31 0001829953 2023-06-20 2023-06-20 0001829953 2021-12-31 0001829953 2022-01-01 2022-12-31 0001829953 2022-09-30 0001829953 2023-03-31 0001829953 2023-06-30 0001829953 2022-06-30 0001829953 2022-03-31 0001829953 us-gaap:CommonClassBMember 2023-09-30 0001829953 us-gaap:CommonClassAMember 2023-09-30 0001829953 srt:MinimumMember 2023-09-30 0001829953 us-gaap:MeasurementInputSharePriceMember coolu:PrivatePlacementWarrantsMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member coolu:MarketableSecuritiesHeldInTrustAccountMember 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 us-gaap:IPOMember us-gaap:CommonClassAMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:CommonClassAMember 2023-09-30 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember coolu:FounderSharesMember 2023-09-30 0001829953 us-gaap:IPOMember 2023-09-30 0001829953 coolu:SponsorMember coolu:SharePriceMoreThanOrEqualsToUsdTwelveMember 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember coolu:SponsorMember 2023-09-30 0001829953 coolu:WorkingCapitalLoanMember 2023-09-30 0001829953 coolu:AdministrativeServicesAgreementMember 2023-09-30 0001829953 coolu:SponsorMember coolu:AdministrativeServicesAgreementMember 2023-09-30 0001829953 coolu:PublicWarrantsMember 2023-09-30 0001829953 coolu:SharePriceMoreThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 coolu:SharePriceLessThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 us-gaap:CommonStockMember coolu:SharePriceLessThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 coolu:SharePriceMoreThanOrEqualsToUsdEighteenMember us-gaap:CommonStockMember 2023-09-30 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-09-30 0001829953 us-gaap:CommonStockMember coolu:SharePriceLessThanOrEqualsToUsdNinePointTwoMember 2023-09-30 0001829953 coolu:SponsorMember us-gaap:CommonClassAMember 2023-09-30 0001829953 coolu:InitialMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionThresholdDaysMember 2023-09-30 0001829953 coolu:RedemptinThresholdConsecutiveTradingDaysMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:InitialMeasurementMember 2023-09-30 0001829953 us-gaap:MeasurementInputRiskFreeInterestRateMember coolu:InitialMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:InitialMeasurementMember us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:InitialMeasurementMember us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001829953 us-gaap:MeasurementInputExercisePriceMember coolu:InitialMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember 2023-09-30 0001829953 coolu:InitialMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:InitialMeasurementMember coolu:RedemptionThresholdPriceMember 2023-09-30 0001829953 coolu:RedemptionPriceMember coolu:InitialMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember 2023-09-30 0001829953 us-gaap:CommonClassBMember coolu:SponsorMember 2023-09-30 0001829953 us-gaap:RelatedPartyMember 2023-09-30 0001829953 us-gaap:CommonClassBMember 2022-12-31 0001829953 us-gaap:CommonClassAMember 2022-12-31 0001829953 us-gaap:MeasurementInputSharePriceMember coolu:PrivatePlacementWarrantsMember 2022-12-31 0001829953 coolu:PublicWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001829953 coolu:MarketableSecuritiesHeldInTrustAccountMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2022-12-31 0001829953 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member coolu:PrivatePlacementWarrantsMember 2022-12-31 0001829953 coolu:AdministrativeServicesAgreementMember 2022-12-31 0001829953 coolu:WorkingCapitalLoanMember 2022-12-31 0001829953 coolu:SubsequentMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionThresholdDaysMember 2022-12-31 0001829953 coolu:SubsequentMeasurementMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptinThresholdConsecutiveTradingDaysMember 2022-12-31 0001829953 us-gaap:MeasurementInputRiskFreeInterestRateMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 us-gaap:MeasurementInputExpectedTermMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 us-gaap:MeasurementInputPriceVolatilityMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 us-gaap:MeasurementInputExercisePriceMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 us-gaap:MeasurementInputSharePriceMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:RedemptionThresholdPriceMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:RedemptionPriceMember coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 us-gaap:RelatedPartyMember coolu:ShareholdersMember 2022-12-31 0001829953 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001829953 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2022-01-01 2022-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2022-01-01 2022-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2022-01-01 2022-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-07-01 2022-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-07-01 2022-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:WarrantLiabilitiesMember 2022-07-01 2022-09-30 0001829953 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001829953 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001829953 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2022-07-01 2022-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2022-07-01 2022-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2022-07-01 2022-09-30 0001829953 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001829953 coolu:FounderSharesMember us-gaap:CommonClassBMember coolu:SponsorMember 2023-01-01 2023-09-30 0001829953 coolu:SharePriceMoreThanOrEqualsToUsdTwelveMember coolu:SponsorMember 2023-01-01 2023-09-30 0001829953 coolu:SponsorMember coolu:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001829953 coolu:OperatingAndFormationCostsMember 2023-01-01 2023-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2023-01-01 2023-09-30 0001829953 coolu:PublicWarrantsMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001829953 coolu:SharePriceLessThanOrEqualsToUsdEighteenMember 2023-01-01 2023-09-30 0001829953 coolu:SharePriceMoreThanOrEqualsToUsdEighteenMember 2023-01-01 2023-09-30 0001829953 us-gaap:CapitalUnitsMember 2023-01-01 2023-09-30 0001829953 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2023-01-01 2023-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2023-01-01 2023-09-30 0001829953 us-gaap:IPOMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001829953 coolu:SponsorMember coolu:OperatingAndFormationCostsMember 2023-01-01 2023-09-30 0001829953 us-gaap:RelatedPartyMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:WarrantLiabilitiesMember 2023-07-01 2023-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2023-07-01 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-07-01 2023-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2023-07-01 2023-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2023-07-01 2023-09-30 0001829953 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001829953 coolu:SponsorMember coolu:AdministrativeServicesAgreementMember 2023-07-01 2023-09-30 0001829953 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001829953 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001829953 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-12-21 2020-12-21 0001829953 us-gaap:IPOMember us-gaap:CommonClassAMember 2020-12-21 2020-12-21 0001829953 coolu:SponsorMember coolu:PrivatePlacementWarrantsMember 2020-12-21 2020-12-21 0001829953 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-12-21 0001829953 coolu:PrivatePlacementWarrantsMember coolu:SponsorMember 2020-12-21 0001829953 us-gaap:IPOMember 2022-12-20 0001829953 us-gaap:CommonClassAMember 2022-12-20 0001829953 us-gaap:CommonClassAMember 2022-12-20 2022-12-20 0001829953 us-gaap:CommonClassAMember 2023-12-20 2023-12-20 0001829953 coolu:NoventiqHoldingsPlcMember 2023-05-04 2023-05-04 0001829953 coolu:NoventiqHoldingsPlcMember 2023-05-04 0001829953 coolu:SponsorMember 2023-05-04 0001829953 srt:MinimumMember 2023-06-20 0001829953 us-gaap:CommonClassAMember 2023-06-20 0001829953 us-gaap:CommonClassAMember 2023-06-20 2023-06-20 0001829953 coolu:SponsorMember coolu:ConversionOfClassBToClassACommonStockMember 2023-06-21 2023-06-21 0001829953 coolu:SponsorMember coolu:ConversionOfClassBToClassACommonStockMember 2023-06-21 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember 2023-06-21 0001829953 us-gaap:CommonClassAMember 2021-12-31 0001829953 coolu:OperatingAndFormationCostsMember 2022-01-01 2022-12-31 0001829953 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001829953 us-gaap:CommonClassAMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001829953 us-gaap:CommonClassBMember coolu:FounderSharesMember coolu:SponsorMember 2020-10-28 2020-10-28 0001829953 coolu:SponsorMember coolu:FounderSharesMember us-gaap:CommonClassBMember 2020-10-28 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember 2020-11-30 2020-11-30 0001829953 us-gaap:CommonClassBMember coolu:SponsorMember coolu:FounderSharesMember 2020-12-16 0001829953 coolu:SponsorMember coolu:ConversionOfClassBToClassACommonStockMember 2023-06-01 2023-06-01 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001829953 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001829953 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-06-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2023-01-01 2023-06-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-06-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-06-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2022-01-01 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-06-30 0001829953 us-gaap:CommonClassAMember 2023-11-13 0001829953 us-gaap:CommonClassBMember 2023-11-13 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2022-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:WarrantLiabilitiesMember 2022-09-30 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001829953 us-gaap:RetainedEarningsMember 2022-09-30 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-09-30 0001829953 us-gaap:RetainedEarningsMember 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001829953 us-gaap:RetainedEarningsMember 2021-12-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001829953 us-gaap:RetainedEarningsMember 2022-03-31 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001829953 us-gaap:RetainedEarningsMember 2022-12-31 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001829953 us-gaap:RetainedEarningsMember 2023-03-31 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001829953 us-gaap:RetainedEarningsMember 2023-06-30 0001829953 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-06-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001829953 us-gaap:RetainedEarningsMember 2022-06-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:WarrantLiabilitiesMember 2022-12-31 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2022-12-31 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PrivatePlacementWarrantsMember 2022-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2023-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember coolu:PublicWarrantsMember 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Month iso4217:USD xbrli:shares utr:Year utr:D utr:Y
 
 
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
 
 
CORNER GROWTH ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
  
001-39814
  
98-1563902
(State or other jurisdiction of
incorporation or organization)
  
(Commission
File Number)
  
(I.R.S. Employer
Identification Number)
 
251 Lytton Avenue, Suite 200
Palo Alto, CA
  
94301
(Address of principal executive offices)
  
(Zip Code)
Registrant’s telephone number, including area code:
(650) 543-8180
Not Applicable
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Units, each consisting of one Class A ordinary share and
one-third
of one redeemable warrant
  
COOLU
  
The Nasdaq Stock Market
Class A ordinary share, par value $0.0001 per share
  
COOL
  
The Nasdaq Stock Market
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
  
COOLW
  
The Nasdaq Stock Market
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to
such fi
ling requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
Non-accelerated
filer		   ☒    Smaller reporting company   ☒
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of November
13
, 2023, 10,244,938 Class A ordinary shares, par value $0.0001, and 175,000 Class B ordinary shares, par value $0.0001, were issued and outstanding.
 
 
 

Table of Contents

CORNER GROWTH ACQUISITION CORP.

Quarterly Report on Form 10-Q

TABLE OF CONTENTS

 

     Page  

PART I—FINANCIAL INFORMATION

     1  

Item 1.

  

Condensed Consolidated Financial Statements

      1  
 

Condensed Consolidated Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022

      1  
 

Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022

      2  
 

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2023 and 2022

      3  
 

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022

      4  
 

Notes to Unaudited Condensed Consolidated Financial Statements

      5  

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

      20  

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

      27  

Item 4.

  

Disclosure Controls and Procedures

      27  

PART II – OTHER INFORMATION

     29  

Item 1.

  

Legal Proceedings

      29  

Item 1A.

  

Risk Factors

      29  

Item 2.

  

Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

      29  

Item 3.

  

Defaults Upon Senior Securities

      29  

Item 4.

  

Mine Safety Disclosures

      29  

Item 5.

  

Other Information

      29  

Item 6.

  

Exhibits

      30  

SIGNATURES

     31  

 

 

i

Table of Contents
PART I—FINANCIAL INFORMATION
 
Item 1.
Condensed Consolidated Financial Statements.
CORNER GROWTH ACQUISITION CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
 

 
  
As of
September 30,
2023
 
 
As of
December 31,
2022
 
 
  
(unaudited)
 
 
 
 
ASSETS
  
 
Current assets
                 
Cash
    $ 21,761     $ 31,547  
Prepaid expenses
      189,995       268,736  
    
 
 
    
 
 
  
Total current assets
      211,756       300,283  
Cash and marketable securities held in Trust Account
      4,493,902       15,489,507  
    
 
 
    
 
 
  
Total Assets
    $ 4,705,658     $ 15,789,790  
    
 
 
    
 
 
  
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT
                 
Current liabilities
                 
Due to related party
    $ 1,622,682     $ 522,500  
Due to shareholders
      —        3,262,655  
Accrued expenses
      2,056,793       932,555  
    
 
 
    
 
 
  
Total current liabilities
      3,679,475       4,717,710  
Warrant liabilities
      1,674,666       628,000  
Deferred underwriting fee payable
      4,000,000       4,000,000  
    
 
 
    
 
 
  
Total Liabilities
      9,354,141       9,345,710  
    
 
 
    
 
 
  
COMMITMENTS AND CONTINGENCIES
             
Class A ordinary shares subject to possible redemption, 419,938 shares at redemption value as of September 30, 2023 and 1,191,437 shares at redemption value as of December 31, 2022
      4,493,902       12,226,852  
Shareholders’ Deficit
                 
Preference Shares, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding
      —        —   
Class A ordinary Shares, $0.0001 par value, 300,000,000 shares authorized; 9,825,000 and 0 issued and outstanding (excluding 419,938 and 1,191,437 shares subject to possible redemption as of September 30, 2023 and December 31, 2022, respectively)
      982       —   
Class B ordinary Shares, $0.0001 par value, 30,000,000 shares authorized; 175,000 and 10,000,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
      18       1,000  
Additional
paid-in
capital
      —        —   
Accumulated deficit
      (9,143,385 )      (5,783,772 ) 
    
 
 
    
 
 
  
Total Shareholders’ Deficit
      (9,142,385 )      (5,782,772 ) 
    
 
 
    
 
 
  
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT
    $ 4,705,658     $ 15,789,790  
    
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
 
1
CORNER GROWTH ACQUISITION CORP.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
 
    
For the Three
Months
Ended
September 30,
2023
    
For the Nine
Months
Ended
September 30,
2023
    
For the Three
Months
Ended
September 30,
2022
    
For the Nine
Months
Ended
September 30,
2022
  
Operating and formation costs
    $ 422,865     $ 2,312,947     $ 352,198     $ 1,291,566  
  
 
 
    
 
 
    
 
 
    
 
 
  
Loss from operations
      (422,865 )      (2,312,947 )      (352,198 )      (1,291,566 ) 
Other income (loss)
         
Earnings and realized gain on marketable securities held in Trust Account
      57,747       352,129       1,931,891       2,558,714  
Change in fair value of warrant liabilities
      1,046,667       (1,046,666 )      640,560       14,101,333  
  
 
 
    
 
 
    
 
 
    
 
 
  
Net income (loss)
    $ 681,549     $ (3,007,484 )    $ 2,220,253     $ 15,368,481  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding of Class A redeemable ordinary shares
      419,938       903,185       40,000,000       40,000,000  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income (loss) per Class A redeemable ordinary share
    $ 0.07     $ (0.28 )    $ 0.04     $ 0.31  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding of Class A nonredeemable ordinary shares and Class B ordinary shares
      10,000,000       10,000,000       10,000,000       10,000,000  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income (loss) per Class A nonredeemable ordinary share and Class B ordinary share
    $ 0.07     $ (0.28 )    $ 0.04     $ 0.31  
  
 
 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
 
2
CORNER GROWTH ACQUISITION CORP.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
 
    
Class A
     
Class B
    
Additional
Paid-
in Capital
     
Accumulated
Deficit
    
Total
Shareholders’
Deficit
  
    
Ordinary Shares
     
Ordinary Shares
  
    
Shares
     
Amount
     
Shares
    
Amount
  
Balance, January 1, 2023
      —     $ —         10,000,000     $ 1,000     $ —       $ (5,783,772 )    $ (5,782,772 ) 
Remeasurement of Class A ordinary shares subject to possible redemption
      —         —         —        —        —         (154,783 )      (154,783 ) 
Net loss
      —         —         —        —        —         (2,381,252 )      (2,381,252 ) 
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
Balance, March 31, 2023
      —       —       10,000,000       1,000       —       (8,319,807 )      (8,318,807 ) 
Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares
      9,825,000        982        (9,825,000 )      (982 )      —         —        —   
Remeasurement of Class A ordinary shares subject to possible redemption
      —         —         —        —        —         (139,599 )      (139,599 ) 
Net loss
      —         —         —        —        —         (1,307,781 )      (1,307,781 ) 
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
Balance, June 30, 2023
      9,825,000        982      175,000       18       —       (9,767,187 )      (9,766,187 ) 
Remeasurement of Class A ordinary shares subject to possible redemption
      —         —         —        —        —         (57,747 )      (57,747 ) 
Net income
      —         —         —        —        —         681,549       681,549  
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
Balance, September 30, 2023
      9,825,000    $ 982        175,000    
$
 18     $ —       $ (9,143,385 )    $ (9,142,385 ) 
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2022
      —     $ —         10,000,000     $ 1,000     $ —       $ (27,567,744 )    $ (27,566,744 ) 
Net income
      —         —         —        —        —         7,896,134       7,896,134  
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
Balance, March 31, 2022
      —       —       10,000,000       1,000       —       (19,671,610 )      (19,670,610 ) 
Remeasurement of Class A ordinary shares subject to possible redemption
      —         —         —        —        —         (769,393 )      (769,393 ) 
Net income
      —         —         —        —        —         5,252,094       5,252,094  
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
Balance, June 30, 2022
      —       —       10,000,000       1,000       —       (15,188,909 )      (15,187,909 ) 
Remeasurement of Class A ordinary shares subject to possible redemption
      —         —         —        —        —         (1,931,891 )      (1,931,891 ) 
Net income
      —         —         —        —        —         2,220,253       2,220,253  
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
Balance, September 30, 2022
      —     $ —         10,000,000     $ 1,000     $ —       $ (14,900,547 )    $ (14,899,547 ) 
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
 
3
CORNER GROWTH ACQUISITION CORP.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
 
    
For the Nine
Months Ended
September 30,
2023
    
For the Nine
Months Ended
September 30,
2022
  
Cash Flows from Operating Activities
     
Net income (loss)
    $ (3,007,484 )    $ 15,368,481  
Adjustments to reconcile net income (loss) to net cash used in operating activities:
     
Earnings and realized gain on marketable securities held in Trust Account
      (352,129 )      (2,558,714 ) 
Change in fair value of warrant liabilities
      1,046,666       (14,101,333 ) 
Changes in operating assets and liabilities:
     
Due to related party
      1,100,182       275,000  
Prepaid expenses
      78,741       280,480  
Accrued expenses
      1,124,238       245,535  
  
 
 
    
 
 
  
Net cash used in operating activities
      (9,786 )      (490,551 ) 
  
 
 
    
 
 
  
Cash Flows from Investing Activities
     
   
Proceeds received from Trust Account
      11,347,734       —   
  
 
 
    
 
 
  
Net cash provided by investing activities
      11,347,734       —   
 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities
     
Payments to Class A ordinary shareholders for redemption of shares
      (11,347,734 )      —   
Payment of offering costs
      —        (70,000 ) 
  
 
 
    
 
 
  
Net cash used in financing activities
      (11,347,734 )      (70,000 ) 
  
 
 
    
 
 
  
Net change in cash
      (9,786 )      (560,551 ) 
Cash at beginning of the period
      31,547       646,558  
  
 
 
    
 
 
  
Cash at end of the period
    $ 21,761     $ 86,007  
  
 
 
    
 
 
  
Non-cash
financing activities:
     
Remeasurement of Class A ordinary shares subject to possible redemption
   
$

 352,129    
$

 2,701,284  
  
 
 
    
 
 
  
Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares
    $ 982     $ —   
  
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
 
4
CORNER GROWTH ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
Note 1—Description of Organization, Business Operations and Basis of Presentation
Corner Growth Acquisition Corp. (the “Company”), was incorporated as a Cayman Islands exempted company on October 20, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus on businesses in the technology industries primarily located in the United States. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation, its initial public offering described below (the “Initial Public Offering”) and, since the closing of the Initial Public Offering, the search for initial Business Combination candidates, and since the signing of the Business Combination Agreement described below, the completion of this proposed transaction. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering and will recognize changes in the fair value of warrant liabilities as other income (loss). The Company has selected December 31 as its fiscal year end.
The registration statements for the Company’s Initial Public Offering were declared effective on December 16, 2020. On December 21, 2020, the Company consummated the Initial Public Offering of 40,000,000 units (the “Units” and, with respect to the shares of Class A ordinary shares, par value $0.0001 per share (the “Class A ordinary shares”), included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriters of the overallotment option to purchase an additional 5,000,000 Units, at $10.00 per Unit, generating gross proceeds of $400,000,000 which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,600,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement (the “Private Placement”) to CGA Sponsor LLC (the “Sponsor”), generating gross proceeds of $11,400,000, which is described in Note 4.
Transaction costs amounted to $22,766,081 consisting of $8,000,000 of underwriting fees, $14,000,000 of deferred underwriting fees and $766,081
of other offering costs. As further described in Note 5, effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit
$10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of an initial business combination, as originally set forth in the underwriting agreement.
Following the closing of the Initial Public Offering on December 21, 2020, an amount of $400,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule
2a-7
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company. To mitigate the risk of us being deemed to have been operating as an unregistered investment company under the Investment Company Act, on or about the
24-month
anniversary of the effective date of the registration statement relating to the Initial Public Offering, or December 21, 2022, the Company instructed Continental Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash (i.e., in one or more bank accounts) until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The
per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be classified
 
5
as temporary equity upon the completion of the Initial Public Offering in accordance with ASC 480. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and the approval of an ordinary resolution. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (as amended, the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material
non-public
information and (ii) clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
Extraordinary General Meeting
On December 20, 2022, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”), which amended the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate a Business Combination from December 21, 2022 to June 21, 2023. The shareholders approved a proposal to amend the trust agreement to change the date on which Continental Stock Transfer & Trust Company must commence liquidation of the Trust Account from (A) the earlier of the Company’s completion of an initial business combination and December 21, 2022 to (B) the earlier of the Company’s completion of an initial business combination and June 21, 2023. In connection with the Extraordinary General Meeting, shareholders elected to redeem 38,808,563 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $393,676,799, or approximately $10.14 per share which includes $5,591,169 of earnings in the Trust Account not previously withdrawn. In January 2023, the Company made redemption payments of $3,262,655 out of the Trust Account that were due to the redeeming shareholders who elected to redeem their shares as part of the Extraordinary General Meeting. This amount was reflected as due to shareholders in the accompanying condensed consolidated balance sheet as of December 31, 2022. Subsequent to the redemptions, 1,191,437
Class A ordinary shares remained issued and outstanding until the Extension Meeting further described below.
Business Combination Agreement
On February 9, 2023, the Company issued a press release announcing that the Company has entered into a
non-binding
letter of intent with Softline Holding plc to proceed with a potential business combination that would result in the combined company being publicly-listed on the Nasdaq. The business combination is subject to the completion of definitive documentation. On May 4, 2023, the Company entered into a definitive business combination agreement with Noventiq Holdings PLC (formerly known as Softline Holding plc).
As disclosed in a Form
8-K
filed with the SEC on May 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) by and among the Company, Noventiq Holdings PLC, a company organized under the laws of the Cyprus (“Noventiq”), and Corner Growth SPAC Merger Sub, Inc., a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”). The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into Noventiq, with Noventiq surviving as a wholly-owned subsidiary of the Company (the “Merger”). Upon the closing of the business combination (the “Closing”), it is anticipated that the Company will change its name to “Noventiq Holding Company” (“New Noventiq”) and certain securities of New Noventiq are expected to be listed on the Nasdaq Stock Market (“Nasdaq”). The date on which the Closing actually occurs is hereinafter referred to as the “Closing Date.” In accordance with the applicable provisions of the Cayman Companies Act (As Revised) and the Cyprus Companies Law, prior to the approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders, Noventiq will
re-domicile
from Cyprus to the Cayman Islands.
 
6
The Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Proposed Business Combination.”
The Business Combination Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Noventiq.
The Proposed Business Combination is subject to certain customary closing conditions, such as the prior approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders and the effectiveness of the Registration Statement on Form
F-6
registering the ADSs (as defined below). There is no assurance that the Proposed Business Combination will be consummated by the Extended Date (or any such later date of termination approved in accordance with the Amended and Restated Memorandum and Articles of Association) described below.
Consideration and Structure
At the effective time of the Merger (the “Effective Time”), each ordinary share of Noventiq outstanding immediately prior to the Effective Time (collectively, the “Noventiq Shares”) (other than shares held in treasury of Noventiq or owned by any subsidiary of Noventiq and held by shareholders of Noventiq who have perfected their dissenters’ rights in accordance with Section 238 of the Cayman Act) will be automatically cancelled, extinguished and converted into a number of the Company’s newly issued Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), equal to the “Exchange Ratio” determined by dividing (A) the Per Share Merger Consideration Value (as defined below) by (B) $10; and each outstanding vested and unvested option to purchase Noventiq Shares (“Noventiq Option”) will be assumed and converted into an option to purchase Ordinary Shares (each a “Rollover Option”). The number of Ordinary Shares (rounded down to the nearest whole number) that are subject to each Rollover Option shall be equal to the product of (i) the number of Noventiq Shares subject to the Noventiq Option and (ii) the Exchange Ratio, and the exercise price per share of the Rollover Option (rounded up to the nearest whole cent) shall be equal to the quotient obtained by dividing (A) the exercise price per share of the Noventiq Option by (B) the Exchange Ratio. For purposes of the Business Combination Agreement, Noventiq’s equity value is $877,000,000 plus the amount equal to aggregate exercise price of the Noventiq’s options (the “Equity Value”) and the “Per Share Merger Consideration Value” is an amount in dollars equal to the sum of the Equity Value, divided by the number of outstanding shares.
In addition to the foregoing consideration, Noventiq shareholders shall be entitled to receive, as additional consideration, one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case, for each Ordinary Share issuable to such Noventiq shareholder at the Effective Time pursuant to the Business Combination Agreement, which provide the holders of such CSRs the contingent right to receive additional newly issued Ordinary Shares (the “Earnout Shares”) upon the occurrence of certain events and subject to certain conditions, as specified under the Business Combination Agreement, during the period from and after the Closing until the fifth anniversary of the Closing (the “Earnout Period”). During the Earnout Period, if New Noventiq experiences a Change of Control (as defined in the Business Combination Agreement), then any Earnout Shares not already earned and issued to the Noventiq shareholders shall be deemed earned and the balance of the Earnout Shares shall be issuable by New Noventiq to the Noventiq shareholders immediately prior to consummation of such Change of Control transaction subject to certain conditions and upon the terms of the Business Combination Agreement.
On May 4, 2023, the Sponsor held 9,825,001 Founder Shares. Of these, 2,500,000 Founder Shares are subject to forfeiture based on the sum of (i) the amount of gross proceeds raised prior to the Effective Time from additional financings, if any, by the Company and (ii) the cash balance of the Company’s Trust Account held for the benefit of its public shareholders, but the consummation of the Proposed Business Combination is not subject to a minimum amount of additional financing having been raised. At the Effective Time, the Founder Shares (net of any forfeited shares) will automatically convert into Ordinary Shares on a
one-for-one
basis, subject to adjustment, on the terms and conditions provided in the Amended and Restated Memorandum and Articles of Association.
An additional 5,000,000 Founder Shares, out of the 9,825,001 Founder Shares described above, will be held in escrow and only released, in three equal installments, upon the occurrence of the same milestone events as the Earnout Shares are issued.
In connection with the Proposed Business Combination and pursuant to the Business Combination Agreement, the Company has agreed to establish a Level 2 ADS facility by entering into a Deposit Agreement with The Bank of New York Mellon (or an affiliate), as depositary, and filing with the Securities and Exchange Commission (the “SEC”) a Registration Statement on
Form F-6 registering
American Depositary Shares (the “ADSs”), each representing one Ordinary Share (the “ADS Facility”).
Following the Closing, each holder of Ordinary Shares will be able to deposit such holder’s shares into the ADS Facility and receive ADSs, which are expected to trade on Nasdaq under the symbol “NVIQ.” Following the Closing, the Company’s outstanding warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer & Trust Company, will remain outstanding and are expected to continue trading on Nasdaq. In connection with the Closing, the ADSs, each representing one Ordinary Share, are expected to be listed on Nasdaq as of the Effective Time.
 
7
Concurrently with the execution of the Business Combination Agreement, the Sponsor entered into a support agreement with the Company and Noventiq (the “Sponsor Support Agreement”), pursuant to which the Sponsor has agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby; (ii) not to solicit, initiate, submit, facilitate (including by means of furnishing or disclosing information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with any third-party with respect to a CGAC Acquisition Proposal (as defined in the Sponsor Support Agreement); (iii) be bound by certain transfer restrictions with respect to its shares in the Company prior to the closing of the Proposed Business Combination; (iv) not to transfer any of the Restricted Securities (as defined in the Sponsor Support Agreement) from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Sponsor Support Agreement).
Concurrently with the execution of the Business Combination Agreement, the Company, Noventiq and certain shareholders of Noventiq (collectively, the “Noventiq Supporting Shareholders”) duly executed and delivered to the Company a support agreement (the “Voting and Support Agreement”), pursuant to which each Noventiq Supporting Shareholder agreed to, among other things, (i) the Business Combination and the adoption of the Business Combination Agreement any other matters necessary or reasonably requested by Noventiq for consummation of the Business Combination and the other transactions contemplated by the Business Combination Agreement, (ii) not to transfer any Noventiq Shares on or prior to the Closing (subject to the exceptions set forth therein), and (ii) to a
lock-up
of the Noventiq Shares from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Voting and Support Agreement).
The Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor Parties and certain Noventiq shareholders will enter into the Registration Rights Agreement, pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares of the Company, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement.
Extension Meeting
On June 15, 2023, the Company held an extraordinary general meeting of shareholders, which was adjourned and reconvened on June 20, 2023 (the “Extension Meeting”), to amend the Company’s amended and restated memorandum and articles of association (the “Articles Amendment”) to (i) extend the date by which the Company has to consummate a business combination from June 21, 2023 to March 21, 2024 (the “Extended Date”) or such earlier date as shall be determined by the Company’s board of directors in its sole discretion (the “Amended Termination Date” and, such proposal, the “Extension Amendment Proposal”), (ii) eliminate from the amended and restated memorandum and articles of association the limitation that the Company shall not redeem Class A ordinary shares included as part of the units sold in the IPO to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation Amendment Proposal”) and (iii) amend the Company’s amended and restated memorandum and articles of association to provide that Class B ordinary shares may be converted either at the time of the consummation of the Company’s initial business combination or at any earlier date at the option of the holders of Class B ordinary shares (the “Founder Conversion Amendment Proposal”). The shareholders of the Company approved the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal at the Extension Meeting and on June 21, 2023, the Company filed the Articles Amendment with the Registrar of Companies of the Cayman Islands.
In connection with the vote to approve the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal, shareholders elected to redeem 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding.
On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor, the holder of an aggregate of 9,825,001 shares of the Company’s Class B Ordinary Shares, par value $0.0001 per share, elected to convert 9,825,000 shares of the Class B Ordinary Shares held by it on a
one-for-one
basis into Class A Ordinary Shares of the Company, with immediate effect. Following such conversion, the Sponsor holds 9,825,000 shares of Class A Ordinary Shares and 1 share of Class B Ordinary Shares and the Company will have an aggregate of 10,244,938 shares of Class A Ordinary Shares issued and outstanding (419,938 of which are subject to possible redemption) and 175,000 shares of Class B Ordinary Shares issued and outstanding. In connection with the conversion, the Sponsor has agreed to certain transfer restrictions, a waiver of redemption rights, a waiver of any right to receive funds from the Trust Account and the obligation to vote in favor of an initial business combination.
The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination by the Extended Date (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or
pre-initial
Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.
 
8
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and other requirements of applicable law.
The Sponsor, officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination during the Combination Period and, in such event, such amount will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Going Concern
As of September 30, 2023, the Company had $21,761 in its operating bank accounts, $4,493,902 in the Trust Account to be used for a Business Combination or to repurchase or redeem its ordinary shares in connection therewith and a working capital deficit of $3,467,719.
Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. Based on its current cash and working capital balances, management believes that the Company will not have sufficient working capital to meet its needs through the consummation of a Business Combination.

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. The terms of such loans have not been determined and no written agreements exist with respect to such loans. However, as discussed in Note 4, as of September 30, 2023, the Company is indebted to the Sponsor and its affiliates for $1,622,682, which represents $1,342,682
 
of operating and formation costs paid by these related parties on the Company’s behalf, along with $280,000 
of unpaid administrative fees. The Sponsor is not under any obligation to make additional expenditures on the Company’s behalf.
In connection with our assessment of going concern considerations in accordance with FASB ASC Subtopic
205-40,
“Presentation of Financial Statements-Going Concern” management has determined that the date for mandatory liquidation and dissolution raise substantial doubt about our ability to continue as a going concern for a reasonable period of time, which is considered one year from the issuance of these unaudited condensed consolidated financial statements. The Company demonstrates other adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these unaudited condensed consolidated financial statements. These other adverse conditions are negative financial trends, specifically a working capital deficiency and other adverse key financial ratios. No adjustments have been made to the carrying amounts or classification of assets or liabilities should the Company be required to liquidate after March 20, 2024, our scheduled liquidation date if we do not complete the Business Combination prior to such date. There is no assurance that the Company will complete the Proposed Business Combination with Noventiq before March 24, 2024, or at all.
 
9
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2022 as filed with the SEC on March 31, 2023. The accompanying condensed consolidated balance sheet as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2022. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Principles of Consolidation
Starting with the second fiscal quarter of 2023, the Company’s unaudited condensed consolidated financial statements include the results of Merger Sub, a direct wholly owned subsidiary of the Company. Merger Sub is a Cayman Islands exempted company which was incorporated on April 4, 2023. Merger Sub was formed solely for the purpose of effectuating the Merger and has not engaged in any business activities or conducted any operations other than in connection with the Merger and has no, and at all times prior to the Merger’s closing except as expressly contemplated by the Merger documents and the related transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation.
All
intercompany balances and transactions have been eliminated in consolidation. For simplicity of presentation, we refer to all accompanying financial statements as condensed consolidated financial statements herein.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
10
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Marketable Securities Held in Trust Account
At September 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee.
The Company accounts for any securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Investments - Debt Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securities held in the Trust Account based on quoted prices in active markets (see Note 8 for more information).
Warrant Liabilities
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the unaudited condensed consolidated statements of operations.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheet.
Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional
paid-in
capital and accumulated deficit.
At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:
 
    
Shares
     
Amounts
  
Class A ordinary shares subject to possible redemption—December 31, 2021
      40,000,000      $ 400,000,000  
Less:
                  
Payments to Class A ordinary shareholders for redemption of shares
      (38,808,563 )       (390,414,144 ) 
Due to shareholders
      —         (3,262,655 ) 
Plus:
                  
Remeasurement of carrying value to redemption value
      —         5,903,651  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—December 31, 2022
      1,191,437        12,226,852  
Less:
                  
 
11
Payments to Class A ordinary shareholders for redemption of shares
      (771,499 )       (11,347,734 ) 
Plus:
                  
Due to shareholders paid in 2023
      —         3,262,655  
Remeasurement of carrying value to redemption value
      —         352,129  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—
September
30, 2023
      419,938      $ 4,493,902  
    
 
 
     
 
 
  
In December of 2022, in connection with the distribution of funds in the Trust Amount to the Company’s shareholders made in connection with the Extraordinary General Meeting (as defined above), funds were deposited from the Trust Account into an operating bank account and held in cash. As of December 31, 2022, $3,262,655 of the December 2022 redemption was not paid out to the shareholders and was classified as Due to shareholders on the condensed consolidated balance sheet. In January 2023, upon completion of the distribution of funds in the amount of $3,262,655 to shareholders made in connection with the Extraordinary General Meeting, the Company
re-deposited
the remaining funds into the Trust Account.
As part of the Extension Meeting, shareholders elected to redeem an additional 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share. $370,088 was paid out to redeeming Class A ordinary shares as their proportionate share of trust earnings through the redemption date and is the difference between the redemption amount per share and the original $10.00 per share times the number of shares redeemed.
During the nine months ended September 30, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $352,129 to reflect current earnings of the Trust Account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Fair value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheet, primarily due to their short-term nature.
 
12
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three and nine months ended September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share
Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,933,333
of the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share for all periods presented, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2023 and 2022.
The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts):
 
    
For the Three Months Ended
     
For the Nine Months Ended
    
For the Three Months Ended
     
For the Nine Months Ended
  
    
September 30, 2023
     
September 30, 202
3
    
September 30, 2022
     
September 30, 2022
  
    
Class A

Redeemable
     
Class A and
Nonredeemable
and

Class B
     
Class A
Redeemable
    
Class A
Nonredeemable
and Class B
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income (loss) per ordinary share:
                                                                      
Numerator:
                                                                      
Allocation of net income (loss)
    $ 27,467      $ 654,082      $ (249,130 )    $ (2,758,354 )    $ 1,776,202      $ 444,051      $ 12,294,785      $ 3,073,696  
Denominator:
                                                                      
Basic and diluted weighted average ordinary shares outstanding
      419,938        10,000,000        903,185       10,000,000       40,000,000        10,000,000        40,000,000        10,000,000  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income (loss) per ordinary share
    $ 0.07      $ 0.07      $ (0.28 )    $ (0.28 )    $ 0.04      $ 0.04      $ 0.31      $ 0.31  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
In June 2016, FASB issued ASU
2016-13,
Measurement of Credit Losses on Financial Instruments (“ASU
2016-13”).
ASU
2016-13
changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU
2016-13
as of January 1, 2023, with no impact to its condensed consolidated financial statements because the Company does not have financial assets within the scope of ASU
2016-13.
 
13
The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.
Risks and Uncertainties
Management is currently evaluating the impact of the
COVID-19
pandemic on its condensed consolidated financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed consolidated financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company.
Note 3 — Initial Public Offering
Pursuant to the Initial Public Offering, the Company sold 40,000,000 Units at a price of $10.00 per Unit, which includes the partial exercise by the underwriter of the overallotment option to purchase an additional 5,000,000 Units. Each Unit consists of one Class A ordinary share and
one-third
of one redeemable warrant (each, a “Public Warrant”), each whole Public Warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).
Note 4 — Related Party Transactions
Founder Shares
On October 28, 2020, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 8,625,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). In November 2020, the Sponsor transferred 50,000 Class B ordinary shares to each of the Company’s independent directors. On December 16, 2020, the Company effected a share capitalization, resulting in 10,062,500 Founder Shares issued and outstanding as of such date. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination, or earlier at the option of the holder, on a
one-for-one
basis, subject to certain adjustments, as described in Note 7. As a result of the underwriters’ election to partially exercise their over-allotment option, 62,500 Founder Shares were forfeited for no consideration on December 23, 2020, resulting in 10,000,000 Class B ordinary shares outstanding. The per share price of the Founder Shares was determined by dividing the amount contributed to the Company by the number of Founder Shares issued. The Founder Shares will be worthless if we do not complete an initial Business Combination (see Note 1).
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares or Class A ordinary shares received upon conversion thereof until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
The Company’s Founder Shares are subject to transfer restrictions pursuant to
lock-up
provisions in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. The Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares. Prior to the closing of the Initial Public Offering, the Sponsor transferred 150,000 Founder Shares to our three independent directors in recognition of and as compensation for their future services to the Company. The transfer of Founder Shares
 
14
to these directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. Compensation expense related to the Founder Shares is recognized only when the performance condition (i.e. the remediation of the
lock-up
provision) is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date the
lock-up
provisions have been remediated, or are probable to be remediated, in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the transfer of the Founder Shares. As of September 30, 2023, the Company has entered into a definitive agreement in connection with a potential Business Combination, but the Business Combination has not yet closed and as such, the
lock-up
provisions have not been remediated and are not probable to be remediated. Any definitive agreements in connection with a Business Combination may also be subject to certain conditions to closing, such as approval by the Company’s shareholders. As a result, the Company determined that, taking into account that there is a possibility that the Business Combination may not close, no stock-based compensation expense should be recognized through September 30, 2023.
Private Placement Warrants
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,600,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant for an aggregate purchase price of $11,400,000. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.
The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.
Working Capital Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $1.50 per warrant. As of the date of this filing, September 30, 2023 and December 31, 2022, the Company had no borrowings under any Working Capital Loans.
Administrative Services Agreement
Pursuant to an administrative services agreement (the “Administrative Services Agreement”) entered into on December 17, 2020, the Company agreed to pay the Sponsor a total of $40,000 per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team until the earlier of (A) the Company’s completion of the initial Business Combination or December 21, 2022 and (B) on December 21, 2022, an amount equal to $960,000 less the actual amount paid under the Administrative Services Agreement. For the three and nine months ended September 30, 2023, the Company incurred $0 in fees for these services. For the three and nine months ended September 30, 2022, the Company incurred $120,000 and $360,000 in fees for these services, respectively, which is included in operating and formation costs on the unaudited condensed consolidated statements of operations. As of September 30, 2023 and December 31, 2022, there were $280,000 and $320,000 in fees outstanding for these services, respectively, that are included in due to related party on the condensed consolidated balance sheets. Notwithstanding the foregoing, on November 18, 2021, the Sponsor permanently waived its right to receive any of the Company’s outstanding, and all of the Company’s remaining, payment obligations under the Administrative Services Agreement.
Operating and Formation Costs
As of September 30, 2023 and December 31, 2022, the Sponsor and affiliates of the Sponsor also paid operating and formation costs of $
1,342,682
 and $202,500, respectively, on behalf of the Company which are due on demand. These amounts are included in due to related party on the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. The Sponsor is not under any obligation to make additional expenditures on the Company’s beh
alf.
 
15
Note 5 — Commitments and Contingencies
Registration Rights
The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement entered in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, these holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
As further described in Note 1 and as such terms used herein are defined therein, the Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor and certain Noventiq shareholders will enter into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement.
Underwriting Agreement
After the Initial Public Offering, the underwriters were entitled to a deferred fee of $0.35 per Unit, or $14,000,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of a Business Combination, as originally set forth in the underwriting agreement. The Company accounted for this forfeiture during the fourth calendar quarter of the year ended December 31, 2022.
Note 6 — Warrant Liabilities
The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and, following the effective date of the registration statement, the Company will use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital-raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, plus interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A ordinary shares during the
10-trading
day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of
 
16
the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
Once the warrants become exercisable, the Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants if they are held by the Sponsor or its permitted transferees):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
In addition, once the warrants become exercisable, the Company may call the warrants for redemption:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares;
 
  •  
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the
30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
  •  
if the closing price of the Class A ordinary shares for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event are the warrants to be exercisable in connection with this redemption feature for more than 0.361
Class A ordinary shares per warrant (subject to adjustment).
If the Company calls the Public Warrants for redemption, management has the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event is the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Following the Closing, the Company’s public warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer & Trust Company, will remain outstanding and are expected to continue trading on Nasdaq.
Note 7 — Shareholders’ Deficit
Preference Shares
— The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
 
17
Class
 A Ordinary Shares
— The Company is authorized to issue 300,000,000 Class A ordinary shares with a par value of $0.0001 per share. At December 31, 2022, there were 1,191,437 Class A ordinary shares issued or outstanding, all of which are considered temporary equity. On June 20, 2023, in connection with the Extension Meeting, shareholders elected to redeem 771,499 additional Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding. On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor elected to convert 9,825,000 shares of the Class B ordinary shares held by it on a
one-for-one
basis into Class A ordinary shares of the Company, with immediate effect. Following such conversion, the Sponsor holds 9,825,000 shares of Class A ordinary shares and at September 30, 2023, the Company has an aggregate of 10,244,938 shares of Class A ordinary shares (419,938 of which are subject to possible redemption) issued and outstanding. The Sponsor’s 9,825,000 Class A ordinary shares received in connection with the conversion are not redeemable.
Class
 B Ordinary Shares
— The Company is authorized to issue 30,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each Class B ordinary share. At December 31, 2022, there were 10,000,000 Class B ordinary shares issued and outstanding. On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor elected to convert 9,825,000 shares of the Class B ordinary shares held by it on a
one-for-one
basis into Class A ordinary shares of the Company, with immediate effect. Following such conversion and at September 30, 2023, the Company has an aggregate of 175,000 shares of Class B ordinary shares issued and outstanding.
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the appointment of the Company’s directors prior to the initial Business Combination.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a
one-for-one
basis (as adjusted). In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the sum of the total number of Class A ordinary shares and Class B ordinary shares issued upon completion of the Initial Public Offering plus the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than
one-for-one
basis.
Note 8 — Fair Value Measurements
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3:    Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
18
Description
   
Level
     
September 30,
2023
     
December 31,
2022
  
Assets:
                           
Cash and Marketable securities held in Trust Account
      1      $ 4,493,902      $ 15,489,507  
             
 
 
     
 
 
  
At September 30, 2023 and December 31, 2022, $0 and $15,489,507, respectively, of the balance held in the Trust Account was held in cash.
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
Description
   
Level
     
September 30,
2023
     
Level
     
December 31,
2022
  
Liabilities:
                                    
Warrant liability—Public Warrants
      1      $ 1,066,666        1      $ 400,000  
Warrant liability—Private Placement Warrants
      3      $ 608,000        3      $ 228,000  
             
 
 
              
 
 
  
Total warrant liabilities
             $ 1,674,666               $ 628,000  
             
 
 
              
 
 
  
The Warrants are accounted for as liabilities in accordance with ASC
815-40
and are presented within the warrant liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of the warrant liabilities in the condensed consolidated statements of operations.
Initial Measurement and Subsequent Measurement
The Company established the initial fair value for the Public Warrants on December 21, 2020, the date of the consummation of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and
one-third
of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of shares of Class B ordinary shares, based on their fair values as determined at initial measurement, Class A ordinary shares and Class B ordinary shares based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.
The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2023 and December 31, 2022 is classified as Level 1 due to quoted prices in an active market since February 8, 2021. The Private Placement Warrants as of September 30, 2023 and December 31, 2022 are classified as Level 3 due to the use of unobservable inputs.
The Monte Carlo model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing since February 8, 2021. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date.
The key inputs into the Monte Carlo simulation model for the Private Placement warrants at September 30, 2023 and December 31, 2022 were as follows:

19
 
  
September 30, 2023
 
 
December 31, 2022
 
Input
  
 
Risk-free interest rate
      4.50 %      3.99 % 
Expected term (years)
      5.48       5.0  
Expected volatility
      5.4 %      0.8 % 
Exercise price
    $ 11.50     $ 11.50  
Fair value of the ordinary share price
    $ 10.96     $ 9.89  
Redemption threshold price
    $ 18.00     $ 18.00  
Redemption threshold days
     
20 days within any
30-day
period
  
 
    
20 days within any
30-day
period
  
 
Redemption price
    $ 0.01     $ 0.01  
As of September 30, 2023, the Public Warrants and Private Placement Warrants were determined to be $0.08 and $0.08 per warrant for aggregate values of approximately $1.1 million and $0.6 million, respectively. As of December 31, 2022, the Public Warrants and Private Placement Warrants were determined to be $0.03 and $0.03, respectively, per warrant for aggregate values of approximately $0.4 million and $0.2 million, respectively.
The following table presents the changes in the fair value of warrant liabilities:
 
    
Private Placement
     
Public
     
Warrant Liabilities
  
Fair value as of December 31, 2022
    $ 228,000      $ 400,000      $ 628,000  
Change in valuation inputs or other assumptions
      760,000        1,333,333        2,093,333  
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2023
      988,000        1,733,333        2,721,333  
Change in valuation inputs or other assumptions
      (380,000 )       (666,667 )       (1,046,667 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of September 30, 2023
    $ 608,000      $ 1,066,666      $ 1,674,666  
    
 
 
     
 
 
     
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value as of December 31, 2021
   
$

 5,320,000     
$

 9,200,000     
$

 14,520,000  
Change in valuation inputs or other assumptions
      (4,935,440 )       (8,525,333 )       (13,460,773 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2022
      384,560        674,667        1,059,227  
Change in valuation inputs or other assumptions
      (232,560 )       (408,000 )       (640,560 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of September 30, 2022
    $ 152,000      $ 266,667      $ 418,667  
    
 
 
     
 
 
     
 
 
  
Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three and nine months ended September 30, 2023 and 2022.
Note 9 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred up to the date condensed consolidated financial statements were issued. Based upon this review, the Company did not identify any other subsequent events, not previously disclosed, that would have required adjustment or disclosure in the condensed consolidated financial statements, except as described below.
On October 4, 2023, the Company transferred its ordinary share of the Merger Sub to New Noventiq. As a result, the Company will no longer have an ownership interest in the Merger Sub. Starting with the fourth quarter of 2023, the Company’s financial statements will no longer be presented on a consolidated basis.
 
 
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References to the “company,” “our,” “us” or “we” refer to Corner Growth Acquisition Corp. The following discussion and analysis of the company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form
10-Q.
Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
 
20

Table of Contents

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). When used in this Quarterly Report on Form 10-Q, words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions, as they relate to us or our management, identify forward looking statements. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2022. Such forward looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. No assurance can be given that results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. The cautionary statements made in this Quarterly Report on Form 10-Q should be read as being applicable to all forward-looking statements whenever they appear in this Quarterly Report. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

Overview

We are a blank check company incorporated on October 20, 2020 (inception) as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we focus on industries that complement our management team’s background, and in our search for targets for our Business Combination seek to capitalize on the ability of our management team to identify and acquire a business, focusing on the technology industry in the United States and other developed countries.

The registration statement for our initial public offering (the “Initial Public Offering”) was declared effective on December 16, 2020. On December 21, 2020, we consummated our Initial Public Offering of 40,000,000 units, at $10.00 per unit, generating gross proceeds of $400,000,000, and incurring offering costs of approximately $22,766,000, inclusive of $14,000,000 in deferred underwriting commissions. Each unit consists of one Class A ordinary share, par value $0.0001 per share (the “Class A ordinary shares”) and one-third of one redeemable warrant, each whole public warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement of 7,600,000 private placement warrants at a price of $1.50 per private placement warrant (the “Private Placement”) to our sponsor, CGA Sponsor LLC (the “Sponsor”), generating gross proceeds of $11,400,000. Each private placement warrant is exercisable for one Class A ordinary share at a price of $11.50 per share.

Upon the closing of the Initial Public Offering and private placement, $400,000,000 ($10.00 per unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the private placement were placed in the Trust Account, located in the United States at UBS Financial Services Inc. and Morgan Stanley, with Continental Stock Transfer & Trust Company acting as trustee, and are only invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the assets held in the Trust Account. Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the private placement, although substantially all of the net proceeds are intended to be applied toward consummating an initial Business Combination.

Extraordinary General Meeting

On December 20, 2022, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”), which amended the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate a Business Combination from December 21, 2022 to June 21, 2023. The shareholders approved a proposal to amend the trust agreement to change the date on which Continental Stock Transfer & Trust Company must commence liquidation of the Trust Account from (A) the earlier of the Company’s completion of an initial business combination and December 21, 2022 to (B) the earlier of the Company’s completion of an initial business combination and June 21, 2023. In connection with the Extraordinary General Meeting, shareholders elected to redeem 38,808,563 Class A ordinary shares, resulting in redemption payments out of the

 

21

Table of Contents

Trust Account totaling $393,676,799, or approximately $10.14 per share which includes $5,591,169 of earnings in the Trust Account not previously withdrawn. In January 2023, the Company made redemption payments of $3,262,655 out of the Trust Account that were due to the redeeming shareholders who elected to redeem their shares as part of the Extraordinary General Meeting. This amount was reflected as due to shareholders in the accompanying condensed consolidated balance sheet as of December 31, 2022. Subsequent to the redemptions, 1,191,437 Class A ordinary shares remained issued and outstanding until the Extension meeting described below.

Business Combination Agreement

On February 9, 2023, the Company issued a press release announcing that the Company has entered into a non-binding letter of intent with Softline Holding plc to proceed with a potential business combination that would result in the combined company being publicly-listed on the Nasdaq. The business combination is subject to the completion of definitive documentation. On May 4, 2023, the Company entered into a definitive business combination agreement with Noventiq Holdings PLC (formerly known as Softline Holding plc), a global provider of IT solutions and services.

As disclosed in a Form 8-K filed with the SEC on May 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) by and among the Company, Noventiq Holdings PLC, a company organized under the laws of the Cyprus (“Noventiq”), and Corner Growth SPAC Merger Sub, Inc., a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”). The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into Noventiq, with Noventiq surviving as a wholly-owned subsidiary of the Company (the “Merger”). Upon the closing of the business combination (the “Closing”), it is anticipated that the Company will change its name to “Noventiq Holding Company” (“New Noventiq”). The date on which the Closing actually occurs is hereinafter referred to as the “Closing Date.” In accordance with the applicable provisions of the Cayman Companies Act (As Revised) and the Cyprus Companies Law, prior to the approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders, Noventiq will re-domicile from Cyprus to the Cayman Islands. The Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Proposed Business Combination.”

The Business Combination Agreement contains representations and warranties of certain of the parties thereto customary for transactions of this type. The representations and warranties made under the Business Combination Agreement will not survive the Closing.

The Business Combination is expected to close in the first half of 2024, following the receipt of the required approval by the Company’s and Noventiq’s shareholders and the fulfilment of other customary closing conditions, such as the effectiveness of the Registration Statement on Form F-6 registering the ADSs (as defined in Note 1 to the notes to the unaudited condensed consolidated financial statements). There is no assurance that the Proposed Business Combination will be consummated by the Extended Date (as defined below) (or any such later date of termination approved in accordance with the Amended and Restated Memorandum and Articles of Association).

If we are unable to complete a Business Combination by the Extended Date, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay for our income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of our company, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Extension Meeting

On June 15, 2023, the Company held an extraordinary general meeting of shareholders, which was adjourned and reconvened on June 20, 2023 (the “Extension Meeting”), to amend the Company’s amended and restated memorandum and articles of association (the “Articles Amendment”) to (i) extend the date by which the Company has to consummate a business combination from June 21, 2023 to March 21, 2024 (the “Extended Date”) or such earlier date as shall be determined by the Company’s board of directors in its sole discretion (the “Amended Termination Date” and, such proposal, the “Extension Amendment Proposal”), (ii) eliminate from the amended and restated memorandum and articles of association the limitation that the Company shall not redeem Class A ordinary shares included as part of the units sold in the IPO to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation Amendment Proposal”) and (ii) amend the Company’s amended and restated memorandum and articles of association to provide that Class B ordinary shares may be converted either at the time of the consummation of the Company’s initial business combination or at any earlier date at the option of the holders of Class B ordinary shares (the “Founder Conversion Amendment Proposal”). The shareholders of the Company approved the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal at the Extension Meeting and on June 21, 2023, the Company filed the Articles Amendment with the Registrar of Companies of the Cayman Islands.

 

22

Table of Contents

In connection with the vote to approve the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal, shareholders elected to redeem 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding.

On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor, the holder of an aggregate of 9,825,001 shares of the Company’s Class B Ordinary Shares, par value $0.0001 per share, elected to convert 9,825,000 shares of the Class B Ordinary Shares held by it on a one-for-one basis into Class A Ordinary Shares of the Company, with immediate effect. Following such conversion, the Sponsor will hold 9,825,000 shares of Class A Ordinary Shares and 1 share of Class B Ordinary Shares and the Company will have an aggregate of 10,244,938 shares of Class A Ordinary Shares issued and outstanding (419,938 of which are subject to possible redemption) and 175,000 shares of Class B Ordinary Shares issued and outstanding. In connection with the conversion, the Sponsor has agreed to certain transfer restrictions, a waiver of redemption rights, a waiver of any right to receive funds from the Trust Account and the obligation to vote in favor of an initial business combination.

Liquidity, Capital Resources and Going Concern

As indicated in the accompanying condensed consolidated financial statements, at September 30, 2023, we had $21,761 in our operating bank account, and a working capital deficit of $3,467,719, and $294,522 of earnings and realized gains on the amounts remaining in the Trust Account after historical redemptions. We expect to continue to incur significant costs in pursuit of our initial Business Combination plans.

Our liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the proceeds of $25,000 from the sale of the founder shares, and loans from the Sponsor of approximately $120,000. The loan was repaid in full on December 22, 2020. Subsequent from the consummation of the Initial Public Offering, our liquidity has been satisfied through the net proceeds received from the consummation of the Initial Public Offering and the Private Placement.

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our officers and directors may, but are not obligated to, loan the Company funds as may be required. The terms of such loans have not been determined and no written agreements exist with respect to such loans. However, as discussed in Note 4 to the notes to the unaudited condensed consolidated financial statements, as of September 30, 2023, the Company is indebted to the Sponsor and its affiliates for $1,622,682, which represents $1,342,682 of operating and formation costs paid by these related parties on the Company’s behalf, along with $280,000 of unpaid administrative fees. The Sponsor is not under any obligation to make additional expenditures on the Company’s behalf.

Based on the foregoing, management believes that we will not have sufficient working capital to meet our needs through the consummation of a Business Combination. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

In connection with our assessment of going concern considerations in accordance with FASB ASC Subtopic 205-40, “Presentation of Financial Statements—Going Concern”, management has determined that the date for mandatory liquidation and dissolution raise substantial doubt about our ability to continue as a going concern through a reasonable period of time, which is considered one year from the issuance of these condensed consolidated financial statements. The Company demonstrates other adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these condensed consolidated financial statements. These other adverse conditions are negative financial trends, specifically working capital deficiency and other adverse key financial ratios. Our scheduled liquidation date is March 20, 2024. No adjustments have been made to the carrying amounts or classification of assets or liabilities should the Company be required to liquidate after March 20, 2024. There is no assurance that the Company will complete the Proposed Business Combination with Noventiq before March 24, 2024, or at all.

 

23

Table of Contents

Results of Operations

Our entire activity since inception through September 30, 2023 related to our formation, Initial Public Offering and, since the closing of our Initial Public Offering, the search for initial Business Combination candidates (see Note 1 to the notes to the unaudited condensed consolidated financial statements). As of September 30, 2023, $21,761 was held outside the Trust Account and was being used to fund the Company’s operating expenses. We are not generating any operating revenues until the closing and completion of our initial Business Combination at the earliest.

For the three and nine months ended September 30, 2023, we had a net income (loss) of $681,549 and $(3,007,484), respectively, which consisted of $57,747 and $352,129 in earnings and realized gains on marketable securities held in the Trust Account, respectively, a decrease (increase) in the fair value of warrant liabilities of $1,046,667 and $(1,046,666), respectively, and $422,865 and $2,312,947 in operating and formation costs, respectively.

For the three and nine months ended September 30, 2022, we had a net income of $2,220,253 and $15,368,481, respectively, which consisted of $1,931,891 and $2,558,714 in earnings and realized gains on marketable securities held in the Trust Account, respectively, a decrease in the fair value of warrant liabilities of $640,560 and $14,101,333, respectively, partially offset by $352,198 and $1,291,566 in operating and formation costs, respectively.

Related Party Transactions

Founder Shares

On October 28, 2020, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 8,625,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). In November 2020, the Sponsor transferred 50,000 Class B ordinary shares to each of the Company’s independent directors. On December 16, 2020, the Company effected a share capitalization, resulting in 10,062,500 Founder Shares issued and outstanding as of such date. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, as described in Note 7. As a result of the underwriters’ election to partially exercise their over-allotment option, 62,500 Founder Shares were forfeited for no consideration on December 23, 2020, resulting in 10,000,000 Class B ordinary shares outstanding. The per share price of the Founder Shares was determined by dividing the amount contributed to the Company by the number of Founder Shares issued. The Founder Shares will be worthless if we do not complete an initial Business Combination (see Note 1).

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares or Class A ordinary shares received upon conversion thereof until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

The Company’s Founder Shares are subject to transfer restrictions pursuant to lock-up provisions in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. The Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares. Prior to the closing of the Initial Public Offering, the Sponsor transferred 150,000 Founder Shares to our three independent directors in recognition of and as compensation for their future services to the Company. The transfer of Founder Shares to these directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. Compensation expense related to the Founder Shares is recognized only when the performance condition (i.e. the remediation of the lock-up provision) is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date the lock-up provisions have been remediated, or are probable to be remediated, in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the transfer of the Founder Shares. As of September 30, 2023, the Company has entered into a agreement in connection with a potential Business Combination, but the Business Combination has not yet closed, and as such, the lock-up provisions have not been remediated and are not probable to be remediated. Any definitive agreements in connection with a Business Combination may also be subject to certain conditions to closing, such as approval by the Company’s shareholders. As a result, the Company determined that, taking into account that there is a possibility that the Business Combination may not close, no stock-based compensation expense should be recognized through September 30, 2023.

 

24

Table of Contents

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). If we complete a Business Combination, we would repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the trust account. In the event that a Business Combination is not completed, we may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the private placement warrants. As of the date of this filing and September 30, 2023, there were no outstanding Working Capital Loans under this arrangement.

Administrative Services Agreement

We agreed, commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of $40,000 per month for office space, utilities and secretarial and administrative support services provided to members of the Company’s management team until the earlier of (A) the Company’s completion of the initial Business Combination or December 21, 2022 and (B) on December 21, 2022, an amount equal to $960,000, less the actual amount paid under the Administrative Services Agreement. On November 18, 2021, the Sponsor waived its right to receive any of the Company’s remaining, payment obligations under the Administrative Services Agreement.

For the three and nine months ended September 30, 2023, the Company incurred $0 in fees for these services. For the three and nine months ended September 30, 2022, the Company incurred $120,000 and $360,000 in fees for these services, respectively, which is included in operating and formation costs on the unaudited condensed consolidated statements of operations. As of September 30, 2023 and December 31, 2022, there were $280,000 and $320,000 in fees outstanding for these services that are included in due to related party on the condensed consolidated balance sheets. Notwithstanding the foregoing, on November 18, 2021, the Sponsor permanently waived its right to receive any of the Company’s outstanding, and all of the Company’s remaining, payment obligations under the Administrative Services Agreement.

Operating and Formation Costs

As of September 30, 2023, the Sponsor and affiliates of the Sponsor also paid operating and formation costs of $1,342,682 on behalf of the Company which are due on demand. These amounts are included in due to related party on the condensed consolidated balance sheet as of September 30, 2023. The Sponsor is not under any obligation to make additional expenditures on the Company’s behalf.

Contractual Obligations

Registration and Shareholder Rights

The holders of founder shares, private placement warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the founder shares, only after conversion of such shares into Class A ordinary shares) pursuant to a registration and shareholder rights agreement entered into during the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration and shareholder rights. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. We will bear the expenses incurred in connection with the filing of any such registration statements.

Amended and Restated Registration Rights Agreement

The Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor and certain Noventiq shareholders will enter into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement.

 

25

Table of Contents

Sponsor Support Agreement

Concurrently with the execution of the Business Combination Agreement, the Sponsor entered into a support agreement with the Company and Noventiq (the “Sponsor Support Agreement”), pursuant to which the Sponsor has agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby; (ii) not to solicit, initiate, submit, facilitate (including by means of furnishing or disclosing information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with any third-party with respect to a CGAC Acquisition Proposal (as defined in the Sponsor Support Agreement); (iii) be bound by certain transfer restrictions with respect to its shares in the Company prior to the closing of the Proposed Business Combination; (iv) not to transfer any of the Restricted Securities (as defined in the Sponsor Support Agreement) from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Sponsor Support Agreement).

Underwriting Agreement

The underwriter was entitled to underwriting discounts of $0.20 per unit sold in the Initial Public Offering, or $8,000,000 in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.35 per unit sold in the Initial Public Offering, or $14,000,000 in the aggregate will be payable to the underwriters for deferred underwriting commissions. Effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000. The deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement. The Company accounted for this forfeiture during the fourth calendar quarter of the year ended December 31, 2022.

Critical Accounting Policies

Our management’s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of income and expenses during the reported period. In accordance with GAAP, we base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

Starting with the second fiscal quarter of 2023, the Company’s unaudited condensed consolidated financial statements include the results of Merger Sub, a direct wholly owned subsidiary of the Company. Merger Sub is a Cayman Islands exempted company which was incorporated on April 4, 2023. Merger Sub was formed solely for the purpose of effectuating the Merger and has not engaged in any business activities or conducted any operations other than in connection with the Merger and has no, and at all times prior to the Merger’s closing except as expressly contemplated by the Merger documents and the related transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation. All intercompany balances and transactions have been eliminated in consolidation. For simplicity of presentation, we refer to all accompanying financial statements as condensed consolidated financial statements herein.

Our significant accounting policies are fully described in Note 2 to our condensed consolidated financial statements appearing elsewhere in this Quarterly Report and are fully described in Note 2 in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. We believe those accounting policies are critical to the process of making significant judgments and estimates in the preparation of our condensed consolidated financial statements. There have been no changes to our significant accounting policies from our Form 10-K.

Recent Accounting Pronouncements

In June 2016, FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU 2016-13 as of January 1, 2023, with no impact to its condensed consolidated financial statements because the Company does not have financial assets within the scope of ASU 2016-13.

Our management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed consolidated financial statements.

 

26

Table of Contents

Off-Balance Sheet Arrangements

For the three and nine months ended September 30, 2023, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our condensed consolidated financial statements may not be comparable to companies that comply with public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the condensed consolidated financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the principal executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4.

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

Our management evaluated, with the participation of our principal executive officer and principal financial and accounting officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2023, our disclosure controls and procedures were not effective, because of material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim condensed consolidated financial statements will not be prevented or detected on a timely basis. Specifically, the Company’s management has concluded that the controls around the interpretation and accounting for certain complex financial instruments were not effectively designed or maintained.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations

 

27

Table of Contents

in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d- 15(f) under the Exchange Act) that occurred during the fiscal quarter of 2023 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

28

Table of Contents

PART II – OTHER INFORMATION

 

Item 1.

Legal Proceedings

None.

 

Item 1A.

Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider our risk factors from those disclosed under “Item 1A. Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2022. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

As of the date of this report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

 

Item 2.

Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

None.

 

Item 3.

Defaults Upon Senior Securities

None.

 

Item 4.

Mine Safety Disclosures

Not applicable.

 

Item 5.

Other Information

During the three months ended September 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

29

Table of Contents
Item 6.

Exhibits

 

Exhibit
Number  		   

Description

    3.1    Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed on December 21, 2020, File No. 001-39814).
    3.2    Extension Amendment, dated December 20, 2022, to the Amended and Restated Memorandum and Articles of Association of Corner Growth Acquisition Corp. (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed on December 23, 2022, File No. 001-39814).
    3.3    Amendment, dated June 20, 2023, to Amended and Restated Memorandum and Articles of Association of Corner Growth Acquisition Corp. (incorporated by reference to Exhibit 99.1 of the Registrant’s Current Report on Form 8-K filed on June 22, 2023, File No. 001-39814).
  31.1*    Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2*    Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1**    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2**    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH    Inline XBRL Taxonomy Extension Schema Document.
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*

Filed herewith.

**

Furnished.

 

30

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 13th day of November, 2023.

 

CORNER GROWTH ACQUISITION CORP.
By:   /s/ Jerome “Jerry” Letter
Name:   Jerome “Jerry” Letter
Title:   Chief Financial Officer and Chief Operating Officer

 

 

31

EX-31.1 2 d452213dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Marvin Tien, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of Corner Growth Acquisition Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the condensed consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of condensed consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 13, 2023

 

By:   /s/ Marvin Tien
  Name:   Marvin Tien
  Title:  

Co-Chairman, Chief Executive Officer and Director

(Principal Executive Officer)

 EX-31.2 3 d452213dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jerome “Jerry” Letter, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of Corner Growth Acquisition Corp.:

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the condensed consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of condensed consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 13, 2023

 

By:   /s/ Jerome “Jerry” Letter
  Name:   Jerome “Jerry” Letter
  Title:   Chief Financial Officer
    (Principal Financial and Accounting Officer)
 EX-32.1 4 d452213dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Corner Growth Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marvin Tien, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2023

 

By:   /s/ Marvin Tien
  Name:   Marvin Tien
  Title:   Co-Chairman, Chief Executive Officer and Director
    (Principal Executive Officer)
 EX-32.2 5 d452213dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Corner Growth Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jerome “Jerry” Letter, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2023

 

By:   /s/ Jerome “Jerry” Letter
  Name:   Jerome “Jerry” Letter
  Title:   Chief Financial Officer
    (Principal Financial and Accounting Officer)
 EX-101.SCH 6 coolu-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Warrant Liabilities link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Commitments - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Warrant Liabilities - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Shareholders' Deficit - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 coolu-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 coolu-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 coolu-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 coolu-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2023
Nov. 13, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Transition Report false  
Entity Registrant Name CORNER GROWTH ACQUISITION CORP.  
Entity Central Index Key 0001829953  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity File Number 001-39814  
Entity Filer Category Non-accelerated Filer  
Entity Tax Identification Number 98-1563902  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One 251 Lytton Avenue  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Palo Alto  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94301  
City Area Code 650  
Local Phone Number 543-8180  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Document Quarterly Report true  
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant [Member]    
Document Information [Line Items]    
Trading Symbol COOLU  
Title of 12(b) Security Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant  
Security Exchange Name NASDAQ  
Common Class A [Member]    
Document Information [Line Items]    
Trading Symbol COOL  
Title of 12(b) Security Class A ordinary share, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   10,244,938
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   175,000
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]    
Document Information [Line Items]    
Trading Symbol COOLW  
Title of 12(b) Security Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash $ 21,761 $ 31,547
Prepaid expenses 189,995 268,736
Total current assets 211,756 300,283
Cash and marketable securities held in Trust Account 4,493,902 15,489,507
Total Assets 4,705,658 15,789,790
Current Liabilities    
Due to related party 1,622,682 522,500
Due to shareholders 0 3,262,655
Accrued Expenses 2,056,793 932,555
Total Current Liabilities 3,679,475 4,717,710
Warrant liabilities 1,674,666 628,000
Deferred underwriting fee payable 4,000,000 4,000,000
Total Liabilities 9,354,141 9,345,710
COMMITMENTS AND CONTINGENCIES
Class A ordinary shares subject to possible redemption, 419,938 shares at redemption value as of September 30, 2023 and 1,191,437 shares at redemption value as of December 31, 2022 4,493,902 12,226,852
Shareholders' Deficit    
Preference Shares, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (9,143,385) (5,783,772)
Total Shareholders' Deficit (9,142,385) (5,782,772)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT 4,705,658 15,789,790
Common Class A [Member]    
Current Liabilities    
Class A ordinary shares subject to possible redemption, 419,938 shares at redemption value as of September 30, 2023 and 1,191,437 shares at redemption value as of December 31, 2022 4,493,902 12,226,852
Shareholders' Deficit    
Common Stock, Value, Issued 982 0
Common Class B [Member]    
Shareholders' Deficit    
Common Stock, Value, Issued $ 18 $ 1,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Jun. 20, 2023
Dec. 31, 2022
Dec. 31, 2021
Temporary equity shares outstanding 419,938   1,191,437 40,000,000
Preferred stock par or stated value per share $ 0.0001   $ 0.0001  
Preferred stock shares authorized 1,000,000   1,000,000  
Preferred stock shares issued 0   0  
Preferred stock shares outstanding 0   0  
Common Class A [Member]        
Temporary equity shares outstanding 419,938   1,191,437  
Common stock par or stated value per share $ 0.0001   $ 0.0001  
Common stock shares authorized 300,000,000   300,000,000  
Common stock shares issued 9,825,000   0  
Common stock shares outstanding 9,825,000 419,938 0  
Common Class B [Member]        
Common stock par or stated value per share $ 0.0001   $ 0.0001  
Common stock shares authorized 30,000,000   30,000,000  
Common stock shares issued 175,000   10,000,000  
Common stock shares outstanding 175,000   10,000,000  
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating and formation costs $ 422,865 $ 352,198 $ 2,312,947 $ 1,291,566
Loss from operations (422,865) (352,198) (2,312,947) (1,291,566)
Other income (loss)        
Earnings and realized gain on marketable securities held in Trust Account 57,747 1,931,891 352,129 2,558,714
Change in fair value of warrant liabilities 1,046,667 640,560 (1,046,666) 14,101,333
Net income (loss) $ 681,549 $ 2,220,253 $ (3,007,484) $ 15,368,481
Class A Redeemable Ordinary Shares [Member]        
Other income (loss)        
Basic net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Diluted net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Basic weighted average shares outstanding 419,938 40,000,000 903,185 40,000,000
Diluted weighted average shares outstanding 419,938 40,000,000 903,185 40,000,000
Class A Nonredeemable Ordinary Shares and Class B Ordinary Shares [Member]        
Other income (loss)        
Basic net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Diluted net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Basic weighted average shares outstanding 10,000,000 10,000,000 10,000,000 10,000,000
Diluted weighted average shares outstanding 10,000,000 10,000,000 10,000,000 10,000,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Shareholders' Deficit - USD ($)
Total
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021 $ (27,566,744) $ 0 $ 1,000 $ 0 $ (27,567,744)
Beginning balance (Shares) at Dec. 31, 2021   0 10,000,000    
Net income (loss) 7,896,134       7,896,134
Ending balance at Mar. 31, 2022 (19,670,610) $ 0 $ 1,000 0 (19,671,610)
Ending balance (Shares) at Mar. 31, 2022   0 10,000,000    
Beginning balance at Dec. 31, 2021 (27,566,744) $ 0 $ 1,000 0 (27,567,744)
Beginning balance (Shares) at Dec. 31, 2021   0 10,000,000    
Net income (loss) 15,368,481        
Ending balance at Sep. 30, 2022 (14,899,547) $ 0 $ 1,000 0 (14,900,547)
Ending balance (Shares) at Sep. 30, 2022   0 10,000,000    
Beginning balance at Mar. 31, 2022 (19,670,610) $ 0 $ 1,000 0 (19,671,610)
Beginning balance (Shares) at Mar. 31, 2022   0 10,000,000    
Remeasurement of Class A ordinary shares subject to possible redemption (769,393)     0 (769,393)
Net income (loss) 5,252,094       5,252,094
Ending balance at Jun. 30, 2022 (15,187,909) $ 1,000 (15,188,909)
Ending balance (Shares) at Jun. 30, 2022   0 10,000,000    
Remeasurement of Class A ordinary shares subject to possible redemption (1,931,891)     0 (1,931,891)
Net income (loss) 2,220,253       2,220,253
Ending balance at Sep. 30, 2022 (14,899,547) $ 0 $ 1,000 0 (14,900,547)
Ending balance (Shares) at Sep. 30, 2022   0 10,000,000    
Beginning balance at Dec. 31, 2022 (5,782,772) $ 1,000 (5,783,772)
Beginning balance (Shares) at Dec. 31, 2022   0 10,000,000    
Remeasurement of Class A ordinary shares subject to possible redemption (154,783)     0 (154,783)
Net income (loss) (2,381,252)       (2,381,252)
Ending balance at Mar. 31, 2023 (8,318,807) $ 1,000 (8,319,807)
Ending balance (Shares) at Mar. 31, 2023   0 10,000,000    
Beginning balance at Dec. 31, 2022 (5,782,772) $ 1,000 (5,783,772)
Beginning balance (Shares) at Dec. 31, 2022   0 10,000,000    
Net income (loss) (3,007,484)        
Ending balance at Sep. 30, 2023 (9,142,385) $ 982 $ 18 0 (9,143,385)
Ending balance (Shares) at Sep. 30, 2023   9,825,000 175,000    
Beginning balance at Mar. 31, 2023 (8,318,807) $ 1,000 (8,319,807)
Beginning balance (Shares) at Mar. 31, 2023   0 10,000,000    
Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares   $ 982 $ (982)    
Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares (Shares)   9,825,000 (9,825,000)    
Remeasurement of Class A ordinary shares subject to possible redemption (139,599)     0 (139,599)
Net income (loss) (1,307,781)       (1,307,781)
Ending balance at Jun. 30, 2023 (9,766,187) $ 982 $ 18 (9,767,187)
Ending balance (Shares) at Jun. 30, 2023   9,825,000 175,000    
Remeasurement of Class A ordinary shares subject to possible redemption (57,747)     0 (57,747)
Net income (loss) 681,549       681,549
Ending balance at Sep. 30, 2023 $ (9,142,385) $ 982 $ 18 $ 0 $ (9,143,385)
Ending balance (Shares) at Sep. 30, 2023   9,825,000 175,000    
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash Flows from Operating Activities                
Net income (loss)   $ 681,549 $ (2,381,252) $ 2,220,253 $ 7,896,134 $ (3,007,484) $ 15,368,481  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
Earnings and realized gain on marketable securities held in Trust Account   (57,747)   (1,931,891)   (352,129) (2,558,714)  
Change in fair value of warrant liabilities   (1,046,667)   (640,560)   1,046,666 (14,101,333)  
Changes in operating assets and liabilities:                
Due to related party           1,100,182 275,000  
Prepaid expenses           78,741 280,480  
Accrued expenses           1,124,238 245,535  
Net cash used in operating activities           (9,786) (490,551)  
Cash Flows from Investing Activities                
Proceeds received from Trust Account           11,347,734    
Net cash provided by investing activities           11,347,734    
Cash Flows from Financing Activities                
Payments to Class A ordinary shareholders for redemption of shares           (11,347,734)    
Payment of offering costs           0 (70,000)  
Net cash used in financing activities           (11,347,734) (70,000)  
Net change in cash           (9,786) (560,551)  
Cash at beginning of the period $ 31,547   $ 31,547   $ 646,558 31,547 646,558 $ 646,558
Cash at end of the period   $ 21,761   $ 86,007   21,761 86,007 $ 31,547
Non-cash financing activities:                
Remeasurement of Class A ordinary shares subject to possible redemption $ 3,262,655         352,129 2,701,284  
Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares           $ 982 $ 0  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Description of Organization and Business Operations
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Organization, Business Operations and Basis of Presentation
Note 1—Description of Organization, Business Operations and Basis of Presentation
Corner Growth Acquisition Corp. (the “Company”), was incorporated as a Cayman Islands exempted company on October 20, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus on businesses in the technology industries primarily located in the United States. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation, its initial public offering described below (the “Initial Public Offering”) and, since the closing of the Initial Public Offering, the search for initial Business Combination candidates, and since the signing of the Business Combination Agreement described below, the completion of this proposed transaction. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering and will recognize changes in the fair value of warrant liabilities as other income (loss). The Company has selected December 31 as its fiscal year end.
The registration statements for the Company’s Initial Public Offering were declared effective on December 16, 2020. On December 21, 2020, the Company consummated the Initial Public Offering of 40,000,000 units (the “Units” and, with respect to the shares of Class A ordinary shares, par value $0.0001 per share (the “Class A ordinary shares”), included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriters of the overallotment option to purchase an additional 5,000,000 Units, at $10.00 per Unit, generating gross proceeds of $400,000,000 which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,600,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement (the “Private Placement”) to CGA Sponsor LLC (the “Sponsor”), generating gross proceeds of $11,400,000, which is described in Note 4.
Transaction costs amounted to $22,766,081 consisting of $8,000,000 of underwriting fees, $14,000,000 of deferred underwriting fees and $766,081
of other offering costs. As further described in Note 5, effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit
$10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of an initial business combination, as originally set forth in the underwriting agreement.
Following the closing of the Initial Public Offering on December 21, 2020, an amount of $400,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule
2a-7
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company. To mitigate the risk of us being deemed to have been operating as an unregistered investment company under the Investment Company Act, on or about the
24-month
anniversary of the effective date of the registration statement relating to the Initial Public Offering, or December 21, 2022, the Company instructed Continental Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash (i.e., in one or more bank accounts) until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The
per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be classified
 
as temporary equity upon the completion of the Initial Public Offering in accordance with ASC 480. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and the approval of an ordinary resolution. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (as amended, the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material
non-public
information and (ii) clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
Extraordinary General Meeting
On December 20, 2022, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”), which amended the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate a Business Combination from December 21, 2022 to June 21, 2023. The shareholders approved a proposal to amend the trust agreement to change the date on which Continental Stock Transfer & Trust Company must commence liquidation of the Trust Account from (A) the earlier of the Company’s completion of an initial business combination and December 21, 2022 to (B) the earlier of the Company’s completion of an initial business combination and June 21, 2023. In connection with the Extraordinary General Meeting, shareholders elected to redeem 38,808,563 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $393,676,799, or approximately $10.14 per share which includes $5,591,169 of earnings in the Trust Account not previously withdrawn. In January 2023, the Company made redemption payments of $3,262,655 out of the Trust Account that were due to the redeeming shareholders who elected to redeem their shares as part of the Extraordinary General Meeting. This amount was reflected as due to shareholders in the accompanying condensed consolidated balance sheet as of December 31, 2022. Subsequent to the redemptions, 1,191,437
Class A ordinary shares remained issued and outstanding until the Extension Meeting further described below.
Business Combination Agreement
On February 9, 2023, the Company issued a press release announcing that the Company has entered into a
non-binding
letter of intent with Softline Holding plc to proceed with a potential business combination that would result in the combined company being publicly-listed on the Nasdaq. The business combination is subject to the completion of definitive documentation. On May 4, 2023, the Company entered into a definitive business combination agreement with Noventiq Holdings PLC (formerly known as Softline Holding plc).
As disclosed in a Form
8-K
filed with the SEC on May 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) by and among the Company, Noventiq Holdings PLC, a company organized under the laws of the Cyprus (“Noventiq”), and Corner Growth SPAC Merger Sub, Inc., a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”). The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into Noventiq, with Noventiq surviving as a wholly-owned subsidiary of the Company (the “Merger”). Upon the closing of the business combination (the “Closing”), it is anticipated that the Company will change its name to “Noventiq Holding Company” (“New Noventiq”) and certain securities of New Noventiq are expected to be listed on the Nasdaq Stock Market (“Nasdaq”). The date on which the Closing actually occurs is hereinafter referred to as the “Closing Date.” In accordance with the applicable provisions of the Cayman Companies Act (As Revised) and the Cyprus Companies Law, prior to the approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders, Noventiq will
re-domicile
from Cyprus to the Cayman Islands.
 
The Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Proposed Business Combination.”
The Business Combination Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Noventiq.
The Proposed Business Combination is subject to certain customary closing conditions, such as the prior approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders and the effectiveness of the Registration Statement on Form
F-6
registering the ADSs (as defined below). There is no assurance that the Proposed Business Combination will be consummated by the Extended Date (or any such later date of termination approved in accordance with the Amended and Restated Memorandum and Articles of Association) described below.
Consideration and Structure
At the effective time of the Merger (the “Effective Time”), each ordinary share of Noventiq outstanding immediately prior to the Effective Time (collectively, the “Noventiq Shares”) (other than shares held in treasury of Noventiq or owned by any subsidiary of Noventiq and held by shareholders of Noventiq who have perfected their dissenters’ rights in accordance with Section 238 of the Cayman Act) will be automatically cancelled, extinguished and converted into a number of the Company’s newly issued Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), equal to the “Exchange Ratio” determined by dividing (A) the Per Share Merger Consideration Value (as defined below) by (B) $10; and each outstanding vested and unvested option to purchase Noventiq Shares (“Noventiq Option”) will be assumed and converted into an option to purchase Ordinary Shares (each a “Rollover Option”). The number of Ordinary Shares (rounded down to the nearest whole number) that are subject to each Rollover Option shall be equal to the product of (i) the number of Noventiq Shares subject to the Noventiq Option and (ii) the Exchange Ratio, and the exercise price per share of the Rollover Option (rounded up to the nearest whole cent) shall be equal to the quotient obtained by dividing (A) the exercise price per share of the Noventiq Option by (B) the Exchange Ratio. For purposes of the Business Combination Agreement, Noventiq’s equity value is $877,000,000 plus the amount equal to aggregate exercise price of the Noventiq’s options (the “Equity Value”) and the “Per Share Merger Consideration Value” is an amount in dollars equal to the sum of the Equity Value, divided by the number of outstanding shares.
In addition to the foregoing consideration, Noventiq shareholders shall be entitled to receive, as additional consideration, one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case, for each Ordinary Share issuable to such Noventiq shareholder at the Effective Time pursuant to the Business Combination Agreement, which provide the holders of such CSRs the contingent right to receive additional newly issued Ordinary Shares (the “Earnout Shares”) upon the occurrence of certain events and subject to certain conditions, as specified under the Business Combination Agreement, during the period from and after the Closing until the fifth anniversary of the Closing (the “Earnout Period”). During the Earnout Period, if New Noventiq experiences a Change of Control (as defined in the Business Combination Agreement), then any Earnout Shares not already earned and issued to the Noventiq shareholders shall be deemed earned and the balance of the Earnout Shares shall be issuable by New Noventiq to the Noventiq shareholders immediately prior to consummation of such Change of Control transaction subject to certain conditions and upon the terms of the Business Combination Agreement.
On May 4, 2023, the Sponsor held 9,825,001 Founder Shares. Of these, 2,500,000 Founder Shares are subject to forfeiture based on the sum of (i) the amount of gross proceeds raised prior to the Effective Time from additional financings, if any, by the Company and (ii) the cash balance of the Company’s Trust Account held for the benefit of its public shareholders, but the consummation of the Proposed Business Combination is not subject to a minimum amount of additional financing having been raised. At the Effective Time, the Founder Shares (net of any forfeited shares) will automatically convert into Ordinary Shares on a
one-for-one
basis, subject to adjustment, on the terms and conditions provided in the Amended and Restated Memorandum and Articles of Association.
An additional 5,000,000 Founder Shares, out of the 9,825,001 Founder Shares described above, will be held in escrow and only released, in three equal installments, upon the occurrence of the same milestone events as the Earnout Shares are issued.
In connection with the Proposed Business Combination and pursuant to the Business Combination Agreement, the Company has agreed to establish a Level 2 ADS facility by entering into a Deposit Agreement with The Bank of New York Mellon (or an affiliate), as depositary, and filing with the Securities and Exchange Commission (the “SEC”) a Registration Statement on
Form F-6 registering
American Depositary Shares (the “ADSs”), each representing one Ordinary Share (the “ADS Facility”).
Following the Closing, each holder of Ordinary Shares will be able to deposit such holder’s shares into the ADS Facility and receive ADSs, which are expected to trade on Nasdaq under the symbol “NVIQ.” Following the Closing, the Company’s outstanding warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer & Trust Company, will remain outstanding and are expected to continue trading on Nasdaq. In connection with the Closing, the ADSs, each representing one Ordinary Share, are expected to be listed on Nasdaq as of the Effective Time.
 
Concurrently with the execution of the Business Combination Agreement, the Sponsor entered into a support agreement with the Company and Noventiq (the “Sponsor Support Agreement”), pursuant to which the Sponsor has agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby; (ii) not to solicit, initiate, submit, facilitate (including by means of furnishing or disclosing information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with any third-party with respect to a CGAC Acquisition Proposal (as defined in the Sponsor Support Agreement); (iii) be bound by certain transfer restrictions with respect to its shares in the Company prior to the closing of the Proposed Business Combination; (iv) not to transfer any of the Restricted Securities (as defined in the Sponsor Support Agreement) from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Sponsor Support Agreement).
Concurrently with the execution of the Business Combination Agreement, the Company, Noventiq and certain shareholders of Noventiq (collectively, the “Noventiq Supporting Shareholders”) duly executed and delivered to the Company a support agreement (the “Voting and Support Agreement”), pursuant to which each Noventiq Supporting Shareholder agreed to, among other things, (i) the Business Combination and the adoption of the Business Combination Agreement any other matters necessary or reasonably requested by Noventiq for consummation of the Business Combination and the other transactions contemplated by the Business Combination Agreement, (ii) not to transfer any Noventiq Shares on or prior to the Closing (subject to the exceptions set forth therein), and (ii) to a
lock-up
of the Noventiq Shares from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Voting and Support Agreement).
The Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor Parties and certain Noventiq shareholders will enter into the Registration Rights Agreement, pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares of the Company, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement.
Extension Meeting
On June 15, 2023, the Company held an extraordinary general meeting of shareholders, which was adjourned and reconvened on June 20, 2023 (the “Extension Meeting”), to amend the Company’s amended and restated memorandum and articles of association (the “Articles Amendment”) to (i) extend the date by which the Company has to consummate a business combination from June 21, 2023 to March 21, 2024 (the “Extended Date”) or such earlier date as shall be determined by the Company’s board of directors in its sole discretion (the “Amended Termination Date” and, such proposal, the “Extension Amendment Proposal”), (ii) eliminate from the amended and restated memorandum and articles of association the limitation that the Company shall not redeem Class A ordinary shares included as part of the units sold in the IPO to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation Amendment Proposal”) and (iii) amend the Company’s amended and restated memorandum and articles of association to provide that Class B ordinary shares may be converted either at the time of the consummation of the Company’s initial business combination or at any earlier date at the option of the holders of Class B ordinary shares (the “Founder Conversion Amendment Proposal”). The shareholders of the Company approved the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal at the Extension Meeting and on June 21, 2023, the Company filed the Articles Amendment with the Registrar of Companies of the Cayman Islands.
In connection with the vote to approve the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal, shareholders elected to redeem 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding.
On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor, the holder of an aggregate of 9,825,001 shares of the Company’s Class B Ordinary Shares, par value $0.0001 per share, elected to convert 9,825,000 shares of the Class B Ordinary Shares held by it on a
one-for-one
basis into Class A Ordinary Shares of the Company, with immediate effect. Following such conversion, the Sponsor holds 9,825,000 shares of Class A Ordinary Shares and 1 share of Class B Ordinary Shares and the Company will have an aggregate of 10,244,938 shares of Class A Ordinary Shares issued and outstanding (419,938 of which are subject to possible redemption) and 175,000 shares of Class B Ordinary Shares issued and outstanding. In connection with the conversion, the Sponsor has agreed to certain transfer restrictions, a waiver of redemption rights, a waiver of any right to receive funds from the Trust Account and the obligation to vote in favor of an initial business combination.
The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination by the Extended Date (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or
pre-initial
Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.
 
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and other requirements of applicable law.
The Sponsor, officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination during the Combination Period and, in such event, such amount will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Going Concern
As of September 30, 2023, the Company had $21,761 in its operating bank accounts, $4,493,902 in the Trust Account to be used for a Business Combination or to repurchase or redeem its ordinary shares in connection therewith and a working capital deficit of $3,467,719.
Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. Based on its current cash and working capital balances, management believes that the Company will not have sufficient working capital to meet its needs through the consummation of a Business Combination.

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. The terms of such loans have not been determined and no written agreements exist with respect to such loans. However, as discussed in Note 4, as of September 30, 2023, the Company is indebted to the Sponsor and its affiliates for $1,622,682, which represents $1,342,682
 
of operating and formation costs paid by these related parties on the Company’s behalf, along with $280,000 
of unpaid administrative fees. The Sponsor is not under any obligation to make additional expenditures on the Company’s behalf.
In connection with our assessment of going concern considerations in accordance with FASB ASC Subtopic
205-40,
“Presentation of Financial Statements-Going Concern” management has determined that the date for mandatory liquidation and dissolution raise substantial doubt about our ability to continue as a going concern for a reasonable period of time, which is considered one year from the issuance of these unaudited condensed consolidated financial statements. The Company demonstrates other adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these unaudited condensed consolidated financial statements. These other adverse conditions are negative financial trends, specifically a working capital deficiency and other adverse key financial ratios. No adjustments have been made to the carrying amounts or classification of assets or liabilities should the Company be required to liquidate after March 20, 2024, our scheduled liquidation date if we do not complete the Business Combination prior to such date. There is no assurance that the Company will complete the Proposed Business Combination with Noventiq before March 24, 2024, or at all.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2022 as filed with the SEC on March 31, 2023. The accompanying condensed consolidated balance sheet as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2022. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Principles of Consolidation
Starting with the second fiscal quarter of 2023, the Company’s unaudited condensed consolidated financial statements include the results of Merger Sub, a direct wholly owned subsidiary of the Company. Merger Sub is a Cayman Islands exempted company which was incorporated on April 4, 2023. Merger Sub was formed solely for the purpose of effectuating the Merger and has not engaged in any business activities or conducted any operations other than in connection with the Merger and has no, and at all times prior to the Merger’s closing except as expressly contemplated by the Merger documents and the related transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation.
All
intercompany balances and transactions have been eliminated in consolidation. For simplicity of presentation, we refer to all accompanying financial statements as condensed consolidated financial statements herein.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Marketable Securities Held in Trust Account
At September 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee.
The Company accounts for any securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Investments - Debt Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securities held in the Trust Account based on quoted prices in active markets (see Note 8 for more information).
Warrant Liabilities
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the unaudited condensed consolidated statements of operations.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheet.
Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional
paid-in
capital and accumulated deficit.
At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:
 
    
Shares
     
Amounts
  
Class A ordinary shares subject to possible redemption—December 31, 2021
      40,000,000      $ 400,000,000  
Less:
                  
Payments to Class A ordinary shareholders for redemption of shares
      (38,808,563 )       (390,414,144 ) 
Due to shareholders
      —         (3,262,655 ) 
Plus:
                  
Remeasurement of carrying value to redemption value
      —         5,903,651  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—December 31, 2022
      1,191,437        12,226,852  
Less:
                  
 
Payments to Class A ordinary shareholders for redemption of shares
      (771,499 )       (11,347,734 ) 
Plus:
                  
Due to shareholders paid in 2023
      —         3,262,655  
Remeasurement of carrying value to redemption value
      —         352,129  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—
September
30, 2023
      419,938      $ 4,493,902  
    
 
 
     
 
 
  
In December of 2022, in connection with the distribution of funds in the Trust Amount to the Company’s shareholders made in connection with the Extraordinary General Meeting (as defined above), funds were deposited from the Trust Account into an operating bank account and held in cash. As of December 31, 2022, $3,262,655 of the December 2022 redemption was not paid out to the shareholders and was classified as Due to shareholders on the condensed consolidated balance sheet. In January 2023, upon completion of the distribution of funds in the amount of $3,262,655 to shareholders made in connection with the Extraordinary General Meeting, the Company
re-deposited
the remaining funds into the Trust Account.
As part of the Extension Meeting, shareholders elected to redeem an additional 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share. $370,088 was paid out to redeeming Class A ordinary shares as their proportionate share of trust earnings through the redemption date and is the difference between the redemption amount per share and the original $10.00 per share times the number of shares redeemed.
During the nine months ended September 30, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $352,129 to reflect current earnings of the Trust Account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Fair value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheet, primarily due to their short-term nature.
 
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three and nine months ended September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share
Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,933,333
of the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share for all periods presented, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2023 and 2022.
The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts):
 
    
For the Three Months Ended
     
For the Nine Months Ended
    
For the Three Months Ended
     
For the Nine Months Ended
  
    
September 30, 2023
     
September 30, 202
3
    
September 30, 2022
     
September 30, 2022
  
    
Class A

Redeemable
     
Class A and
Nonredeemable
and

Class B
     
Class A
Redeemable
    
Class A
Nonredeemable
and Class B
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income (loss) per ordinary share:
                                                                      
Numerator:
                                                                      
Allocation of net income (loss)
    $ 27,467      $ 654,082      $ (249,130 )    $ (2,758,354 )    $ 1,776,202      $ 444,051      $ 12,294,785      $ 3,073,696  
Denominator:
                                                                      
Basic and diluted weighted average ordinary shares outstanding
      419,938        10,000,000        903,185       10,000,000       40,000,000        10,000,000        40,000,000        10,000,000  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income (loss) per ordinary share
    $ 0.07      $ 0.07      $ (0.28 )    $ (0.28 )    $ 0.04      $ 0.04      $ 0.31      $ 0.31  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
In June 2016, FASB issued ASU
2016-13,
Measurement of Credit Losses on Financial Instruments (“ASU
2016-13”).
ASU
2016-13
changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU
2016-13
as of January 1, 2023, with no impact to its condensed consolidated financial statements because the Company does not have financial assets within the scope of ASU
2016-13.
 
The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.
Risks and Uncertainties
Management is currently evaluating the impact of the
COVID-19
pandemic on its condensed consolidated financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed consolidated financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Initial Public Offering
 9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Initial Public Offering
Note 3 — Initial Public Offering
Pursuant to the Initial Public Offering, the Company sold 40,000,000 Units at a price of $10.00 per Unit, which includes the partial exercise by the underwriter of the overallotment option to purchase an additional 5,000,000 Units. Each Unit consists of one Class A ordinary share and
one-third
of one redeemable warrant (each, a “Public Warrant”), each whole Public Warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
Note 4 — Related Party Transactions
Founder Shares
On October 28, 2020, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 8,625,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). In November 2020, the Sponsor transferred 50,000 Class B ordinary shares to each of the Company’s independent directors. On December 16, 2020, the Company effected a share capitalization, resulting in 10,062,500 Founder Shares issued and outstanding as of such date. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination, or earlier at the option of the holder, on a
one-for-one
basis, subject to certain adjustments, as described in Note 7. As a result of the underwriters’ election to partially exercise their over-allotment option, 62,500 Founder Shares were forfeited for no consideration on December 23, 2020, resulting in 10,000,000 Class B ordinary shares outstanding. The per share price of the Founder Shares was determined by dividing the amount contributed to the Company by the number of Founder Shares issued. The Founder Shares will be worthless if we do not complete an initial Business Combination (see Note 1).
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares or Class A ordinary shares received upon conversion thereof until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
The Company’s Founder Shares are subject to transfer restrictions pursuant to
lock-up
provisions in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. The Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares. Prior to the closing of the Initial Public Offering, the Sponsor transferred 150,000 Founder Shares to our three independent directors in recognition of and as compensation for their future services to the Company. The transfer of Founder Shares
 
to these directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. Compensation expense related to the Founder Shares is recognized only when the performance condition (i.e. the remediation of the
lock-up
provision) is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date the
lock-up
provisions have been remediated, or are probable to be remediated, in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the transfer of the Founder Shares. As of September 30, 2023, the Company has entered into a definitive agreement in connection with a potential Business Combination, but the Business Combination has not yet closed and as such, the
lock-up
provisions have not been remediated and are not probable to be remediated. Any definitive agreements in connection with a Business Combination may also be subject to certain conditions to closing, such as approval by the Company’s shareholders. As a result, the Company determined that, taking into account that there is a possibility that the Business Combination may not close, no stock-based compensation expense should be recognized through September 30, 2023.
Private Placement Warrants
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,600,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant for an aggregate purchase price of $11,400,000. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.
The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.
Working Capital Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $1.50 per warrant. As of the date of this filing, September 30, 2023 and December 31, 2022, the Company had no borrowings under any Working Capital Loans.
Administrative Services Agreement
Pursuant to an administrative services agreement (the “Administrative Services Agreement”) entered into on December 17, 2020, the Company agreed to pay the Sponsor a total of $40,000 per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team until the earlier of (A) the Company’s completion of the initial Business Combination or December 21, 2022 and (B) on December 21, 2022, an amount equal to $960,000 less the actual amount paid under the Administrative Services Agreement. For the three and nine months ended September 30, 2023, the Company incurred $0 in fees for these services. For the three and nine months ended September 30, 2022, the Company incurred $120,000 and $360,000 in fees for these services, respectively, which is included in operating and formation costs on the unaudited condensed consolidated statements of operations. As of September 30, 2023 and December 31, 2022, there were $280,000 and $320,000 in fees outstanding for these services, respectively, that are included in due to related party on the condensed consolidated balance sheets. Notwithstanding the foregoing, on November 18, 2021, the Sponsor permanently waived its right to receive any of the Company’s outstanding, and all of the Company’s remaining, payment obligations under the Administrative Services Agreement.
Operating and Formation Costs
As of September 30, 2023 and December 31, 2022, the Sponsor and affiliates of the Sponsor also paid operating and formation costs of $
1,342,682
 and $202,500, respectively, on behalf of the Company which are due on demand. These amounts are included in due to related party on the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. The Sponsor is not under any obligation to make additional expenditures on the Company’s beh
alf.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 5 — Commitments and Contingencies
Registration Rights
The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement entered in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, these holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
As further described in Note 1 and as such terms used herein are defined therein, the Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor and certain Noventiq shareholders will enter into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement.
Underwriting Agreement
After the Initial Public Offering, the underwriters were entitled to a deferred fee of $0.35 per Unit, or $14,000,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of a Business Combination, as originally set forth in the underwriting agreement. The Company accounted for this forfeiture during the fourth calendar quarter of the year ended December 31, 2022.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Warrant Liabilities
 9 Months Ended
Sep. 30, 2023
Warrant Liability Disclosure [Abstract]  
Warrant Liabilities
Note 6 — Warrant Liabilities
The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and, following the effective date of the registration statement, the Company will use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital-raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, plus interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A ordinary shares during the
10-trading
day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of
 
the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
Once the warrants become exercisable, the Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants if they are held by the Sponsor or its permitted transferees):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
In addition, once the warrants become exercisable, the Company may call the warrants for redemption:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares;
 
  •  
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the
30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
  •  
if the closing price of the Class A ordinary shares for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event are the warrants to be exercisable in connection with this redemption feature for more than 0.361
Class A ordinary shares per warrant (subject to adjustment).
If the Company calls the Public Warrants for redemption, management has the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event is the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Following the Closing, the Company’s public warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer & Trust Company, will remain outstanding and are expected to continue trading on Nasdaq.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders' Deficit
 9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Shareholders' Deficit
Note 7 — Shareholders’ Deficit
Preference Shares
— The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
 
Class
 A Ordinary Shares
— The Company is authorized to issue 300,000,000 Class A ordinary shares with a par value of $0.0001 per share. At December 31, 2022, there were 1,191,437 Class A ordinary shares issued or outstanding, all of which are considered temporary equity. On June 20, 2023, in connection with the Extension Meeting, shareholders elected to redeem 771,499 additional Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding. On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor elected to convert 9,825,000 shares of the Class B ordinary shares held by it on a
one-for-one
basis into Class A ordinary shares of the Company, with immediate effect. Following such conversion, the Sponsor holds 9,825,000 shares of Class A ordinary shares and at September 30, 2023, the Company has an aggregate of 10,244,938 shares of Class A ordinary shares (419,938 of which are subject to possible redemption) issued and outstanding. The Sponsor’s 9,825,000 Class A ordinary shares received in connection with the conversion are not redeemable.
Class
 B Ordinary Shares
— The Company is authorized to issue 30,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each Class B ordinary share. At December 31, 2022, there were 10,000,000 Class B ordinary shares issued and outstanding. On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor elected to convert 9,825,000 shares of the Class B ordinary shares held by it on a
one-for-one
basis into Class A ordinary shares of the Company, with immediate effect. Following such conversion and at September 30, 2023, the Company has an aggregate of 175,000 shares of Class B ordinary shares issued and outstanding.
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the appointment of the Company’s directors prior to the initial Business Combination.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a
one-for-one
basis (as adjusted). In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the sum of the total number of Class A ordinary shares and Class B ordinary shares issued upon completion of the Initial Public Offering plus the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than
one-for-one
basis.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 8 — Fair Value Measurements
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3:    Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
Description
   
Level
     
September 30,
2023
     
December 31,
2022
  
Assets:
                           
Cash and Marketable securities held in Trust Account
      1      $ 4,493,902      $ 15,489,507  
             
 
 
     
 
 
  
At September 30, 2023 and December 31, 2022, $0 and $15,489,507, respectively, of the balance held in the Trust Account was held in cash.
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
Description
   
Level
     
September 30,
2023
     
Level
     
December 31,
2022
  
Liabilities:
                                    
Warrant liability—Public Warrants
      1      $ 1,066,666        1      $ 400,000  
Warrant liability—Private Placement Warrants
      3      $ 608,000        3      $ 228,000  
             
 
 
              
 
 
  
Total warrant liabilities
             $ 1,674,666               $ 628,000  
             
 
 
              
 
 
  
The Warrants are accounted for as liabilities in accordance with ASC
815-40
and are presented within the warrant liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of the warrant liabilities in the condensed consolidated statements of operations.
Initial Measurement and Subsequent Measurement
The Company established the initial fair value for the Public Warrants on December 21, 2020, the date of the consummation of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and
one-third
of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of shares of Class B ordinary shares, based on their fair values as determined at initial measurement, Class A ordinary shares and Class B ordinary shares based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.
The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2023 and December 31, 2022 is classified as Level 1 due to quoted prices in an active market since February 8, 2021. The Private Placement Warrants as of September 30, 2023 and December 31, 2022 are classified as Level 3 due to the use of unobservable inputs.
The Monte Carlo model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing since February 8, 2021. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date.
The key inputs into the Monte Carlo simulation model for the Private Placement warrants at September 30, 2023 and December 31, 2022 were as follows:

 
  
September 30, 2023
 
 
December 31, 2022
 
Input
  
 
Risk-free interest rate
      4.50 %      3.99 % 
Expected term (years)
      5.48       5.0  
Expected volatility
      5.4 %      0.8 % 
Exercise price
    $ 11.50     $ 11.50  
Fair value of the ordinary share price
    $ 10.96     $ 9.89  
Redemption threshold price
    $ 18.00     $ 18.00  
Redemption threshold days
     
20 days within any
30-day
period
  
 
    
20 days within any
30-day
period
  
 
Redemption price
    $ 0.01     $ 0.01  
As of September 30, 2023, the Public Warrants and Private Placement Warrants were determined to be $0.08 and $0.08 per warrant for aggregate values of approximately $1.1 million and $0.6 million, respectively. As of December 31, 2022, the Public Warrants and Private Placement Warrants were determined to be $0.03 and $0.03, respectively, per warrant for aggregate values of approximately $0.4 million and $0.2 million, respectively.
The following table presents the changes in the fair value of warrant liabilities:
 
    
Private Placement
     
Public
     
Warrant Liabilities
  
Fair value as of December 31, 2022
    $ 228,000      $ 400,000      $ 628,000  
Change in valuation inputs or other assumptions
      760,000        1,333,333        2,093,333  
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2023
      988,000        1,733,333        2,721,333  
Change in valuation inputs or other assumptions
      (380,000 )       (666,667 )       (1,046,667 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of September 30, 2023
    $ 608,000      $ 1,066,666      $ 1,674,666  
    
 
 
     
 
 
     
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value as of December 31, 2021
   
$

 5,320,000     
$

 9,200,000     
$

 14,520,000  
Change in valuation inputs or other assumptions
      (4,935,440 )       (8,525,333 )       (13,460,773 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2022
      384,560        674,667        1,059,227  
Change in valuation inputs or other assumptions
      (232,560 )       (408,000 )       (640,560 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of September 30, 2022
    $ 152,000      $ 266,667      $ 418,667  
    
 
 
     
 
 
     
 
 
  
Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three and nine months ended September 30, 2023 and 2022.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
 9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events
Note 9 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred up to the date condensed consolidated financial statements were issued. Based upon this review, the Company did not identify any other subsequent events, not previously disclosed, that would have required adjustment or disclosure in the condensed consolidated financial statements, except as described below.
On October 4, 2023, the Company transferred its ordinary share of the Merger Sub to New Noventiq. As a result, the Company will no longer have an ownership interest in the Merger Sub. Starting with the fourth quarter of 2023, the Company’s financial statements will no longer be presented on a consolidated basis.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation
Starting with the second fiscal quarter of 2023, the Company’s unaudited condensed consolidated financial statements include the results of Merger Sub, a direct wholly owned subsidiary of the Company. Merger Sub is a Cayman Islands exempted company which was incorporated on April 4, 2023. Merger Sub was formed solely for the purpose of effectuating the Merger and has not engaged in any business activities or conducted any operations other than in connection with the Merger and has no, and at all times prior to the Merger’s closing except as expressly contemplated by the Merger documents and the related transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation.
All
intercompany balances and transactions have been eliminated in consolidation. For simplicity of presentation, we refer to all accompanying financial statements as condensed consolidated financial statements herein.
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2022 as filed with the SEC on March 31, 2023. The accompanying condensed consolidated balance sheet as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2022. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Use of Estimates
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Marketable Securities Held in Trust Account
Marketable Securities Held in Trust Account
At September 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee.
The Company accounts for any securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Investments - Debt Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securities held in the Trust Account based on quoted prices in active markets (see Note 8 for more information).
Warrant Liabilities
Warrant Liabilities
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the unaudited condensed consolidated statements of operations.
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheet.
Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional
paid-in
capital and accumulated deficit.
At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:
 
    
Shares
     
Amounts
  
Class A ordinary shares subject to possible redemption—December 31, 2021
      40,000,000      $ 400,000,000  
Less:
                  
Payments to Class A ordinary shareholders for redemption of shares
      (38,808,563 )       (390,414,144 ) 
Due to shareholders
      —         (3,262,655 ) 
Plus:
                  
Remeasurement of carrying value to redemption value
      —         5,903,651  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—December 31, 2022
      1,191,437        12,226,852  
Less:
                  
 
Payments to Class A ordinary shareholders for redemption of shares
      (771,499 )       (11,347,734 ) 
Plus:
                  
Due to shareholders paid in 2023
      —         3,262,655  
Remeasurement of carrying value to redemption value
      —         352,129  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—
September
30, 2023
      419,938      $ 4,493,902  
    
 
 
     
 
 
  
In December of 2022, in connection with the distribution of funds in the Trust Amount to the Company’s shareholders made in connection with the Extraordinary General Meeting (as defined above), funds were deposited from the Trust Account into an operating bank account and held in cash. As of December 31, 2022, $3,262,655 of the December 2022 redemption was not paid out to the shareholders and was classified as Due to shareholders on the condensed consolidated balance sheet. In January 2023, upon completion of the distribution of funds in the amount of $3,262,655 to shareholders made in connection with the Extraordinary General Meeting, the Company
re-deposited
the remaining funds into the Trust Account.
As part of the Extension Meeting, shareholders elected to redeem an additional 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share. $370,088 was paid out to redeeming Class A ordinary shares as their proportionate share of trust earnings through the redemption date and is the difference between the redemption amount per share and the original $10.00 per share times the number of shares redeemed.
During the nine months ended September 30, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $352,129 to reflect current earnings of the Trust Account.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts.
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Fair Value of Financial Instruments
Fair value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheet, primarily due to their short-term nature.
Income Taxes
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three and nine months ended September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share
Net Income (Loss) Per Ordinary Share
Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,933,333
of the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share for all periods presented, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2023 and 2022.
The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts):
 
    
For the Three Months Ended
     
For the Nine Months Ended
    
For the Three Months Ended
     
For the Nine Months Ended
  
    
September 30, 2023
     
September 30, 202
3
    
September 30, 2022
     
September 30, 2022
  
    
Class A

Redeemable
     
Class A and
Nonredeemable
and

Class B
     
Class A
Redeemable
    
Class A
Nonredeemable
and Class B
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income (loss) per ordinary share:
                                                                      
Numerator:
                                                                      
Allocation of net income (loss)
    $ 27,467      $ 654,082      $ (249,130 )    $ (2,758,354 )    $ 1,776,202      $ 444,051      $ 12,294,785      $ 3,073,696  
Denominator:
                                                                      
Basic and diluted weighted average ordinary shares outstanding
      419,938        10,000,000        903,185       10,000,000       40,000,000        10,000,000        40,000,000        10,000,000  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income (loss) per ordinary share
    $ 0.07      $ 0.07      $ (0.28 )    $ (0.28 )    $ 0.04      $ 0.04      $ 0.31      $ 0.31  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In June 2016, FASB issued ASU
2016-13,
Measurement of Credit Losses on Financial Instruments (“ASU
2016-13”).
ASU
2016-13
changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU
2016-13
as of January 1, 2023, with no impact to its condensed consolidated financial statements because the Company does not have financial assets within the scope of ASU
2016-13.
 
The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.
Risks and Uncertainties
Risks and Uncertainties
Management is currently evaluating the impact of the
COVID-19
pandemic on its condensed consolidated financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed consolidated financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Temporary Equity
At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:
 
    
Shares
     
Amounts
  
Class A ordinary shares subject to possible redemption—December 31, 2021
      40,000,000      $ 400,000,000  
Less:
                  
Payments to Class A ordinary shareholders for redemption of shares
      (38,808,563 )       (390,414,144 ) 
Due to shareholders
      —         (3,262,655 ) 
Plus:
                  
Remeasurement of carrying value to redemption value
      —         5,903,651  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—December 31, 2022
      1,191,437        12,226,852  
Less:
                  
 
Payments to Class A ordinary shareholders for redemption of shares
      (771,499 )       (11,347,734 ) 
Plus:
                  
Due to shareholders paid in 2023
      —         3,262,655  
Remeasurement of carrying value to redemption value
      —         352,129  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption—
September
30, 2023
      419,938      $ 4,493,902  
    
 
 
     
 
 
  
Summary of Basic and Diluted Net Income Per Share
The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts):
 
    
For the Three Months Ended
     
For the Nine Months Ended
    
For the Three Months Ended
     
For the Nine Months Ended
  
    
September 30, 2023
     
September 30, 202
3
    
September 30, 2022
     
September 30, 2022
  
    
Class A

Redeemable
     
Class A and
Nonredeemable
and

Class B
     
Class A
Redeemable
    
Class A
Nonredeemable
and Class B
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income (loss) per ordinary share:
                                                                      
Numerator:
                                                                      
Allocation of net income (loss)
    $ 27,467      $ 654,082      $ (249,130 )    $ (2,758,354 )    $ 1,776,202      $ 444,051      $ 12,294,785      $ 3,073,696  
Denominator:
                                                                      
Basic and diluted weighted average ordinary shares outstanding
      419,938        10,000,000        903,185       10,000,000       40,000,000        10,000,000        40,000,000        10,000,000  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income (loss) per ordinary share
    $ 0.07      $ 0.07      $ (0.28 )    $ (0.28 )    $ 0.04      $ 0.04      $ 0.31      $ 0.31  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
  
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Fair Value Assets Measured On Recurring Basis
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
Description
   
Level
     
September 30,
2023
     
December 31,
2022
  
Assets:
                           
Cash and Marketable securities held in Trust Account
      1      $ 4,493,902      $ 15,489,507  
             
 
 
     
 
 
  
Summary of Fair Value Liabilities Measured On Recurring Basis
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
Description
   
Level
     
September 30,
2023
     
Level
     
December 31,
2022
  
Liabilities:
                                    
Warrant liability—Public Warrants
      1      $ 1,066,666        1      $ 400,000  
Warrant liability—Private Placement Warrants
      3      $ 608,000        3      $ 228,000  
             
 
 
              
 
 
  
Total warrant liabilities
             $ 1,674,666               $ 628,000  
             
 
 
              
 
 
  
Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants [Table Text Block]
The key inputs into the Monte Carlo simulation model for the Private Placement warrants at September 30, 2023 and December 31, 2022 were as follows:

 
  
September 30, 2023
 
 
December 31, 2022
 
Input
  
 
Risk-free interest rate
      4.50 %      3.99 % 
Expected term (years)
      5.48       5.0  
Expected volatility
      5.4 %      0.8 % 
Exercise price
    $ 11.50     $ 11.50  
Fair value of the ordinary share price
    $ 10.96     $ 9.89  
Redemption threshold price
    $ 18.00     $ 18.00  
Redemption threshold days
     
20 days within any
30-day
period
  
 
    
20 days within any
30-day
period
  
 
Redemption price
    $ 0.01     $ 0.01  
Summary of Fair Value of Warrant Liabilities
The following table presents the changes in the fair value of warrant liabilities:
 
    
Private Placement
     
Public
     
Warrant Liabilities
  
Fair value as of December 31, 2022
    $ 228,000      $ 400,000      $ 628,000  
Change in valuation inputs or other assumptions
      760,000        1,333,333        2,093,333  
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2023
      988,000        1,733,333        2,721,333  
Change in valuation inputs or other assumptions
      (380,000 )       (666,667 )       (1,046,667 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of September 30, 2023
    $ 608,000      $ 1,066,666      $ 1,674,666  
    
 
 
     
 
 
     
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value as of December 31, 2021
   
$

 5,320,000     
$

 9,200,000     
$

 14,520,000  
Change in valuation inputs or other assumptions
      (4,935,440 )       (8,525,333 )       (13,460,773 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2022
      384,560        674,667        1,059,227  
Change in valuation inputs or other assumptions
      (232,560 )       (408,000 )       (640,560 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of September 30, 2022
    $ 152,000      $ 266,667      $ 418,667  
    
 
 
     
 
 
     
 
 
  
Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three and nine months ended September 30, 2023 and 2022.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Description of Organization and Business Operations - Additional Information (Detail) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Dec. 20, 2023
Jun. 21, 2023
Jun. 20, 2023
Jun. 01, 2023
May 04, 2023
Dec. 20, 2022
Dec. 21, 2020
Jan. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Entity incorporation, date of incorporation                 Oct. 20, 2020      
Share price                 $ 10      
Percentage of redeeming shares of public shares without the company's prior written consent                 15.00%      
Percentage of public shares to be redeemed on non completion of business combination                 100.00%      
Dissolution expense                 $ 100,000      
Cash                 21,761   $ 31,547  
Assets held-in-trust                 4,493,902      
Working capital (deficit)                 3,467,719      
Temporary equity accretion to redemption value               $ 3,262,655 $ 352,129 $ 2,701,284    
Temporary equity shares outstanding                 419,938   1,191,437 40,000,000
Due to related party                 $ 1,622,682   $ 522,500  
Number of stock bought back by the entity at the exercise price or redemption price.                 771,499   38,808,563  
Cash withdrawn from trust account for redeemption of stock     $ 370,088                  
Noventiq Holdings PLC [Member]                        
Common stock par or stated value per share         $ 0.0001              
Share price         $ 10              
Equity value of expected business acquisition          $ 877,000,000              
Bussiness combination additional earnt out shares description         one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case              
Operating And Formation Costs [Member]                        
Related Party Transaction, Amounts of Transaction                 $ 1,342,682   $ 202,500  
Administrative Services Agreement [Member]                        
Due to related party                 280,000   $ 320,000  
Minimum [Member]                        
Net tangible assets required for consummation of business combination     $ 5,000,001           5,000,001      
Sponsor [Member]                        
Common stock shares outstanding         9,825,001              
Common Stock Subject to Forfeiture         2,500,000              
Common Stock Held in Escrow Account         5,000,000              
Sponsor [Member] | Conversion of Class B to Class A Common Stock [Member]                        
Common stock par or stated value per share   $ 0.0001                    
Conversion of stock, shares issued   9,825,000   9,825,000                
Conversion of stock, description   one-for-one                    
Sponsor [Member] | Operating And Formation Costs [Member]                        
Related Party Transaction, Amounts of Transaction                 1,342,682      
Sponsor [Member] | Administrative Services Agreement [Member]                        
Due to related party                 280,000      
Related Party Transaction, Amounts of Transaction                 $ 40,000      
Sponsor [Member] | Private Placement Warrants [Member]                        
Class of warrants and rights issued during the period             7,600,000   7,600,000      
Class of warrants and rights issued, price per warrant             $ 1.5   $ 1.5      
Proceeds from issuance of warrants             $ 11,400,000   $ 11,400,000      
Related Party [Member]                        
Due to related party                 $ 1,622,682      
Common Class A [Member]                        
Common stock par or stated value per share                 $ 0.0001   $ 0.0001  
Temporary equity par or stated value per share                 $ 0.0001      
Stock issued during period, stock options exercised           38,808,563            
Temporary equity accretion to redemption value $ 393,676,799                      
Temproary equity redemption price, per share           $ 10.14            
Temporary equity redemption earnings in the trust account not previously withdrawn           $ 5,591,169            
Common stock shares outstanding     419,938           9,825,000   0  
Common stock shares issued                 9,825,000   0  
Temporary equity shares outstanding                 419,938   1,191,437  
Temporary equity shares issued     419,938               1,191,437  
Number of stock bought back by the entity at the exercise price or redemption price.     771,499           771,499      
Value of stock bought back by the entity at the exercise price or redemption price     $ 8,085,078           $ 8,085,078      
Stock redeemption price     $ 10.48           $ 10.48      
Cash withdrawn from trust account for redeemption of stock     $ 370,088                  
Aggregate common shares outstanding                 10,244,938      
Aggregate common shares issued                 10,244,938      
Common Class A [Member] | Sponsor [Member]                        
Common stock shares outstanding                 9,825,000      
Common Class B [Member]                        
Common stock par or stated value per share                 $ 0.0001   $ 0.0001  
Common stock shares outstanding                 175,000   10,000,000  
Common stock shares issued                 175,000   10,000,000  
Common Class B [Member] | Sponsor [Member]                        
Common stock shares outstanding   9,825,001             1      
IPO [Member]                        
Transaction costs of share issuance                 $ 22,766,081      
Underwriting expenses on issuance of shares                 8,000,000      
Deferred Underwriting Fees           4,000,000     14,000,000      
Other offering costs                 $ 766,081      
Deferred fee forfeited           10,000,000            
Deferred fee payable in cash           $ 14,000,000            
IPO [Member] | Common Class A [Member]                        
Stock issued during period shares             40,000,000   40,000,000      
Shares issued price per share             $ 10   $ 10      
Proceeds from issuance of IPO             $ 400,000,000          
Common stock par or stated value per share             $ 0.0001          
Restricted investments term             185 days          
Over-Allotment Option [Member] | Common Class A [Member]                        
Stock issued during period shares             5,000,000   5,000,000      
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Jun. 20, 2023
Jan. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Cash equivalents     $ 0 $ 0
FDIC insured     250,000  
Unrecognized tax benefits     0 0
Accrued for interest and penalties     $ 0 $ 0
Number of stock bought back by the entity at the exercise price or redemption price.     771,499 38,808,563
Share price     $ 10  
Aggregate cash withdrawn from trust account for redeemption of stock     $ 370,088  
Other liabilities current     1,622,682 $ 522,500
Payments to Acquire Restricted Investments   $ 3,262,655    
Related Party [Member]        
Other liabilities current     1,622,682  
Related Party [Member] | Shareholders [Member]        
Other liabilities current       $ 3,262,655
Common Class A [Member]        
Increase In carrying amount of subject to possible redemption     $ 352,129  
Number of stock bought back by the entity at the exercise price or redemption price. 771,499   771,499  
Value of stock bought back by the entity at the exercise price or redemption price $ 8,085,078   $ 8,085,078  
Stock redeemption price $ 10.48   $ 10.48  
Warrant [Member]        
Antidilutive securities excluded from computation of earnings per share     20,933,333  
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail) - USD ($)
 9 Months Ended 12 Months Ended
Jun. 20, 2023
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Temporary Equity [Line Items]        
Payments to Class A ordinary shareholders for redemption of shares   $ (11,347,734)    
Class A ordinary shares subject to possible redemption   $ 4,493,902 $ 12,226,852  
Class A ordinary shares subject to possible redemption   419,938 1,191,437 40,000,000
Payments to Class A ordinary shareholders for redemption of shares   (771,499) (38,808,563)  
Common Class A [Member]        
Temporary Equity [Line Items]        
Payments to Class A ordinary shareholders for redemption of shares   $ (11,347,734) $ (390,414,144)  
Remeasurement of carrying value to redemption value   352,129 5,903,651  
Class A ordinary shares subject to possible redemption   $ 4,493,902 $ 12,226,852 $ 400,000,000
Class A ordinary shares subject to possible redemption   419,938 1,191,437  
Payments to Class A ordinary shareholders for redemption of shares (771,499) (771,499)    
Common Class A [Member] | Related Party [Member]        
Temporary Equity [Line Items]        
Due to Shareholders Paid   $ 3,262,655 $ (3,262,655)  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Common Class A [Member]        
Numerator: Net Income (loss) minus Net Earnings        
Allocation of net income (loss)   $ 1,776,202   $ 12,294,785
Denominator [Abstract]        
Basic weighted average shares outstanding   40,000,000   40,000,000
Diluted weighted average shares outstanding   40,000,000   40,000,000
Basic net income (loss) per ordinary share   $ 0.04   $ 0.31
Diluted net income (loss) per ordinary share   $ 0.04   $ 0.31
Common Class B [Member]        
Numerator: Net Income (loss) minus Net Earnings        
Allocation of net income (loss)   $ 444,051   $ 3,073,696
Denominator [Abstract]        
Basic weighted average shares outstanding   10,000,000   10,000,000
Diluted weighted average shares outstanding   10,000,000   10,000,000
Basic net income (loss) per ordinary share   $ 0.04   $ 0.31
Diluted net income (loss) per ordinary share   $ 0.04   $ 0.31
Class A Redeemable [Member]        
Numerator: Net Income (loss) minus Net Earnings        
Allocation of net income (loss) $ 27,467   $ (249,130)  
Denominator [Abstract]        
Basic weighted average shares outstanding 419,938 40,000,000 903,185 40,000,000
Diluted weighted average shares outstanding 419,938 40,000,000 903,185 40,000,000
Basic net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Diluted net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Class A Nonredeemable and Class B [Member]        
Numerator: Net Income (loss) minus Net Earnings        
Allocation of net income (loss) $ 654,082   $ (2,758,354)  
Denominator [Abstract]        
Basic weighted average shares outstanding 10,000,000 10,000,000 10,000,000 10,000,000
Diluted weighted average shares outstanding 10,000,000 10,000,000 10,000,000 10,000,000
Basic net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
Diluted net income (loss) per ordinary share $ 0.07 $ 0.04 $ (0.28) $ 0.31
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Initial Public Offering - Additional Information (Detail) - $ / shares
 9 Months Ended
Dec. 21, 2020
Sep. 30, 2023
Public Warrants [Member]    
Exercise price of warrant   $ 11.5
Common Class A [Member]    
Stock conversion basis   Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a “Public Warrant”)
Shares issuable per warrant   1
Common Class A [Member] | Public Warrants [Member]    
Shares issuable per warrant   1
Exercise price of warrant   $ 11.5
Common Class A [Member] | IPO [Member]    
Stock issued during period shares 40,000,000 40,000,000
Shares issued price per share $ 10 $ 10
Common Class A [Member] | Over-Allotment Option [Member]    
Stock issued during period shares 5,000,000 5,000,000
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions - Additional Information (Detail) - USD ($)
 2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 21, 2020
Nov. 30, 2020
Oct. 28, 2020
Dec. 31, 2020
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jun. 21, 2023
Jun. 20, 2023
May 04, 2023
Dec. 16, 2020
Minimum lock In period for transfer, assign or sell warrants after completion of IPO             30 days            
Due to related parties current         $ 1,622,682   $ 1,622,682   $ 522,500        
Sale of Stock, Number of Shares Issued in Transaction       150,000                  
Working Capital Loan [Member]                          
Debt instrument convertible into warrants         $ 1,500,000   $ 1,500,000            
Debt instrument conversion price         $ 1.5   $ 1.5            
Due to related parties current         $ 0   $ 0   0        
Administrative Services Agreement [Member]                          
Due to related parties current         $ 280,000   280,000   320,000        
Operating And Formation Costs [Member]                          
Related party transaction, amounts of transaction             $ 1,342,682   $ 202,500        
Public Warrants [Member]                          
Exercise price of warrant         $ 11.5   $ 11.5            
Sponsor [Member]                          
Common stock shares outstanding                       9,825,001  
Sponsor [Member] | Administrative Services Agreement [Member]                          
Due to related parties current         $ 280,000   $ 280,000            
Related party transaction, amounts of transaction             40,000            
Maximum threshold on administrative support expense         960,000   960,000            
Related party transaction accrued expenses from transactions with related party         $ 0 $ 120,000 0 $ 360,000          
Sponsor [Member] | Operating And Formation Costs [Member]                          
Related party transaction, amounts of transaction             $ 1,342,682            
Sponsor [Member] | Private Placement Warrants [Member]                          
Class of warrants and rights issued during the period 7,600,000           7,600,000            
Class of warrants and rights issued, price per warrant $ 1.5       $ 1.5   $ 1.5            
Proceeds from issuance of warrants $ 11,400,000           $ 11,400,000            
Sponsor [Member] | Share Price More Than Or Equals To USD Twelve [Member]                          
Share transfer, trigger price per share.         12   $ 12            
Number of consecutive trading days for determining share price             20 days            
Number of trading days for determining share price             30 days            
Threshold number of trading days for determining share price from date of business combination             150 days            
Common Class B [Member]                          
Common stock par or stated value per share         $ 0.0001   $ 0.0001   $ 0.0001        
Common stock shares issued         175,000   175,000   10,000,000        
Common stock shares outstanding         175,000   175,000   10,000,000        
Common Class B [Member] | Sponsor [Member]                          
Common stock shares outstanding         1   1     9,825,001      
Number of founder shares transferred   50,000                      
Common Class A [Member]                          
Common stock par or stated value per share         $ 0.0001   $ 0.0001   $ 0.0001        
Common stock shares issued         9,825,000   9,825,000   0        
Common stock shares outstanding         9,825,000   9,825,000   0   419,938    
Shares issuable per warrant         1   1            
Common Class A [Member] | Public Warrants [Member]                          
Shares issuable per warrant         1   1            
Exercise price of warrant         $ 11.5   $ 11.5            
Common Class A [Member] | Sponsor [Member]                          
Common stock shares outstanding         9,825,000   9,825,000            
Founder Shares [Member] | Common Class B [Member] | Sponsor [Member]                          
Stock shares issued during the period for services value     $ 25,000                    
Shares issued price per share     $ 0.003                    
Stock issued during period, shares, issued for services     8,625,000                    
Common stock par or stated value per share     $ 0.0001                    
Common stock shares issued                         10,062,500
Common stock shares outstanding         10,000,000   10,000,000            
Stock forfeited during period, shares             62,500            
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments - Additional Information (Detail) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 20, 2022
Loss Contingencies [Line Items]      
Deferred underwriting fee per unit $ 0.35    
Deferred underwriting fee payable noncurrent $ 4,000,000 $ 4,000,000  
IPO [Member]      
Loss Contingencies [Line Items]      
Deferred underwriting fee payable noncurrent 14,000,000    
Deferred fee forfeited     $ 10,000,000
Deferred fee payable in cash     14,000,000
Deferred underwriting fees $ 14,000,000   $ 4,000,000
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Warrant Liabilities - Additional Information (Detail)
 9 Months Ended
Sep. 30, 2023
$ / shares
Share Price $ 10
Percentage of capital raised for business combination to total equity proceeds 60.00%
Share Price More Than Or Equals To USD Eighteen [Member]  
Number of consecutive trading days for determining share price 20 days
Share Price $ 18
Class of warrants, redemption price per unit $ 0.01
Class of warrants, redemption notice period 30 days
Number of trading days for determining share price 30 days
Share Price Less Than Or Equals To USD Eighteen [Member]  
Number of consecutive trading days for determining share price 20 days
Share Price $ 10
Class of warrants, redemption price per unit $ 0.1
Class of warrants, redemption notice period 30 days
Number of trading days for determining share price 30 days
Common Stock [Member] | Share Price Less Than Or Equals To USD Nine Point Two [Member]  
Class of warrant or right, redemption price adjustment percentage 115.00%
Common Stock [Member] | Share Price More Than Or Equals To USD Eighteen [Member]  
Share Price $ 18
Class of warrant or right, redemption price adjustment percentage 180.00%
Common Stock [Member] | Share Price Less Than Or Equals To USD Eighteen [Member]  
Share Price $ 10
Common Class A [Member] | Common Stock [Member]  
Number of consecutive trading days for determining share price 10 days
Share Price $ 9.2
Fair market value per share 0.361
Public Warrants [Member]  
Exercise price of warrant $ 11.5
Warrants exercisable term from the date of completion of business combination 30 days
Warrants exercisable term from the closing of IPO 12 months
Minimum lock In period For SEC Registration From Date Of Business Combination 15 days
Minimum lock In period to become effective after the closing of the initial Business Combination 60 days
Public Warrants [Member] | Common Class A [Member]  
Exercise price of warrant $ 11.5
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders' Deficit - Additional Information (Detail) - USD ($)
 9 Months Ended 12 Months Ended
Jun. 21, 2023
Jun. 20, 2023
Jun. 01, 2023
Sep. 30, 2023
Dec. 31, 2022
May 04, 2023
Dec. 31, 2021
Preferred stock shares authorized       1,000,000 1,000,000    
Preferred stock par or stated value per share       $ 0.0001 $ 0.0001    
Preferred stock shares issued       0 0    
Preferred stock shares outstanding       0 0    
Temporary equity shares outstanding       419,938 1,191,437   40,000,000
Minimum percentage of common stock to be held after conversion of shares       20.00%      
Number of stock bought back by the entity at the exercise price or redemption price.       771,499 38,808,563    
Cash withdrawn from trust account for redeemption of stock   $ 370,088          
Sponsor [Member]              
Common stock shares outstanding           9,825,001  
Conversion of Class B to Class A Common Stock [Member] | Sponsor [Member]              
Common stock par or stated value per share $ 0.0001            
Conversion of stock, shares converted 9,825,000            
Conversion of stock, description one-for-one            
Conversion of stock, shares issued 9,825,000   9,825,000        
Common Class A [Member]              
Common stock shares authorized       300,000,000 300,000,000    
Common stock par or stated value per share       $ 0.0001 $ 0.0001    
Common stock shares issued       9,825,000 0    
Common stock shares outstanding   419,938   9,825,000 0    
Temporary equity shares issued   419,938     1,191,437    
Temporary equity shares outstanding       419,938 1,191,437    
Number of stock bought back by the entity at the exercise price or redemption price.   771,499   771,499      
Value of stock bought back by the entity at the exercise price or redemption price   $ 8,085,078   $ 8,085,078      
Stock redemption price   $ 10.48          
Cash withdrawn from trust account for redeemption of stock   $ 370,088          
Aggregate common shares outstanding       10,244,938      
Aggregate common shares issued       10,244,938      
Common Class A [Member] | Sponsor [Member]              
Common stock shares outstanding       9,825,000      
Common Class B [Member]              
Common stock shares authorized       30,000,000 30,000,000    
Common stock par or stated value per share       $ 0.0001 $ 0.0001    
Common stock shares issued       175,000 10,000,000    
Common stock shares outstanding       175,000 10,000,000    
Common stock, voting rights       one vote      
Common Class B [Member] | Sponsor [Member]              
Common stock shares outstanding 9,825,001     1      
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Additional Information (Detail) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Assets held-in-trust, current $ 0 $ 15,489,507
Public Warrants [Member] | Measurement Input, Share Price [Member]    
Aggregate value of warrants outstanding $ 1,100,000 $ 400,000
Aggregate value of warrants outstanding per share $ 0.08 $ 0.03
Private Placement Warrants [Member] | Measurement Input, Share Price [Member]    
Aggregate value of warrants outstanding $ 600,000 $ 200,000
Aggregate value of warrants outstanding per share $ 0.08 $ 0.03
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Cash and Marketable Securities Held In Trust Account [Member] | Level 1 [Member] | Fair Value, Recurring [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Marketable securities held in Trust Account $ 4,493,902 $ 15,489,507
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Warrant liability $ 1,674,666   $ 628,000      
Public Warrants [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Warrant liability 1,066,666 $ 1,733,333 400,000 $ 266,667 $ 674,667 $ 9,200,000
Public Warrants [Member] | Level 1 [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Warrant liability 1,066,666   400,000      
Private Placement Warrants [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Warrant liability 608,000 $ 988,000 228,000 $ 152,000 $ 384,560 $ 5,320,000
Private Placement Warrants [Member] | Level 3 [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Warrant liability $ 608,000   $ 228,000      
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Change in valuation inputs or other assumptions $ (1,046,667) $ (640,560)     $ 1,046,666 $ (14,101,333)
Fair Value, Recurring [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value, Beginning Balance     $ 628,000   628,000  
Fair value, Ending Balance 1,674,666       1,674,666  
Public Warrants [Member] | Fair Value, Recurring [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value, Beginning Balance 1,733,333 674,667 400,000 $ 9,200,000 400,000 9,200,000
Change in valuation inputs or other assumptions (666,667) (408,000) 1,333,333 (8,525,333)    
Fair value, Ending Balance 1,066,666 266,667 1,733,333 674,667 1,066,666 266,667
Private Placement Warrants [Member] | Fair Value, Recurring [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value, Beginning Balance 988,000 384,560 228,000 5,320,000 228,000 5,320,000
Change in valuation inputs or other assumptions (380,000) (232,560) 760,000 (4,935,440)    
Fair value, Ending Balance 608,000 152,000 988,000 384,560 608,000 152,000
Warrant Liabilities [Member] | Fair Value, Recurring [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value, Beginning Balance 2,721,333 1,059,227 628,000 14,520,000 628,000 14,520,000
Change in valuation inputs or other assumptions (1,046,667) (640,560) 2,093,333 (13,460,773)    
Fair value, Ending Balance $ 1,674,666 $ 418,667 $ 2,721,333 $ 1,059,227 $ 1,674,666 $ 418,667
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail) - Public Warrants And Private Placement Warrants [Member]
Sep. 30, 2023
d
yr
Dec. 31, 2022
d
yr
Initial Measurement [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 4.5  
Initial Measurement [Member] | Measurement Input, Expected Term [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input | yr 5.48  
Initial Measurement [Member] | Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 5.4  
Initial Measurement [Member] | Measurement Input, Exercise Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 11.5  
Initial Measurement [Member] | Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 10.96  
Initial Measurement [Member] | Redemption Threshold Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 18  
Initial Measurement [Member] | Redemption Threshold Days [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 20  
Initial Measurement [Member] | Redemptin Threshold Consecutive Trading Days [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 30  
Initial Measurement [Member] | Redemption Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 0.01  
Subsequent Measurement [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   3.99
Subsequent Measurement [Member] | Measurement Input, Expected Term [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input | yr   5
Subsequent Measurement [Member] | Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   0.8
Subsequent Measurement [Member] | Measurement Input, Exercise Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   11.5
Subsequent Measurement [Member] | Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   9.89
Subsequent Measurement [Member] | Redemption Threshold Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   18
Subsequent Measurement [Member] | Redemption Threshold Days [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   20
Subsequent Measurement [Member] | Redemptin Threshold Consecutive Trading Days [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   30
Subsequent Measurement [Member] | Redemption Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input   0.01
XML 43 d452213d10q_htm.xml IDEA: XBRL DOCUMENT 0001829953 2023-09-30 0001829953 2022-12-31 0001829953 2022-01-01 2022-09-30 0001829953 2023-01-01 2023-09-30 0001829953 2023-07-01 2023-09-30 0001829953 2022-07-01 2022-09-30 0001829953 2022-04-01 2022-06-30 0001829953 2023-04-01 2023-06-30 0001829953 2023-01-01 2023-03-31 0001829953 2020-10-29 2020-12-31 0001829953 2022-01-01 2022-03-31 0001829953 2023-01-01 2023-01-31 0001829953 2023-06-20 2023-06-20 0001829953 2021-12-31 0001829953 2022-01-01 2022-12-31 0001829953 2022-09-30 0001829953 2023-03-31 0001829953 2023-06-30 0001829953 2022-06-30 0001829953 2022-03-31 0001829953 us-gaap:CommonClassBMember 2023-09-30 0001829953 us-gaap:CommonClassAMember 2023-09-30 0001829953 srt:MinimumMember 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001829953 coolu:MarketableSecuritiesHeldInTrustAccountMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:CommonClassAMember 2023-09-30 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember coolu:FounderSharesMember 2023-09-30 0001829953 us-gaap:IPOMember 2023-09-30 0001829953 coolu:SponsorMember coolu:SharePriceMoreThanOrEqualsToUsdTwelveMember 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember coolu:SponsorMember 2023-09-30 0001829953 coolu:WorkingCapitalLoanMember 2023-09-30 0001829953 coolu:AdministrativeServicesAgreementMember 2023-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2023-09-30 0001829953 coolu:PublicWarrantsMember 2023-09-30 0001829953 coolu:SharePriceMoreThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 coolu:SharePriceLessThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 us-gaap:CommonStockMember coolu:SharePriceLessThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 us-gaap:CommonStockMember coolu:SharePriceMoreThanOrEqualsToUsdEighteenMember 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0001829953 us-gaap:CommonStockMember coolu:SharePriceLessThanOrEqualsToUsdNinePointTwoMember 2023-09-30 0001829953 coolu:SponsorMember us-gaap:CommonClassAMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionThresholdDaysMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptinThresholdConsecutiveTradingDaysMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionThresholdPriceMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionPriceMember coolu:InitialMeasurementMember 2023-09-30 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember 2023-09-30 0001829953 us-gaap:RelatedPartyMember 2023-09-30 0001829953 us-gaap:CommonClassBMember 2022-12-31 0001829953 us-gaap:CommonClassAMember 2022-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001829953 coolu:PublicWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001829953 coolu:MarketableSecuritiesHeldInTrustAccountMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 coolu:AdministrativeServicesAgreementMember 2022-12-31 0001829953 coolu:WorkingCapitalLoanMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionThresholdDaysMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptinThresholdConsecutiveTradingDaysMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionThresholdPriceMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 coolu:PublicWarrantsAndPrivatePlacementWarrantsMember coolu:RedemptionPriceMember coolu:SubsequentMeasurementMember 2022-12-31 0001829953 us-gaap:RelatedPartyMember coolu:ShareholdersMember 2022-12-31 0001829953 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001829953 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2022-01-01 2022-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2022-01-01 2022-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2022-01-01 2022-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-07-01 2022-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-07-01 2022-09-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-07-01 2022-09-30 0001829953 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001829953 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001829953 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2022-07-01 2022-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2022-07-01 2022-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2022-07-01 2022-09-30 0001829953 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember coolu:FounderSharesMember 2023-01-01 2023-09-30 0001829953 coolu:SponsorMember coolu:SharePriceMoreThanOrEqualsToUsdTwelveMember 2023-01-01 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember coolu:SponsorMember 2023-01-01 2023-09-30 0001829953 coolu:OperatingAndFormationCostsMember 2023-01-01 2023-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2023-01-01 2023-09-30 0001829953 coolu:PublicWarrantsMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001829953 coolu:SharePriceLessThanOrEqualsToUsdEighteenMember 2023-01-01 2023-09-30 0001829953 coolu:SharePriceMoreThanOrEqualsToUsdEighteenMember 2023-01-01 2023-09-30 0001829953 us-gaap:CapitalUnitsMember 2023-01-01 2023-09-30 0001829953 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2023-01-01 2023-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2023-01-01 2023-09-30 0001829953 us-gaap:IPOMember 2023-01-01 2023-09-30 0001829953 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001829953 coolu:OperatingAndFormationCostsMember coolu:SponsorMember 2023-01-01 2023-09-30 0001829953 us-gaap:RelatedPartyMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-07-01 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-07-01 2023-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-07-01 2023-09-30 0001829953 coolu:ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember 2023-07-01 2023-09-30 0001829953 coolu:ClassaredeemableordinarySharesMember 2023-07-01 2023-09-30 0001829953 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001829953 coolu:AdministrativeServicesAgreementMember coolu:SponsorMember 2023-07-01 2023-09-30 0001829953 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001829953 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001829953 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-12-21 2020-12-21 0001829953 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-12-21 2020-12-21 0001829953 coolu:PrivatePlacementWarrantsMember coolu:SponsorMember 2020-12-21 2020-12-21 0001829953 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-12-21 0001829953 coolu:PrivatePlacementWarrantsMember coolu:SponsorMember 2020-12-21 0001829953 us-gaap:IPOMember 2022-12-20 0001829953 us-gaap:CommonClassAMember 2022-12-20 0001829953 us-gaap:CommonClassAMember 2022-12-20 2022-12-20 0001829953 us-gaap:CommonClassAMember 2023-12-20 2023-12-20 0001829953 coolu:NoventiqHoldingsPlcMember 2023-05-04 2023-05-04 0001829953 coolu:NoventiqHoldingsPlcMember 2023-05-04 0001829953 coolu:SponsorMember 2023-05-04 0001829953 srt:MinimumMember 2023-06-20 0001829953 us-gaap:CommonClassAMember 2023-06-20 0001829953 us-gaap:CommonClassAMember 2023-06-20 2023-06-20 0001829953 coolu:ConversionOfClassBToClassACommonStockMember coolu:SponsorMember 2023-06-21 2023-06-21 0001829953 coolu:ConversionOfClassBToClassACommonStockMember coolu:SponsorMember 2023-06-21 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember 2023-06-21 0001829953 us-gaap:CommonClassAMember 2021-12-31 0001829953 coolu:OperatingAndFormationCostsMember 2022-01-01 2022-12-31 0001829953 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001829953 us-gaap:RelatedPartyMember us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember coolu:FounderSharesMember 2020-10-28 2020-10-28 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember coolu:FounderSharesMember 2020-10-28 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember 2020-11-30 2020-11-30 0001829953 coolu:SponsorMember us-gaap:CommonClassBMember coolu:FounderSharesMember 2020-12-16 0001829953 coolu:ConversionOfClassBToClassACommonStockMember coolu:SponsorMember 2023-06-01 2023-06-01 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001829953 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001829953 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-06-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-06-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-06-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-06-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-06-30 0001829953 us-gaap:CommonClassAMember 2023-11-13 0001829953 us-gaap:CommonClassBMember 2023-11-13 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001829953 us-gaap:RetainedEarningsMember 2022-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001829953 us-gaap:RetainedEarningsMember 2023-09-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001829953 us-gaap:RetainedEarningsMember 2021-12-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001829953 us-gaap:RetainedEarningsMember 2022-03-31 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001829953 us-gaap:RetainedEarningsMember 2022-12-31 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001829953 us-gaap:RetainedEarningsMember 2023-03-31 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001829953 us-gaap:RetainedEarningsMember 2023-06-30 0001829953 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001829953 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001829953 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001829953 us-gaap:RetainedEarningsMember 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001829953 coolu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001829953 coolu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001829953 coolu:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 iso4217:USD shares utr:Day pure utr:Month iso4217:USD shares utr:Year utr:D utr:Y false 0001829953 Q3 --12-31 CA 10-Q true 2023-09-30 2023 false CORNER GROWTH ACQUISITION CORP. E9 001-39814 98-1563902 251 Lytton Avenue Suite 200 Palo Alto 94301 650 543-8180 Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant COOLU NASDAQ Class A ordinary share, par value $0.0001 per share COOL NASDAQ Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 COOLW NASDAQ Yes Yes Non-accelerated Filer true true false true 10244938 175000 21761 31547 189995 268736 211756 300283 4493902 15489507 4705658 15789790 1622682 522500 0 3262655 2056793 932555 3679475 4717710 1674666 628000 4000000 4000000 9354141 9345710 419938 1191437 4493902 12226852 0.0001 0.0001 1000000 1000000 0 0 0 0 0 0 0.0001 0.0001 300000000 300000000 9825000 9825000 0 0 419938 1191437 982 0 0.0001 0.0001 30000000 30000000 175000 175000 10000000 10000000 18 1000 0 0 -9143385 -5783772 -9142385 -5782772 4705658 15789790 422865 2312947 352198 1291566 -422865 -2312947 -352198 -1291566 57747 352129 1931891 2558714 -1046667 1046666 -640560 -14101333 681549 -3007484 2220253 15368481 419938 419938 903185 903185 40000000 40000000 40000000 40000000 0.07 0.07 -0.28 -0.28 0.04 0.04 0.31 0.31 10000000 10000000 10000000 10000000 10000000 10000000 10000000 10000000 0.07 0.07 -0.28 -0.28 0.04 0.04 0.31 0.31 0 10000000 1000 -5783772 -5782772 0 154783 154783 -2381252 -2381252 0 10000000 1000 -8319807 -8318807 9825000 982 -9825000 -982 0 139599 139599 -1307781 -1307781 9825000 982 175000 18 -9767187 -9766187 0 57747 57747 681549 681549 9825000 982 175000 18 0 -9143385 -9142385 0 0 10000000 1000 0 -27567744 -27566744 7896134 7896134 0 0 10000000 1000 0 -19671610 -19670610 0 769393 769393 5252094 5252094 0 10000000 1000 -15188909 -15187909 0 1931891 1931891 2220253 2220253 0 0 10000000 1000 0 -14900547 -14899547 -3007484 15368481 352129 2558714 1046666 -14101333 1100182 275000 -78741 -280480 1124238 245535 -9786 -490551 11347734 11347734 11347734 0 70000 -11347734 -70000 -9786 -560551 31547 646558 21761 86007 352129 2701284 982 0 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1—Description of Organization, Business Operations and Basis of Presentation </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Corner Growth Acquisition Corp. (the “Company”), was incorporated as a Cayman Islands exempted company on October 20, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus on businesses in the technology industries primarily located in the United States. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation, its initial public offering described below (the “Initial Public Offering”) and, since the closing of the Initial Public Offering, the search for initial Business Combination candidates, and since the signing of the Business Combination Agreement described below, the completion of this proposed transaction. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering and will recognize changes in the fair value of warrant liabilities as other income (loss). The Company has selected December 31 as its fiscal year end. </div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration statements for the Company’s Initial Public Offering were declared effective on December 16, 2020. On December 21, 2020, the Company consummated the Initial Public Offering of 40,000,000 units (the “Units” and, with respect to the shares of Class A ordinary shares, par value $0.0001 per share (the “Class A ordinary shares”), included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriters of the overallotment option to purchase an additional 5,000,000 Units, at $10.00 per Unit, generating gross proceeds of $400,000,000 which is described in Note 3. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,600,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement (the “Private Placement”) to CGA Sponsor LLC (the “Sponsor”), generating gross proceeds of $11,400,000, which is described in Note 4. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transaction costs amounted to $22,766,081 consisting of $8,000,000 of underwriting fees, $14,000,000 of deferred underwriting fees and $766,081 <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">of other offering costs. As further described in Note 5, effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit</div></div> $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of an initial business combination, as originally set forth in the underwriting agreement. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the closing of the Initial Public Offering on December 21, 2020, an amount of $400,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company. To mitigate the risk of us being deemed to have been operating as an unregistered investment company under the Investment Company Act, on or about the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">24-month</div> anniversary of the effective date of the registration statement relating to the Initial Public Offering, or December 21, 2022, the Company instructed Continental Stock Transfer &amp; Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash (i.e., in one or more bank accounts) until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be classified </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as temporary equity upon the completion of the Initial Public Offering in accordance with ASC 480. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and the approval of an ordinary resolution. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (as amended, the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> information and (ii) clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Extraordinary General Meeting </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 20, 2022, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”), which amended the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate a Business Combination from December 21, 2022 to June 21, 2023. The shareholders approved a proposal to amend the trust agreement to change the date on which Continental Stock Transfer &amp; Trust Company must commence liquidation of the Trust Account from (A) the earlier of the Company’s completion of an initial business combination and December 21, 2022 to (B) the earlier of the Company’s completion of an initial business combination and June 21, 2023. In connection with the Extraordinary General Meeting, shareholders elected to redeem 38,808,563 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $393,676,799, or approximately $10.14 per share which includes $5,591,169 of earnings in the Trust Account not previously withdrawn. In January 2023, the Company made redemption payments of $3,262,655 out of the Trust Account that were due to the redeeming shareholders who elected to redeem their shares as part of the Extraordinary General Meeting. This amount was reflected as due to shareholders in the accompanying condensed consolidated balance sheet as of December 31, 2022. Subsequent to the redemptions, 1,191,437 <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares remained issued and outstanding until the Extension Meeting further described below. </div></div></div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combination Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 9, 2023, the Company issued a press release announcing that the Company has entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-binding</div> letter of intent with Softline Holding plc to proceed with a potential business combination that would result in the combined company being publicly-listed on the Nasdaq. The business combination is subject to the completion of definitive documentation. On May 4, 2023, the Company entered into a definitive business combination agreement with Noventiq Holdings PLC (formerly known as Softline Holding plc). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As disclosed in a Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</div> filed with the SEC on May 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) by and among the Company, Noventiq Holdings PLC, a company organized under the laws of the Cyprus (“Noventiq”), and Corner Growth SPAC Merger Sub, Inc., a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”). The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into Noventiq, with Noventiq surviving as a wholly-owned subsidiary of the Company (the “Merger”). Upon the closing of the business combination (the “Closing”), it is anticipated that the Company will change its name to “Noventiq Holding Company” (“New Noventiq”) and certain securities of New Noventiq are expected to be listed on the Nasdaq Stock Market (“Nasdaq”). The date on which the Closing actually occurs is hereinafter referred to as the “Closing Date.” In accordance with the applicable provisions of the Cayman Companies Act (As Revised) and the Cyprus Companies Law, prior to the approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders, Noventiq will <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-domicile</div> from Cyprus to the Cayman Islands. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Proposed Business Combination.” </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Noventiq. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">The Proposed Business Combination is subject to certain customary closing conditions, such as the prior approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders and the effectiveness of the Registration Statement on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-6</div> registering the ADSs (as defined below). There is no assurance that the Proposed Business Combination will be consummated by the Extended Date (or any such later date of termination approved in accordance with the Amended and Restated Memorandum and Articles of Association) described below. </div></div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consideration and Structure </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time of the Merger (the “Effective Time”), each ordinary share of Noventiq outstanding immediately prior to the Effective Time (collectively, the “Noventiq Shares”) (other than shares held in treasury of Noventiq or owned by any subsidiary of Noventiq and held by shareholders of Noventiq who have perfected their dissenters’ rights in accordance with Section 238 of the Cayman Act) will be automatically cancelled, extinguished and converted into a number of the Company’s newly issued Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), equal to the “Exchange Ratio” determined by dividing (A) the Per Share Merger Consideration Value (as defined below) by (B) $10; and each outstanding vested and unvested option to purchase Noventiq Shares (“Noventiq Option”) will be assumed and converted into an option to purchase Ordinary Shares (each a “Rollover Option”). The number of Ordinary Shares (rounded down to the nearest whole number) that are subject to each Rollover Option shall be equal to the product of (i) the number of Noventiq Shares subject to the Noventiq Option and (ii) the Exchange Ratio, and the exercise price per share of the Rollover Option (rounded up to the nearest whole cent) shall be equal to the quotient obtained by dividing (A) the exercise price per share of the Noventiq Option by (B) the Exchange Ratio. For purposes of the Business Combination Agreement, Noventiq’s equity value is $877,000,000 plus the amount equal to aggregate exercise price of the Noventiq’s options (the “Equity Value”) and the “Per Share Merger Consideration Value” is an amount in dollars equal to the sum of the Equity Value, divided by the number of outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the foregoing consideration, Noventiq shareholders shall be entitled to receive, as additional consideration, one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case, for each Ordinary Share issuable to such Noventiq shareholder at the Effective Time pursuant to the Business Combination Agreement, which provide the holders of such CSRs the contingent right to receive additional newly issued Ordinary Shares (the “Earnout Shares”) upon the occurrence of certain events and subject to certain conditions, as specified under the Business Combination Agreement, during the period from and after the Closing until the fifth anniversary of the Closing (the “Earnout Period”). During the Earnout Period, if New Noventiq experiences a Change of Control (as defined in the Business Combination Agreement), then any Earnout Shares not already earned and issued to the Noventiq shareholders shall be deemed earned and the balance of the Earnout Shares shall be issuable by New Noventiq to the Noventiq shareholders immediately prior to consummation of such Change of Control transaction subject to certain conditions and upon the terms of the Business Combination Agreement. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 4, 2023, the Sponsor held 9,825,001 Founder Shares. Of these, 2,500,000 Founder Shares are subject to forfeiture based on the sum of (i) the amount of gross proceeds raised prior to the Effective Time from additional financings, if any, by the Company and (ii) the cash balance of the Company’s Trust Account held for the benefit of its public shareholders, but the consummation of the Proposed Business Combination is not subject to a minimum amount of additional financing having been raised. At the Effective Time, the Founder Shares (net of any forfeited shares) will automatically convert into Ordinary Shares on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, subject to adjustment, on the terms and conditions provided in the Amended and Restated Memorandum and Articles of Association. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An additional 5,000,000 Founder Shares, out of the 9,825,001 Founder Shares described above, will be held in escrow and only released, in three equal installments, upon the occurrence of the same milestone events as the Earnout Shares are issued. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Proposed Business Combination and pursuant to the Business Combination Agreement, the Company has agreed to establish a Level 2 ADS facility by entering into a Deposit Agreement with The Bank of New York Mellon (or an affiliate), as depositary, and filing with the Securities and Exchange Commission (the “SEC”) a Registration Statement on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form F-6 registering</div> American Depositary Shares (the “ADSs”), each representing one Ordinary Share (the “ADS Facility”). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Closing, each holder of Ordinary Shares will be able to deposit such holder’s shares into the ADS Facility and receive ADSs, which are expected to trade on Nasdaq under the symbol “NVIQ.” Following the Closing, the Company’s outstanding warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer &amp; Trust Company, will remain outstanding and are expected to continue trading on Nasdaq. In connection with the Closing, the ADSs, each representing one Ordinary Share, are expected to be listed on Nasdaq as of the Effective Time. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Business Combination Agreement, the Sponsor entered into a support agreement with the Company and Noventiq (the “Sponsor Support Agreement”), pursuant to which the Sponsor has agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby; (ii) not to solicit, initiate, submit, facilitate (including by means of furnishing or disclosing information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with any third-party with respect to a CGAC Acquisition Proposal (as defined in the Sponsor Support Agreement); (iii) be bound by certain transfer restrictions with respect to its shares in the Company prior to the closing of the Proposed Business Combination; (iv) not to transfer any of the Restricted Securities (as defined in the Sponsor Support Agreement) from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Sponsor Support Agreement). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Business Combination Agreement, the Company, Noventiq and certain shareholders of Noventiq (collectively, the “Noventiq Supporting Shareholders”) duly executed and delivered to the Company a support agreement (the “Voting and Support Agreement”), pursuant to which each Noventiq Supporting Shareholder agreed to, among other things, (i) the Business Combination and the adoption of the Business Combination Agreement any other matters necessary or reasonably requested by Noventiq for consummation of the Business Combination and the other transactions contemplated by the Business Combination Agreement, (ii) not to transfer any Noventiq Shares on or prior to the Closing (subject to the exceptions set forth therein), and (ii) to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> of the Noventiq Shares from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Voting and Support Agreement). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor Parties and certain Noventiq shareholders will enter into the Registration Rights Agreement, pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares of the Company, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Extension Meeting </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June 15, 2023, the Company held an extraordinary general meeting of shareholders, which was adjourned and reconvened on June 20, 2023 (the “Extension Meeting”), to amend the Company’s amended and restated memorandum and articles of association (the “Articles Amendment”) to (i) extend the date by which the Company has to consummate a business combination from June 21, 2023 to March 21, 2024 (the “Extended Date”) or such earlier date as shall be determined by the Company’s board of directors in its sole discretion (the “Amended Termination Date” and, such proposal, the “Extension Amendment Proposal”), (ii) eliminate from the amended and restated memorandum and articles of association the limitation that the Company shall not redeem Class A ordinary shares included as part of the units sold in the IPO to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation Amendment Proposal”) and (iii) amend the Company’s amended and restated memorandum and articles of association to provide that Class B ordinary shares may be converted either at the time of the consummation of the Company’s initial business combination or at any earlier date at the option of the holders of Class B ordinary shares (the “Founder Conversion Amendment Proposal”). The shareholders of the Company approved the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal at the Extension Meeting and on June 21, 2023, the Company filed the Articles Amendment with the Registrar of Companies of the Cayman Islands. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the vote to approve the Extension Amendment Proposal, the Redemption Limitation Amendment Proposal and the Founder Conversion Amendment Proposal, shareholders elected to redeem 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor, the holder of an aggregate of 9,825,001 shares of the Company’s Class B Ordinary Shares, par value $0.0001 per share, elected to convert 9,825,000 shares of the Class B Ordinary Shares held by it on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis into Class A Ordinary Shares of the Company, with immediate effect. Following such conversion, the Sponsor holds 9,825,000 shares of Class A Ordinary Shares and 1 share of Class B Ordinary Shares and the Company will have an aggregate of 10,244,938 shares of Class A Ordinary Shares issued and outstanding (419,938 of which are subject to possible redemption) and 175,000 shares of Class B Ordinary Shares issued and outstanding. In connection with the conversion, the Sponsor has agreed to certain transfer restrictions, a waiver of redemption rights, a waiver of any right to receive funds from the Trust Account and the obligation to vote in favor of an initial business combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination by the Extended Date (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-initial</div> Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and other requirements of applicable law. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor, officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination during the Combination Period and, in such event, such amount will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liquidity and Going Concern </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023, the Company had $21,761 in its operating bank accounts, $4,493,902 in the Trust Account to be used for a Business Combination or to repurchase or redeem its ordinary shares in connection therewith and a working capital deficit of $3,467,719.</div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. Based on its current cash and working capital balances, management believes that the Company will not have sufficient working capital to meet its needs through the consummation of a Business Combination. </div></div><br/></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. The terms of such loans have not been determined and no written agreements exist with respect to such loans. However, as discussed in Note 4, as of September 30, 2023, the Company is indebted to the Sponsor and its affiliates for $1,622,682, which represents $1,342,682<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>of operating and formation costs paid by these related parties on the Company’s behalf, along with $280,000 <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of unpaid administrative fees. The Sponsor is not under any obligation to make additional expenditures on the Company’s behalf. </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In connection with our assessment of going concern considerations in accordance with FASB ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">205-40,</div> “Presentation of Financial Statements-Going Concern” management has determined that the date for mandatory liquidation and dissolution raise substantial doubt about our ability to continue as a going concern for a reasonable period of time, which is considered one year from the issuance of these unaudited condensed consolidated financial statements. The Company demonstrates other adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these unaudited condensed consolidated financial statements. These other adverse conditions are negative financial trends, specifically a working capital deficiency and other adverse key financial ratios. No adjustments have been made to the carrying amounts or classification of assets or liabilities should the Company be required to liquidate after March 20, 2024, our scheduled liquidation date if we do not complete the Business Combination prior to such date. There is no assurance that the Company will complete the Proposed Business Combination with Noventiq before March 24, 2024, or at all. </div></div> 2020-10-20 40000000 0.0001 5000000 10 400000000 7600000 1.5 11400000 22766081 8000000 14000000 766081 10000000 14000000 4000000 400000000 10 P185D 0.0001 10 5000001 0.15 38808563 393676799 10.14 5591169 3262655 1191437 1191437 0.0001 10 877000000 one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case 9825001 2500000 5000000 9825001 5000001 771499 8085078 10.48 370088 419938 9825001 0.0001 9825000 one-for-one 9825000 1 10244938 10244938 419938 175000 175000 1 100000 21761 4493902 3467719 1622682 1342682 280000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2 — Summary of Significant Accounting Policies </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2022 as filed with the SEC on March 31, 2023. The accompanying condensed consolidated balance sheet as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2022. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Starting with the second fiscal quarter of 2023, the Company’s unaudited condensed consolidated financial statements include the results of Merger Sub, a direct wholly owned subsidiary of the Company. Merger Sub is a Cayman Islands exempted company which was incorporated on April 4, 2023. Merger Sub was formed solely for the purpose of effectuating the Merger and has not engaged in any business activities or conducted any operations other than in connection with the Merger and has no, and at all times prior to the Merger’s closing except as expressly contemplated by the Merger documents and the related transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation. <div style="letter-spacing: 0px; top: 0px;;display:inline;">All </div>intercompany balances and transactions have been eliminated in consolidation. For simplicity of presentation, we refer to all accompanying financial statements as condensed consolidated financial statements herein. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> <div style="margin-top: 8pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketable Securities Held in Trust Account </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer &amp; Trust Company acting as trustee. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for any securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Investments - Debt Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securities held in the Trust Account based on quoted prices in active markets (see Note 8 for more information). </div></div></div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Liabilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the unaudited condensed consolidated statements of operations. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheet. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and accumulated deficit. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amounts</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—December 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments to Class A ordinary shareholders for redemption of shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,808,563</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(390,414,144</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,262,655</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement of carrying value to redemption value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,903,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—December 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,191,437</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,226,852</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments to Class A ordinary shareholders for redemption of shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(771,499</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,347,734</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to shareholders paid in 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,262,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement of carrying value to redemption value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">352,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">September</div> 30, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,493,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December of 2022, in connection with the distribution of funds in the Trust Amount to the Company’s shareholders made in connection with the Extraordinary General Meeting (as defined above), funds were deposited from the Trust Account into an operating bank account and held in cash. As of December 31, 2022, $3,262,655 of the December 2022 redemption was not paid out to the shareholders and was classified as Due to shareholders on the condensed consolidated balance sheet. In January 2023, upon completion of the distribution of funds in the amount of $3,262,655 to shareholders made in connection with the Extraordinary General Meeting, the Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-deposited</div> the remaining funds into the Trust Account. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the Extension Meeting, shareholders elected to redeem an additional 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share. $370,088 was paid out to redeeming Class A ordinary shares as their proportionate share of trust earnings through the redemption date and is the difference between the redemption amount per share and the original $10.00 per share times the number of shares redeemed. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the nine months ended September 30, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $352,129 to reflect current earnings of the Trust Account. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of Financial Instruments </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheet, primarily due to their short-term nature. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three and nine months ended September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) Per Ordinary Share </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,933,333 <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share for all periods presented, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2023 and 2022. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:22%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 202<div style="display:inline;">3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A and<br/> Nonredeemable<br/> and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/> Redeemable</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/> Nonredeemable<br/> and Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income (loss) per ordinary share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,467</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">654,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(249,130</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,758,354</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,776,202</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">444,051</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,294,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,073,696</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">903,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income (loss) per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In June 2016, FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> Measurement of Credit Losses on Financial Instruments (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13”).</div> ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> as of January 1, 2023, with no impact to its condensed consolidated financial statements because the Company does not have financial assets within the scope of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13.</div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks and Uncertainties </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management is currently evaluating the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic on its condensed consolidated financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed consolidated financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2022 as filed with the SEC on March 31, 2023. The accompanying condensed consolidated balance sheet as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2022. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Starting with the second fiscal quarter of 2023, the Company’s unaudited condensed consolidated financial statements include the results of Merger Sub, a direct wholly owned subsidiary of the Company. Merger Sub is a Cayman Islands exempted company which was incorporated on April 4, 2023. Merger Sub was formed solely for the purpose of effectuating the Merger and has not engaged in any business activities or conducted any operations other than in connection with the Merger and has no, and at all times prior to the Merger’s closing except as expressly contemplated by the Merger documents and the related transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation. <div style="letter-spacing: 0px; top: 0px;;display:inline;">All </div>intercompany balances and transactions have been eliminated in consolidation. For simplicity of presentation, we refer to all accompanying financial statements as condensed consolidated financial statements herein. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022. </div> 0 0 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketable Securities Held in Trust Account </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer &amp; Trust Company acting as trustee. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for any securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Investments - Debt Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securities held in the Trust Account based on quoted prices in active markets (see Note 8 for more information). </div></div></div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Liabilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the unaudited condensed consolidated statements of operations. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheet. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and accumulated deficit. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amounts</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—December 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments to Class A ordinary shareholders for redemption of shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,808,563</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(390,414,144</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,262,655</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement of carrying value to redemption value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,903,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—December 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,191,437</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,226,852</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments to Class A ordinary shareholders for redemption of shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(771,499</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,347,734</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to shareholders paid in 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,262,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement of carrying value to redemption value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">352,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">September</div> 30, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,493,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December of 2022, in connection with the distribution of funds in the Trust Amount to the Company’s shareholders made in connection with the Extraordinary General Meeting (as defined above), funds were deposited from the Trust Account into an operating bank account and held in cash. As of December 31, 2022, $3,262,655 of the December 2022 redemption was not paid out to the shareholders and was classified as Due to shareholders on the condensed consolidated balance sheet. In January 2023, upon completion of the distribution of funds in the amount of $3,262,655 to shareholders made in connection with the Extraordinary General Meeting, the Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-deposited</div> the remaining funds into the Trust Account. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the Extension Meeting, shareholders elected to redeem an additional 771,499 Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share. $370,088 was paid out to redeeming Class A ordinary shares as their proportionate share of trust earnings through the redemption date and is the difference between the redemption amount per share and the original $10.00 per share times the number of shares redeemed. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the nine months ended September 30, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $352,129 to reflect current earnings of the Trust Account. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amounts</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—December 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments to Class A ordinary shareholders for redemption of shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,808,563</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(390,414,144</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,262,655</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement of carrying value to redemption value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,903,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—December 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,191,437</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,226,852</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments to Class A ordinary shareholders for redemption of shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(771,499</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,347,734</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to shareholders paid in 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,262,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement of carrying value to redemption value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">352,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption—<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">September</div> 30, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,493,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 40000000 400000000 38808563 390414144 -3262655 5903651 1191437 12226852 771499 11347734 3262655 352129 419938 4493902 3262655 3262655 771499 8085078 10.48 370088 10 352129 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts. </div> 250000 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of Financial Instruments </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheet, primarily due to their short-term nature. </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three and nine months ended September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div> 0 0 0 0 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) Per Ordinary Share </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,933,333 <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share for all periods presented, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2023 and 2022. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:22%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 202<div style="display:inline;">3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A and<br/> Nonredeemable<br/> and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/> Redeemable</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/> Nonredeemable<br/> and Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income (loss) per ordinary share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,467</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">654,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(249,130</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,758,354</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,776,202</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">444,051</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,294,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,073,696</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">903,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income (loss) per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 20933333 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except share amounts): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:22%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 202<div style="display:inline;">3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A and<br/> Nonredeemable<br/> and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/> Redeemable</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/> Nonredeemable<br/> and Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income (loss) per ordinary share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,467</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">654,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(249,130</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,758,354</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,776,202</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">444,051</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,294,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,073,696</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">903,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income (loss) per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 27467 654082 -249130 -2758354 1776202 444051 12294785 3073696 419938 419938 10000000 10000000 903185 903185 10000000 10000000 40000000 40000000 10000000 10000000 40000000 40000000 10000000 10000000 0.07 0.07 0.07 0.07 -0.28 -0.28 -0.28 -0.28 0.04 0.04 0.04 0.04 0.31 0.31 0.31 0.31 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In June 2016, FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> Measurement of Credit Losses on Financial Instruments (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13”).</div> ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> as of January 1, 2023, with no impact to its condensed consolidated financial statements because the Company does not have financial assets within the scope of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13.</div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks and Uncertainties </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management is currently evaluating the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic on its condensed consolidated financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed consolidated financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3 — Initial Public Offering </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Initial Public Offering, the Company sold 40,000,000 Units at a price of $10.00 per Unit, which includes the partial exercise by the underwriter of the overallotment option to purchase an additional 5,000,000 Units. Each Unit consists of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant (each, a “Public Warrant”), each whole Public Warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6). </div> 40000000 10 5000000 Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a “Public Warrant”) 1 11.5 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4 — Related Party Transactions </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 28, 2020, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 8,625,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). In November 2020, the Sponsor transferred 50,000 Class B ordinary shares to each of the Company’s independent directors. On December 16, 2020, the Company effected a share capitalization, resulting in 10,062,500 Founder Shares issued and outstanding as of such date. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination, or earlier at the option of the holder, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, subject to certain adjustments, as described in Note 7. As a result of the underwriters’ election to partially exercise their over-allotment option, 62,500 Founder Shares were forfeited for no consideration on December 23, 2020, resulting in 10,000,000 Class B ordinary shares outstanding. The per share price of the Founder Shares was determined by dividing the amount contributed to the Company by the number of Founder Shares issued. The Founder Shares will be worthless if we do not complete an initial Business Combination (see Note 1). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares or Class A ordinary shares received upon conversion thereof until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s Founder Shares are subject to transfer restrictions pursuant to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> provisions in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. The Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares. Prior to the closing of the Initial Public Offering, the Sponsor transferred 150,000 Founder Shares to our three independent directors in recognition of and as compensation for their future services to the Company. The transfer of Founder Shares </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to these directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. Compensation expense related to the Founder Shares is recognized only when the performance condition (i.e. the remediation of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> provision) is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> provisions have been remediated, or are probable to be remediated, in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the transfer of the Founder Shares. As of September 30, 2023, the Company has entered into a definitive agreement in connection with a potential Business Combination, but the Business Combination has not yet closed and as such, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> provisions have not been remediated and are not probable to be remediated. Any definitive agreements in connection with a Business Combination may also be subject to certain conditions to closing, such as approval by the Company’s shareholders. As a result, the Company determined that, taking into account that there is a possibility that the Business Combination may not close, no stock-based compensation expense should be recognized through September 30, 2023. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Private Placement Warrants </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,600,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant for an aggregate purchase price of $11,400,000. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Working Capital Loans </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $1.50 per warrant. As of the date of this filing, September 30, 2023 and December 31, 2022, the Company had no borrowings under any Working Capital Loans. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Services Agreement </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to an administrative services agreement (the “Administrative Services Agreement”) entered into on December 17, 2020, the Company agreed to pay the Sponsor a total of $40,000 per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team until the earlier of (A) the Company’s completion of the initial Business Combination or December 21, 2022 and (B) on December 21, 2022, an amount equal to $960,000 less the actual amount paid under the Administrative Services Agreement. For the three and nine months ended September 30, 2023, the Company incurred $0 in fees for these services. For the three and nine months ended September 30, 2022, the Company incurred $120,000 and $360,000 in fees for these services, respectively, which is included in operating and formation costs on the unaudited condensed consolidated statements of operations. As of September 30, 2023 and December 31, 2022, there were $280,000 and $320,000 in fees outstanding for these services, respectively, that are included in due to related party on the condensed consolidated balance sheets. Notwithstanding the foregoing, on November 18, 2021, the Sponsor permanently waived its right to receive any of the Company’s outstanding, and all of the Company’s remaining, payment obligations under the Administrative Services Agreement. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Operating and Formation Costs </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023 and December 31, 2022, the Sponsor and affiliates of the Sponsor also paid operating and formation costs of $<div style="letter-spacing: 0px; top: 0px;;display:inline;">1,342,682</div> and $202,500, respectively, on behalf of the Company which are due on demand. These amounts are included in due to related party on the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. The Sponsor is not under any obligation to make additional expenditures on the Company’s beh<div style="display:inline;">alf.</div></div> 25000 0.003 8625000 0.0001 50000 10062500 62500 10000000 12 P20D P30D P150D 150000 7600000 1.5 11400000 1 11.5 P30D 1500000 1.5 0 0 40000 960000 0 0 120000 360000 280000 320000 1342682 202500 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5 — Commitments and Contingencies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration Rights </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement entered in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, these holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As further described in Note 1 and as such terms used herein are defined therein, the Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor and certain Noventiq shareholders will enter into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the Initial Public Offering, the underwriters were entitled to a deferred fee of $0.35 per Unit, or $14,000,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of a Business Combination, as originally set forth in the underwriting agreement. The Company accounted for this forfeiture during the fourth calendar quarter of the year ended December 31, 2022. </div> 0.35 14000000 10000000 14000000 4000000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6 — Warrant Liabilities </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and, following the effective date of the registration statement, the Company will use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital-raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, plus interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A ordinary shares during the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-trading</div> day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. </div> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 10pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 10pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants if they are held by the Sponsor or its permitted transferees): </div></div></div> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">in whole and not in part; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">at a price of $0.01 per warrant; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">upon a minimum of 30 days’ prior written notice of redemption; and </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, once the warrants become exercisable, the Company may call the warrants for redemption: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">in whole and not in part; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:14%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:2%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">if the closing price of the Class A ordinary shares for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event are the warrants to be exercisable in connection with this redemption feature for more than 0.361 <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares per warrant (subject to adjustment). </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 10pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, management has the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event is the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 10pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Following the Closing, the Company’s public warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer &amp; Trust Company, will remain outstanding and are expected to continue trading on Nasdaq. </div></div></div> 11.5 P30D P12M P15D P60D 9.2 0.60 P10D 1.15 18 1.80 10 0.01 P30D 18 P20D P30D 0.1 P30D 10 P20D P30D P30D 18 0.361 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Note 7 — Shareholders’ Deficit </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares</div></div></div></div> — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Shares</div></div></div></div> — The Company is authorized to issue 300,000,000 Class A ordinary shares with a par value of $0.0001 per share. At December 31, 2022, there were 1,191,437 Class A ordinary shares issued or outstanding, all of which are considered temporary equity. On June 20, 2023, in connection with the Extension Meeting, shareholders elected to redeem 771,499 additional Class A ordinary shares, resulting in redemption payments out of the Trust Account totaling $8,085,078, or approximately $10.48 per share which includes $370,088 of earnings in the Trust Account not previously withdrawn. Subsequent to the redemptions, 419,938 Class A ordinary shares remained issued and outstanding. On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor elected to convert 9,825,000 shares of the Class B ordinary shares held by it on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis into Class A ordinary shares of the Company, with immediate effect. Following such conversion, the Sponsor holds 9,825,000 shares of Class A ordinary shares and at September 30, 2023, the Company has an aggregate of 10,244,938 shares of Class A ordinary shares (419,938 of which are subject to possible redemption) issued and outstanding. The Sponsor’s 9,825,000 Class A ordinary shares received in connection with the conversion are not redeemable. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B Ordinary Shares</div></div></div></div> — The Company is authorized to issue 30,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each Class B ordinary share. At December 31, 2022, there were 10,000,000 Class B ordinary shares issued and outstanding. On June 21, 2023, in connection with the approval of the Founder Conversion Amendment, the Sponsor elected to convert 9,825,000 shares of the Class B ordinary shares held by it on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis into Class A ordinary shares of the Company, with immediate effect. Following such conversion and at September 30, 2023, the Company has an aggregate of 175,000 shares of Class B ordinary shares issued and outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the appointment of the Company’s directors prior to the initial Business Combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis (as adjusted). In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the sum of the total number of Class A ordinary shares and Class B ordinary shares issued upon completion of the Initial Public Offering plus the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. </div> 1000000 1000000 0.0001 0.0001 0 0 0 0 300000000 300000000 0.0001 0.0001 1191437 1191437 771499 8085078 10.48 370088 419938 9825000 one-for-one 9825000 10244938 10244938 419938 9825000 30000000 0.0001 one vote 10000000 9825000 one-for-one 175000 175000 175000 0.20 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8 — Fair Value Measurements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:6%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:93%"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Level 1:</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</td> </tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Level 2:</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</td> </tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Level 3:</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:68%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and Marketable securities held in Trust Account</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,493,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,489,507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023 and December 31, 2022, $0 and $15,489,507, respectively, of the balance held in the Trust Account was held in cash. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:68%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant liability—Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,066,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant liability—Private Placement Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">608,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">228,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total warrant liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,674,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">628,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrants are accounted for as liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40</div> and are presented within the warrant liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of the warrant liabilities in the condensed consolidated statements of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Initial Measurement and Subsequent Measurement </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company established the initial fair value for the Public Warrants on December 21, 2020, the date of the consummation of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of shares of Class B ordinary shares, based on their fair values as determined at initial measurement, Class A ordinary shares and Class B ordinary shares based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2023 and December 31, 2022 is classified as Level 1 due to quoted prices in an active market since February 8, 2021. The Private Placement Warrants as of September 30, 2023 and December 31, 2022 are classified as Level 3 due to the use of unobservable inputs. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Monte Carlo model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing since February 8, 2021. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The key inputs into the Monte Carlo simulation model for the Private Placement warrants at September 30, 2023 and December 31, 2022 were as follows: </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"></td> <td style="width: 18%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 17%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">September 30, 2023</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">December 31, 2022</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Input</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.99</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.48</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of the ordinary share price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption threshold price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption threshold days</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20 days within any <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> period</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20 days within any <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> period</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.01</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.01</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023, the Public Warrants and Private Placement Warrants were determined to be $0.08 and $0.08 per warrant for aggregate values of approximately $1.1 million and $0.6 million, respectively. As of December 31, 2022, the Public Warrants and Private Placement Warrants were determined to be $0.03 and $0.03, respectively, per warrant for aggregate values of approximately $0.4 million and $0.2 million, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the changes in the fair value of warrant liabilities: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:56%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of December 31, 2022</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">228,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">628,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">760,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,333,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,093,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of June 30, 2023</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">988,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,733,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,721,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(380,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(666,667</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,046,667</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of September 30, 2023</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">608,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,066,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,674,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr> <td style="vertical-align: top; line-height: 6pt; font-size: 6pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 6pt; font-family: &quot;Times New Roman&quot;; font-style: normal; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 6pt; font-size: 6pt;;font-style:italic;display:inline;"><div style="line-height: 6pt; font-size: 6pt;;font-weight:bold;display:inline;width:100%;"> </div></div></div></div> </td> <td style="vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of December 31, 2021</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,320,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,200,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,520,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,935,440</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,525,333</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,460,773</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of June 30, 2022</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">384,560</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">674,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,059,227</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(232,560</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(408,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(640,560</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of September 30, 2022</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three and nine months ended September 30, 2023 and 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:68%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and Marketable securities held in Trust Account</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,493,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,489,507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 4493902 15489507 0 15489507 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:68%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant liability—Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,066,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant liability—Private Placement Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">608,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">228,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total warrant liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,674,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">628,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 1066666 400000 608000 228000 1674666 628000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The key inputs into the Monte Carlo simulation model for the Private Placement warrants at September 30, 2023 and December 31, 2022 were as follows: </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"></td> <td style="width: 18%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 17%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">September 30, 2023</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">December 31, 2022</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Input</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.99</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.48</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of the ordinary share price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption threshold price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption threshold days</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20 days within any <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> period</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20 days within any <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> period</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.01</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.01</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> 4.5 3.99 5.48 5 5.4 0.8 11.5 11.5 10.96 9.89 18 18 20 30 20 30 0.01 0.01 0.08 0.08 1100000 600000 0.03 0.03 400000 200000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the changes in the fair value of warrant liabilities: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:56%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of December 31, 2022</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">228,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">628,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">760,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,333,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,093,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of June 30, 2023</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">988,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,733,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,721,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(380,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(666,667</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,046,667</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of September 30, 2023</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">608,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,066,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,674,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr> <td style="vertical-align: top; line-height: 6pt; font-size: 6pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 6pt; font-family: &quot;Times New Roman&quot;; font-style: normal; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 6pt; font-size: 6pt;;font-style:italic;display:inline;"><div style="line-height: 6pt; font-size: 6pt;;font-weight:bold;display:inline;width:100%;"> </div></div></div></div> </td> <td style="vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="white-space: nowrap; vertical-align: bottom; line-height: 6pt; font-size: 6pt;"> <div style="font-size: 6pt; line-height: 6pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of December 31, 2021</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,320,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,200,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,520,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,935,440</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,525,333</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,460,773</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of June 30, 2022</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">384,560</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">674,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,059,227</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation inputs or other assumptions</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(232,560</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(408,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(640,560</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value as of September 30, 2022</div></div></div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three and nine months ended September 30, 2023 and 2022. </div> 228000 400000 628000 760000 1333333 2093333 988000 1733333 2721333 -380000 -666667 -1046667 608000 1066666 1674666 5320000 9200000 14520000 -4935440 -8525333 -13460773 384560 674667 1059227 -232560 -408000 -640560 152000 266667 418667 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9 — Subsequent Events </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred up to the date condensed consolidated financial statements were issued. Based upon this review, the Company did not identify any other subsequent events, not previously disclosed, that would have required adjustment or disclosure in the condensed consolidated financial statements, except as described below. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October 4, 2023, the Company transferred its ordinary share of the Merger Sub to New Noventiq. As a result, the Company will no longer have an ownership interest in the Merger Sub. Starting with the fourth quarter of 2023, the Company’s financial statements will no longer be presented on a consolidated basis. </div></div></div> EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO=V]R:W-H965T&UL4$L! A0#% @ MQX1M5^9K ;2I%@ 4T0 !@ ("!@4\ 'AL+W=O&PO=V]R M:W-H965T$;5?I4O#^E 4 /L- M 9 " @1YS !X;"]W;W)K&UL M4$L! A0#% @ QX1M5X15DIR%"P 24 !D ("!Z7@ M 'AL+W=O&PO=V]R:W-H965T$;5?0(]M: 0H !\> 9 M " @>Z' !X;"]W;W)K&UL4$L! A0#% @ MQX1M5Q\ZCH1, P ?P< !D ("!)I( 'AL+W=O&PO=V]R:W-H965T$;5?<7N_^J@0 ,$, 9 " @:"M !X;"]W M;W)K&UL4$L! A0#% @ QX1M5RGI%*=9!@ M9A( !D ("!@;( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ R(1M5\6\OQBI! 1AL !D M ("!P]8 'AL+W=O&PO=V]R:W-H M965T8;1?JS@, ,P/ 9 M " @3#B !X;"]W;W)K&UL4$L! M A0#% @ R(1M5[NUU_K"$ ?/, !D ("!->8 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ R(1M M5R$VQ7LK"0 ?5\ !D ("!%P ! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ R(1M5X/MY*MZ! KB( M !D ("!9@\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ R(1M5XG&Z,A1 P SA4 T M ( !0"$! 'AL+W-T>6QE&PO=V]R:V)O;VLN M>&UL4$L! A0#% @ R(1M5XH3@V1C 0 MQ, !H ( ! M RD! 'AL+U]R96QS+W=O XML 45 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 214 202 1 false 45 0 false 9 false false R1.htm 1001 - Document - Cover Page Sheet http://www.cga.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.cga.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit Sheet http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit Condensed Consolidated Statements of Changes in Shareholders' Deficit Statements 5 false false R6.htm 1006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Description of Organization and Business Operations Sheet http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperations Description of Organization and Business Operations Notes 7 false false R8.htm 1008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cga.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://www.cga.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Related Party Transactions Sheet http://www.cga.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 1011 - Disclosure - Commitments and Contingencies Sheet http://www.cga.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 1012 - Disclosure - Warrant Liabilities Sheet http://www.cga.com/role/WarrantLiabilities Warrant Liabilities Notes 12 false false R13.htm 1013 - Disclosure - Shareholders' Deficit Sheet http://www.cga.com/role/ShareholdersDeficit Shareholders' Deficit Notes 13 false false R14.htm 1014 - Disclosure - Fair Value Measurements Sheet http://www.cga.com/role/FairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 1015 - Disclosure - Subsequent Events Sheet http://www.cga.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 1016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.cga.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 1017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.cga.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.cga.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.cga.com/role/FairValueMeasurements 18 false false R19.htm 1019 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) Sheet http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail Description of Organization and Business Operations - Additional Information (Detail) Details 19 false false R20.htm 1020 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 20 false false R21.htm 1021 - Disclosure - Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail) Sheet http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail) Details 21 false false R22.htm 1022 - Disclosure - Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail) Sheet http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail) Details 22 false false R23.htm 1023 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional Information (Detail) Details 23 false false R24.htm 1024 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 24 false false R25.htm 1025 - Disclosure - Commitments - Additional Information (Detail) Sheet http://www.cga.com/role/CommitmentsAdditionalInformationDetail Commitments - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Warrant Liabilities - Additional Information (Detail) Sheet http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail Warrant Liabilities - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - Shareholders' Deficit - Additional Information (Detail) Sheet http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail Shareholders' Deficit - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail) Sheet http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail) Details 29 false false R30.htm 1030 - Disclosure - Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail) Sheet http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail) Details 30 false false R31.htm 1031 - Disclosure - Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail) Sheet http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail) Details 31 false false R32.htm 1032 - Disclosure - Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail) Sheet http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail) Details 32 false false All Reports Book All Reports coolu-20230930.xsd coolu-20230930_cal.xml coolu-20230930_def.xml coolu-20230930_lab.xml coolu-20230930_pre.xml d452213d10q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 50 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d452213d10q.htm": { "nsprefix": "coolu", "nsuri": "http://www.cga.com/20230930", "dts": { "schema": { "local": [ "coolu-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "coolu-20230930_cal.xml" ] }, "definitionLink": { "local": [ "coolu-20230930_def.xml" ] }, "labelLink": { "local": [ "coolu-20230930_lab.xml" ] }, "presentationLink": { "local": [ "coolu-20230930_pre.xml" ] }, "inline": { "local": [ "d452213d10q.htm" ] } }, "keyStandard": 142, "keyCustom": 60, "axisStandard": 14, "axisCustom": 3, "memberStandard": 19, "memberCustom": 25, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 214, "entityCount": 1, "segmentCount": 45, "elementCount": 329, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 475, "http://xbrl.sec.gov/dei/2023": 39 }, "report": { "R1": { "role": "http://www.cga.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "longName": "1002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:Cash", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R3": { "role": "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "longName": "1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:TemporaryEquitySharesOutstanding", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "longName": "1004 - Statement - Condensed Consolidated Statements of Operations", "shortName": "Condensed Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "coolu:OperatingAndFormationCosts", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "coolu:OperatingAndFormationCosts", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "longName": "1005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit", "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Deficit", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "PAsOn12_31_2021", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R6": { "role": "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows", "longName": "1006 - Statement - Condensed Consolidated Statements of Cash Flows", "shortName": "Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R7": { "role": "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperations", "longName": "1007 - Disclosure - Description of Organization and Business Operations", "shortName": "Description of Organization and Business Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.cga.com/role/SummaryOfSignificantAccountingPolicies", "longName": "1008 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.cga.com/role/InitialPublicOffering", "longName": "1009 - Disclosure - Initial Public Offering", "shortName": "Initial Public Offering", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "coolu:InitialPublicOfferingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "coolu:InitialPublicOfferingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.cga.com/role/RelatedPartyTransactions", "longName": "1010 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.cga.com/role/CommitmentsAndContingencies", "longName": "1011 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.cga.com/role/WarrantLiabilities", "longName": "1012 - Disclosure - Warrant Liabilities", "shortName": "Warrant Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "coolu:WarrantLiabilityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "coolu:WarrantLiabilityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.cga.com/role/ShareholdersDeficit", "longName": "1013 - Disclosure - Shareholders' Deficit", "shortName": "Shareholders' Deficit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.cga.com/role/FairValueMeasurements", "longName": "1014 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.cga.com/role/SubsequentEvents", "longName": "1015 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "1016 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "16", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "1017 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "17", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:TemporaryEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "coolu:ClassaOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:TemporaryEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "coolu:ClassaOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.cga.com/role/FairValueMeasurementsTables", "longName": "1018 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "longName": "1019 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail)", "shortName": "Description of Organization and Business Operations - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "longName": "1020 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail", "longName": "1021 - Disclosure - Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail)", "shortName": "Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:PaymentsForRepurchaseOfCommonStock", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:PaymentsForRepurchaseOfCommonStock", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R22": { "role": "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "longName": "1022 - Disclosure - Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail)", "shortName": "Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "longName": "1023 - Disclosure - Initial Public Offering - Additional Information (Detail)", "shortName": "Initial Public Offering - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "PAsOn09_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "coolu:WarrantLiabilityDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:CommonStockConversionBasis", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "coolu:InitialPublicOfferingDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R24": { "role": "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "longName": "1024 - Disclosure - Related Party Transactions - Additional Information (Detail)", "shortName": "Related Party Transactions - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "coolu:MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "coolu:MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "longName": "1025 - Disclosure - Commitments - Additional Information (Detail)", "shortName": "Commitments - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "coolu:DeferredUnderwritingFeePerUnit", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "coolu:DeferredUnderwritingFeePerUnit", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail", "longName": "1026 - Disclosure - Warrant Liabilities - Additional Information (Detail)", "shortName": "Warrant Liabilities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:SharePrice", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "coolu:PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "coolu:WarrantLiabilityDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R27": { "role": "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "longName": "1027 - Disclosure - Shareholders' Deficit - Additional Information (Detail)", "shortName": "Shareholders' Deficit - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "coolu:MinimumPercentageOfCommonStockToBeHeldAfterConversionOfShares", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R28": { "role": "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "longName": "1028 - Disclosure - Fair Value Measurements - Additional Information (Detail)", "shortName": "Fair Value Measurements - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:AssetsHeldInTrustCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:AssetsHeldInTrustCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "longName": "1029 - Disclosure - Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail)", "shortName": "Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_MarketableSecuritiesHeldInTrustAccountMemberusgaapFairValueByAssetClassAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_MarketableSecuritiesHeldInTrustAccountMemberusgaapFairValueByAssetClassAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "longName": "1030 - Disclosure - Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail)", "shortName": "Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "name": "us-gaap:WarrantsAndRightsOutstanding", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:WarrantsAndRightsOutstanding", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R31": { "role": "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail", "longName": "1031 - Disclosure - Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail)", "shortName": "Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "coolu:ScheduleOfFairValueOfWarrantLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "unique": true } }, "R32": { "role": "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail", "longName": "1032 - Disclosure - Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail)", "shortName": "Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "PAsOn09_30_2023_InitialMeasurementMemberCOOLUTimeOfMeasurementAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PublicWarrantsAndPrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Unit_D", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_InitialMeasurementMemberCOOLUTimeOfMeasurementAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PublicWarrantsAndPrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Unit_D", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d452213d10q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Shares Converted", "terseLabel": "Conversion of stock, shares converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of Fair Value Assets Measured On Recurring Basis", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r47", "r78" ] }, "us-gaap_ConversionOfStockAmountConverted1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountConverted1", "crdr": "debit", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Amount Converted", "verboseLabel": "Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares", "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "verboseLabel": "Basic net income (loss) per ordinary share", "terseLabel": "Basic net income (loss) per ordinary share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r106", "r120", "r121", "r122", "r123", "r124", "r129", "r132", "r136", "r137", "r138", "r140", "r233", "r234", "r279", "r289", "r394" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of Fair Value Liabilities Measured On Recurring Basis", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r47", "r78" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r420" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Shares Issued", "verboseLabel": "Conversion of stock, shares issued", "terseLabel": "Conversion of stock, shares issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireRestrictedInvestments", "crdr": "credit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Restricted Investments", "terseLabel": "Payments to Acquire Restricted Investments", "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions." } } }, "auth_ref": [ "r62" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Due to Related Parties, Current", "terseLabel": "Due to related party", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r28" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from operations", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r144", "r145", "r147", "r149", "r396" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r198", "r254", "r255", "r322", "r323", "r324", "r325", "r326", "r347", "r349", "r378" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r139" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/CoverPage", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r88", "r95", "r96", "r97", "r112", "r132", "r133", "r136", "r138", "r142", "r143", "r150", "r161", "r163", "r164", "r165", "r168", "r169", "r174", "r175", "r178", "r181", "r188", "r243", "r298", "r299", "r300", "r301", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r318", "r329", "r351", "r371", "r384", "r385", "r386", "r387", "r388", "r426", "r432", "r438" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r44", "r45", "r220", "r404", "r405" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r220", "r404", "r405" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRedeemedOrCalledDuringPeriodShares", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Stock Redeemed or Called During Period, Shares", "verboseLabel": "Number of stock bought back by the entity at the exercise price or redemption price.", "terseLabel": "Number of stock bought back by the entity at the exercise price or redemption price.", "negatedLabel": "Payments to Class A ordinary shareholders for redemption of shares", "documentation": "Number of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r8" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r235", "r242" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrant", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r189" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r24" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r63" ] }, "us-gaap_TemporaryEquityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityTableTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Temporary Equity [Table Text Block]", "terseLabel": "Summary of Temporary Equity", "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r12", "r35" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodStartLabel": "Cash at beginning of the period", "periodEndLabel": "Cash at end of the period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r23", "r63", "r109" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related party transaction, amounts of transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r49", "r254" ] }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "crdr": "credit", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt instrument convertible into warrants", "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion." } } }, "auth_ref": [ "r33" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 }, "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r60", "r65", "r81", "r90", "r100", "r101", "r105", "r112", "r118", "r120", "r121", "r122", "r123", "r126", "r127", "r134", "r144", "r145", "r147", "r149", "r150", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r234", "r243", "r288", "r350", "r369", "r370", "r396", "r417", "r444" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt instrument conversion price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r71", "r170" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r115", "r116", "r117", "r141", "r266", "r296", "r318", "r321", "r322", "r323", "r324", "r325", "r326", "r329", "r332", "r333", "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r349", "r352", "r353", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r371", "r412" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic", "definitionGuidance": "Allocation of net income (loss)", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r107", "r120", "r121", "r122", "r123", "r129", "r130", "r135", "r138", "r144", "r145", "r147", "r149", "r396" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r251", "r252", "r253", "r255", "r258", "r303", "r304", "r305", "r354", "r355", "r356", "r375", "r377" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r3" ] }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityRedemptionPricePerShare", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temproary equity redemption price, per share", "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r12", "r35" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "presentationGuidance": "Due to related party", "definitionGuidance": "Other liabilities current", "terseLabel": "Due to related parties current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r15", "r407" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r254", "r255", "r450" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "verboseLabel": "Numerator: Net Income (loss) minus Net Earnings" } } }, "auth_ref": [] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r47", "r48" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r56", "r76", "r286", "r294", "r295", "r302", "r330", "r407" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) Per Ordinary Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r28", "r29" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r209", "r213" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "coolu_WarrantLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantLiabilityPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Warrant Liability [Policy Text Block]", "terseLabel": "Warrant Liabilities", "documentation": "Warrant liability." } } }, "auth_ref": [] }, "coolu_RisksAndUncertaintiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RisksAndUncertaintiesPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Risks And Uncertainties [Policy Text Block]", "terseLabel": "Risks and Uncertainties", "documentation": "Risks and uncertainties." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "coolu_ClassaOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassaOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "ClassA Ordinary Shares Subject To Possible Redemption [Policy Text Block]", "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption", "documentation": "Class\u00a0A ordinary shares subject to possible redemption." } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r128", "r200", "r427", "r428", "r437" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.cga.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r259", "r260" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Payments to Class A ordinary shareholders for redemption of shares", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r22" ] }, "coolu_EmergingGrowthCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "EmergingGrowthCompanyPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company", "documentation": "Emerging growth company." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityAccretionToRedemptionValue", "crdr": "credit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Remeasurement of carrying value to redemption value", "documentation": "Value of accretion of temporary equity to its redemption value during the period." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r128", "r200", "r427", "r437" ] }, "coolu_MarketableSecuritiesHeldInTrustAccountPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MarketableSecuritiesHeldInTrustAccountPolicyPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Marketable Securities Held In Trust Account Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account", "documentation": "Marketable securities held in trust account." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r21" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock shares issued", "verboseLabel": "Preferred stock shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r53", "r174" ] }, "us-gaap_CommitmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsDisclosureTextBlock", "presentation": [ "http://www.cga.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights." } } }, "auth_ref": [ "r70" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "terseLabel": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par or stated value per share", "verboseLabel": "Common stock par or stated value per share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r54" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)", "terseLabel": "Increase In carrying amount of subject to possible redemption", "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r12", "r35" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized", "verboseLabel": "Preferred stock shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r53", "r329" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding", "verboseLabel": "Preferred stock shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r53", "r329", "r348", "r462", "r463" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "crdr": "debit", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "terseLabel": "Remeasurement of Class A ordinary shares subject to possible redemption", "verboseLabel": "Temporary equity accretion to redemption value", "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents [Axis]", "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage." } } }, "auth_ref": [ "r13" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par or stated value per share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r53", "r174" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_CapitalUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalUnitsMember", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Capital Units [Member]", "terseLabel": "Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant [Member]", "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r424" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r448" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.cga.com/role/CoverPage", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "verboseLabel": "Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]", "terseLabel": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r409", "r410", "r413", "r414", "r415", "r416" ] }, "us-gaap_ProceedsFromSaleOfRestrictedInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfRestrictedInvestments", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Restricted Investments", "terseLabel": "Proceeds received from Trust Account", "documentation": "The cash inflow associated with the sale of investments that are pledged or subject to withdrawal restrictions during the period." } } }, "auth_ref": [ "r20" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Share Price [Member]", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r448" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r448" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "presentation": [ "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]", "documentation": "Represents settlement terms for the group of mandatorily redeemable securities, including the description and the details of all terms for each outstanding financial instrument and each settlement option." } } }, "auth_ref": [ "r5", "r7", "r34" ] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding", "terseLabel": "Warrant liability", "periodStartLabel": "Fair value, Beginning Balance", "periodEndLabel": "Fair value, Ending Balance", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain", "presentation": [ "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]", "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur." } } }, "auth_ref": [ "r5", "r7" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Accrued for interest and penalties", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r212" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference Shares, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r53", "r283", "r407" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r102", "r210", "r211", "r214", "r215", "r216", "r217", "r297" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r30", "r31", "r32", "r83", "r84", "r86", "r87" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/CoverPage", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r88", "r95", "r96", "r97", "r112", "r132", "r133", "r136", "r138", "r142", "r143", "r150", "r161", "r163", "r164", "r165", "r168", "r169", "r174", "r175", "r178", "r181", "r188", "r243", "r298", "r299", "r300", "r301", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r318", "r329", "r351", "r371", "r384", "r385", "r386", "r387", "r388", "r426", "r432", "r438" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "presentationGuidance": "Class A ordinary shares subject to possible redemption, 419,938 shares at redemption value as of September 30, 2023 and 1,191,437 shares at redemption value as of December 31, 2022", "terseLabel": "Class\u00a0A ordinary shares subject to possible redemption", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r161", "r163", "r164", "r165", "r168", "r169", "r208", "r285" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Shareholders' Deficit", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r54", "r57", "r58", "r69", "r331", "r348", "r372", "r373", "r407", "r418", "r433", "r440", "r449", "r462" ] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Warrants and Rights Outstanding, Measurement Input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r240" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r66", "r110" ] }, "coolu_BussinessCombinationAdditionalEarntOutSharesDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.cga.com/20230930", "localname": "BussinessCombinationAdditionalEarntOutSharesDescription", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Bussiness Combination Additional Earnt Out Shares Description", "verboseLabel": "Bussiness combination additional earnt out shares description", "documentation": "Bussiness combination additional earnt out shares description." } } }, "auth_ref": [] }, "coolu_ShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ShareholdersMember", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Shareholders [Member]", "documentation": "Shareholders Member" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r420" ] }, "coolu_DeferredUnderwritingFeePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DeferredUnderwritingFeePerUnit", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Underwriting Fee Per Unit", "terseLabel": "Deferred underwriting fee per unit", "documentation": "Deferred underwriting fee per unit." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r238" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r55", "r407", "r461" ] }, "coolu_WarrantsExercisableTermFromTheClosingOfIpo": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantsExercisableTermFromTheClosingOfIpo", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable Term From The Closing Of IPO", "terseLabel": "Warrants exercisable term from the closing of IPO", "documentation": "Warrants exercisable term from the closing of IPO." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Description of Organization, Business Operations and Basis of Presentation", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r66", "r67", "r68", "r77" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average shares outstanding", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r131", "r138" ] }, "coolu_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable Term From The Date Of Completion Of Business Combination", "terseLabel": "Warrants exercisable term from the date of completion of business combination", "documentation": "Warrants exercisable term from the date of completion of business combination." } } }, "auth_ref": [] }, "coolu_CommonStockSubjectToForfeiture": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "CommonStockSubjectToForfeiture", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock Subject to Forfeiture", "terseLabel": "Common Stock Subject to Forfeiture", "documentation": "Common stock subject to forfeiture." } } }, "auth_ref": [] }, "coolu_MinimumLockInPeriodtoBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MinimumLockInPeriodtoBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum lock In PeriodTo Become Effective After The Closing Of The Initial Business Combination", "terseLabel": "Minimum lock In period\u00a0to become effective after the closing of the initial Business Combination", "documentation": "Minimum lock in period\u00a0to become effective after the closing of the initial business combination." } } }, "auth_ref": [] }, "coolu_PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds": { "xbrltype": "percentItemType", "nsuri": "http://www.cga.com/20230930", "localname": "PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Percentage Of Capital Raised For Business Combination To Total Equity Proceeds", "terseLabel": "Percentage of capital raised for business combination to total equity proceeds", "documentation": "Percentage of capital raised for business combination to total equity proceeds." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average shares outstanding", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r129", "r138" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRedeemedOrCalledDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Redeemed or Called During Period, Value", "verboseLabel": "Value of stock bought back by the entity at the exercise price or redemption price", "terseLabel": "Value of stock bought back by the entity at the exercise price or redemption price", "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r8" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r155", "r156", "r157", "r160", "r442", "r443" ] }, "coolu_DueToShareholdersPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DueToShareholdersPaid", "crdr": "debit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Due to Shareholders Paid", "documentation": "Due to shareholders paid." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CoverPage", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r462" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued", "verboseLabel": "Common stock shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r54" ] }, "coolu_DenominatorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DenominatorAbstract", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Denominator [Abstract]", "documentation": "Denominator" } } }, "auth_ref": [] }, "coolu_TransactionCostsOfShareIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "TransactionCostsOfShareIssuance", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Transaction Costs Of Share Issuance", "terseLabel": "Transaction costs of share issuance", "documentation": "Transaction costs of share issuance." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r155", "r156", "r157", "r160", "r442", "r443" ] }, "coolu_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "PublicWarrantsMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]", "documentation": "Public Warrants." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r54", "r284", "r407" ] }, "coolu_WarrantLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Warrant Liability Noncurrent", "terseLabel": "Warrant liabilities", "documentation": "Warrant liability noncurrent." } } }, "auth_ref": [] }, "coolu_WorkingCapitalLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WorkingCapitalLoanMember", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Working Capital Loan [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized", "verboseLabel": "Common stock shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r54", "r329" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding", "verboseLabel": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r54", "r329", "r348", "r462", "r463" ] }, "coolu_DueToShareholdersCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DueToShareholdersCurrent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Due To Shareholders Current", "terseLabel": "Due to shareholders", "documentation": "Due to shareholders current." } } }, "auth_ref": [] }, "coolu_SharePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SharePriceRangeAxis", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price Range [Axis]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Shares issuable per warrant", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "coolu_ScheduleOfFairValueOfWarrantLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ScheduleOfFairValueOfWarrantLiabilitiesTableTextBlock", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of Warrant Liabilities [Table Text Block]", "terseLabel": "Summary of Fair Value of Warrant Liabilities", "documentation": "Schedule Of Fair Value Of Warrant Liabilities." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "coolu_DisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsTableTextBlock", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants [Table Text Block]", "documentation": "Disclosure of inputs used in measuring the fair value of warrants." } } }, "auth_ref": [] }, "coolu_NoventiqHoldingsPlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "NoventiqHoldingsPlcMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Noventiq Holdings PLC [Member]", "documentation": "Noventiq holdings plc." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExercisePriceMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Exercise Price [Member]", "documentation": "Measurement input using agreed upon price for exchange of underlying asset." } } }, "auth_ref": [ "r448" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "coolu_SharePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SharePriceRangeDomain", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price Range [Domain]" } } }, "auth_ref": [] }, "coolu_OperatingAndFormationCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "OperatingAndFormationCostsMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating And Formation Costs [Member]", "terseLabel": "Operating And Formation Costs [Member]" } } }, "auth_ref": [] }, "coolu_AdministrativeServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "AdministrativeServicesAgreementMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Administrative Services Agreement [Member]", "documentation": "Administrative services agreement." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r236", "r237", "r241" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r422" ] }, "coolu_SharePriceMoreThanOrEqualsToUsdTwelveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SharePriceMoreThanOrEqualsToUsdTwelveMember", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price More Than Or Equals To USD Twelve [Member]", "terseLabel": "Share Price More Than Or Equals To USD Twelve [Member]" } } }, "auth_ref": [] }, "coolu_DeferredUnderwritingFeePayableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DeferredUnderwritingFeePayableNoncurrent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Underwriting Fee Payable Noncurrent", "terseLabel": "Deferred underwriting fee payable", "verboseLabel": "Deferred underwriting fee payable noncurrent", "documentation": "Deferred underwriting fee payable noncurrent." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current", "terseLabel": "Accrued Expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC Insured Amount", "terseLabel": "FDIC insured", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r9" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r420" ] }, "coolu_FounderSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "FounderSharesMember", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Founder Shares [Member]", "terseLabel": "Founder Shares [Member]" } } }, "auth_ref": [] }, "coolu_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r423" ] }, "coolu_NumberOfTradingDaysForDeterminingSharePrice": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "NumberOfTradingDaysForDeterminingSharePrice", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number Of trading Days For Determining Share Price", "terseLabel": "Number of trading days for determining share price", "documentation": "Number of trading days for determining share price." } } }, "auth_ref": [] }, "coolu_MaximumThresholdOnAdministrativeSupportExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MaximumThresholdOnAdministrativeSupportExpense", "crdr": "credit", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Maximum Threshold On Administrative Support Expense", "terseLabel": "Maximum threshold on administrative support expense", "documentation": "Maximum threshold on administrative support expense." } } }, "auth_ref": [] }, "coolu_OperatingAndFormationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "OperatingAndFormationCosts", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating And Formation Costs", "terseLabel": "Operating and formation costs", "documentation": "Operating and formation costs." } } }, "auth_ref": [] }, "coolu_NumberOfFounderSharesTransferred": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "NumberOfFounderSharesTransferred", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number Of Founder Shares Transferred", "terseLabel": "Number of founder shares transferred", "documentation": "Number of founder shares transferred." } } }, "auth_ref": [] }, "coolu_ShareTransferTriggerPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ShareTransferTriggerPricePerShare", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Transfer Trigger Price Per Share", "terseLabel": "Share transfer, trigger price per share.", "documentation": "Share transfer, trigger price per share." } } }, "auth_ref": [] }, "coolu_ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassaNonredeemableOrdinarySharesAndClassbOrdinarySharesMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Class A Nonredeemable Ordinary Shares and Class B Ordinary Shares [Member]", "terseLabel": "Class A Nonredeemable and Class B [Member]", "documentation": "Class\u00a0A nonredeemable ordinary shares and Class\u00a0B ordinary shares." } } }, "auth_ref": [] }, "coolu_StockForfeitedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "StockForfeitedDuringPeriodShares", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Forfeited During Period Shares", "terseLabel": "Stock forfeited during period, shares", "documentation": "Stock forfeited during period, shares." } } }, "auth_ref": [] }, "coolu_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of IPO", "terseLabel": "Minimum lock In period\u00a0for transfer, assign or sell warrants after completion of IPO", "documentation": "Minimum lock in period\u00a0for transfer, assign or sell warrants after completion of IPO." } } }, "auth_ref": [] }, "coolu_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SponsorMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Sponsor [Member]", "terseLabel": "Sponsor [Member]" } } }, "auth_ref": [] }, "coolu_NumberOfConsecutiveTradingDaysForDeterminingSharePrice": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "NumberOfConsecutiveTradingDaysForDeterminingSharePrice", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number Of Consecutive Trading Days For Determining Share Price", "terseLabel": "Number of consecutive trading days for determining share price", "documentation": "Number of consecutive trading days for determining share price." } } }, "auth_ref": [] }, "coolu_CashWithdrawnFromTrustAccountForRedeemptionOfStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "CashWithdrawnFromTrustAccountForRedeemptionOfStock", "crdr": "credit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash Withdrawn From Trust Account for Redeemption of Stock", "verboseLabel": "Cash withdrawn from trust account for redeemption of stock", "terseLabel": "Cash withdrawn from trust account for redeemption of stock", "documentation": "Cash Withdrawn From Trust Account for Redeemption of Stock" } } }, "auth_ref": [] }, "coolu_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Threshold Number Of Trading Days For Determining Share Price From Date Of Business Combination", "terseLabel": "Threshold number of trading days for determining share price from date of business combination", "documentation": "Threshold number of trading days for determining share price from date of business combination." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r448" ] }, "coolu_RelatedPartyTransactionAccruedExpensesFromTransactionsWithRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RelatedPartyTransactionAccruedExpensesFromTransactionsWithRelatedParty", "crdr": "debit", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction Accrued Expenses From Transactions With Related Party", "terseLabel": "Related party transaction accrued expenses from transactions with related party", "documentation": "Related party transaction accrued expenses from transactions with related party." } } }, "auth_ref": [] }, "coolu_ConversionOfClassBToClassACommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ConversionOfClassBToClassACommonStockMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Conversion of Class B to Class A Common Stock [Member]", "terseLabel": "Conversion of Class B to Class A Common Stock [Member]", "documentation": "Conversion of Class B to Class A Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "coolu_UnderwritingExpensesOnIssuanceOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "UnderwritingExpensesOnIssuanceOfShares", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Underwriting Expenses On Issuance Of Shares", "terseLabel": "Underwriting expenses on issuance of shares", "documentation": "Underwriting expenses on issuance of shares." } } }, "auth_ref": [] }, "coolu_ClassOfWarrantsAndRightsIssuedPricePerWarrant": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassOfWarrantsAndRightsIssuedPricePerWarrant", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants And Rights Issued Price Per Warrant", "terseLabel": "Class of warrants and rights issued, price per warrant", "documentation": "Class of warrants and rights issued, price per warrant." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r6", "r11" ] }, "coolu_DissolutionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DissolutionExpense", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Dissolution Expense", "terseLabel": "Dissolution expense", "documentation": "Dissolution expense." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r156", "r157", "r158", "r159", "r191", "r199", "r202", "r203", "r204", "r264", "r265", "r290", "r319", "r320", "r379", "r380", "r381", "r382", "r383", "r390", "r391", "r397", "r400", "r406", "r408", "r411", "r441", "r446", "r454", "r455", "r456", "r457", "r458" ] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OverAllotmentOptionMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "coolu_WorkingCapitalDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WorkingCapitalDeficit", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "working Capital Deficit", "terseLabel": "Working capital (deficit)", "documentation": "working capital (deficit)." } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r156", "r157", "r158", "r159", "r191", "r199", "r202", "r203", "r204", "r264", "r265", "r290", "r319", "r320", "r379", "r380", "r381", "r382", "r383", "r390", "r391", "r397", "r400", "r406", "r408", "r411", "r441", "r446", "r454", "r455", "r456", "r457", "r458" ] }, "coolu_ClassOfWarrantsAndRightsIssuedDuringThePeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassOfWarrantsAndRightsIssuedDuringThePeriod", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants And Rights Issued During The Period", "terseLabel": "Class of warrants and rights issued during the period", "documentation": "Class of warrants and rights issued during the period." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "coolu_TemporaryEquityRedemptionEarningsInTheTrustAccountNotPreviouslyWithdrawn": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "TemporaryEquityRedemptionEarningsInTheTrustAccountNotPreviouslyWithdrawn", "crdr": "credit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity Redemption Earnings In The Trust Account Not Previously Withdrawn", "terseLabel": "Temporary equity redemption earnings in the trust account not previously withdrawn", "documentation": "Temporary equity redemption earnings in the trust account not previously withdrawn." } } }, "auth_ref": [] }, "us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseInCarryingAmountOfRedeemablePreferredStock", "crdr": "debit", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Increase in Carrying Amount of Redeemable Preferred Stock", "negatedLabel": "Remeasurement of Class A ordinary shares subject to possible redemption", "documentation": "Adjustment to retained earnings for the increase in carrying amount of redeemable preferred stock that is classified as temporary equity." } } }, "auth_ref": [ "r72" ] }, "coolu_DeferredFeePayableInCash": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DeferredFeePayableInCash", "crdr": "credit", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Fee Payable In Cash", "terseLabel": "Deferred fee\u00a0payable in cash", "documentation": "Deferred fee\u00a0payable in cash." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "auth_ref": [ "r156", "r157", "r158", "r159", "r199", "r265", "r290", "r319", "r320", "r379", "r380", "r381", "r382", "r383", "r390", "r391", "r397", "r400", "r406", "r408", "r446", "r453", "r454", "r455", "r456", "r457", "r458" ] }, "coolu_CategoryOfRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.cga.com/20230930", "localname": "CategoryOfRelatedPartyAxis", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Category Of Related Party [Axis]", "documentation": "Category of related party." } } }, "auth_ref": [] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, Date of Incorporation", "terseLabel": "Entity incorporation, date of incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "coolu_CategoryOfRelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "CategoryOfRelatedPartyDomain", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Category Of Related Party [Domain]", "documentation": "Category of related party." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r74", "r75", "r76", "r95", "r96", "r97", "r142", "r174", "r175", "r176", "r178", "r181", "r186", "r188", "r298", "r299", "r300", "r301", "r400", "r426", "r432" ] }, "coolu_AggregateCashWithdrawnFromTrustAccountForRedeemptionOfStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "AggregateCashWithdrawnFromTrustAccountForRedeemptionOfStock", "crdr": "debit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Aggregate Cash Withdrawn From Trust Account for Redeemption of Stock", "terseLabel": "Aggregate cash withdrawn from trust account for redeemption of stock", "documentation": "Aggregate cash withdrawn from trust account for redeemption of stock." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "terseLabel": "Basic and diluted net income per ordinary share:", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r95", "r96", "r97", "r142", "r174", "r175", "r176", "r178", "r181", "r186", "r188", "r298", "r299", "r300", "r301", "r400", "r426", "r432" ] }, "coolu_RestrictedInvestmentsTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RestrictedInvestmentsTerm", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Restricted Investments Term", "terseLabel": "Restricted investments term", "documentation": "Restricted investments term." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' Deficit" } } }, "auth_ref": [] }, "coolu_ClassaredeemableordinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassaredeemableordinarySharesMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "ClassARedeemableOrdinary Shares [Member]", "verboseLabel": "Class\u00a0A\u00a0Redeemable\u00a0Ordinary Shares [Member]", "terseLabel": "Class A Redeemable [Member]", "documentation": "Class\u00a0A\u00a0redeemable\u00a0ordinary shares." } } }, "auth_ref": [] }, "coolu_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://www.cga.com/20230930", "localname": "PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination", "terseLabel": "Percentage of public shares to be redeemed on non completion of business combination", "documentation": "Percentage of public shares to be redeemed on non completion of business combination." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.cga.com/role/ShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Shareholders' Deficit", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r73", "r111", "r173", "r175", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r187", "r190", "r231", "r374", "r376", "r389" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r51", "r85" ] }, "coolu_OtherOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "OtherOfferingCosts", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Other Offering Costs", "terseLabel": "Other offering costs", "documentation": "Other offering costs." } } }, "auth_ref": [] }, "us-gaap_CommonStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockVotingRights", "presentation": [ "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Voting Rights", "verboseLabel": "Common stock, voting rights", "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r39" ] }, "coolu_DeferredUnderwritingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DeferredUnderwritingFees", "crdr": "credit", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Underwriting Fees", "terseLabel": "Deferred underwriting fees", "documentation": "Deferred underwriting fees." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r409", "r410", "r411", "r413", "r414", "r415", "r416", "r434", "r435", "r447", "r460", "r462" ] }, "coolu_PercentageOfRedeemingSharesOfPublicSharesWithoutTheCompanysPriorWrittenConsent": { "xbrltype": "percentItemType", "nsuri": "http://www.cga.com/20230930", "localname": "PercentageOfRedeemingSharesOfPublicSharesWithoutTheCompanysPriorWrittenConsent", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Percentage Of Redeeming Shares Of Public Shares Without The Companys Prior Written Consent", "terseLabel": "Percentage of redeeming shares of public shares without the company's prior written consent", "documentation": "Percentage of redeeming shares of public shares without the company's prior written consent." } } }, "auth_ref": [] }, "coolu_DeferredFeeForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "DeferredFeeForfeited", "crdr": "credit", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Fee Forfeited", "terseLabel": "Deferred fee\u00a0forfeited", "documentation": "Deferred fee\u00a0forfeited." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash financing activities:" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r171", "r192", "r193", "r194", "r195", "r196", "r197", "r261", "r262", "r263", "r398", "r399", "r401", "r402", "r403" ] }, "coolu_InitialPublicOfferingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "InitialPublicOfferingDisclosureTextBlock", "presentation": [ "http://www.cga.com/role/InitialPublicOffering" ], "lang": { "en-us": { "role": { "label": "Initial Public Offering Disclosure [Text Block]", "terseLabel": "Initial Public Offering", "documentation": "Initial public offering disclosure." } } }, "auth_ref": [] }, "coolu_StockRedeemptionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "StockRedeemptionPrice", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Redeemption Price", "verboseLabel": "Stock redeemption price", "terseLabel": "Stock redeemption price", "documentation": "Stock redeemption price." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "verboseLabel": "COMMITMENTS AND CONTINGENCIES", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r17", "r50", "r281", "r328" ] }, "coolu_WarrantLiabilityDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantLiabilityDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Warrant Liability Disclosure [Abstract]", "documentation": "Warrant Liability Disclosure." } } }, "auth_ref": [] }, "coolu_AggregateCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "AggregateCommonStockSharesOutstanding", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Aggregate Common Stock Shares Outstanding", "terseLabel": "Aggregate common shares outstanding", "documentation": "Aggregate common stock shares outstanding." } } }, "auth_ref": [] }, "coolu_WarrantLiabilityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantLiabilityDisclosureTextBlock", "presentation": [ "http://www.cga.com/role/WarrantLiabilities" ], "lang": { "en-us": { "role": { "label": "Warrant Liability Disclosure [Text Block]", "terseLabel": "Warrant Liabilities", "documentation": "Disclosure of warrant liability." } } }, "auth_ref": [] }, "coolu_NetTangibleAssetsRequiredForConsummationOfBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "NetTangibleAssetsRequiredForConsummationOfBusinessCombination", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Net Tangible Assets Required For Consummation Of Business Combination", "terseLabel": "Net tangible assets required for consummation of business combination", "documentation": "Net tangible assets required for consummation of business combination." } } }, "auth_ref": [] }, "coolu_AggregateCommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "AggregateCommonStockSharesIssued", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Aggregate Common Stock Shares Issued", "terseLabel": "Aggregate common shares issued", "documentation": "Aggregate common stock shares issued." } } }, "auth_ref": [] }, "coolu_CommonStockHeldInEscrowAccount": { "xbrltype": "sharesItemType", "nsuri": "http://www.cga.com/20230930", "localname": "CommonStockHeldInEscrowAccount", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock Held in Escrow Account", "terseLabel": "Common Stock Held in Escrow Account", "documentation": "Common stock held in escrow account." } } }, "auth_ref": [] }, "coolu_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum lock In periodFor SEC Registration From Date Of Business Combination", "terseLabel": "Minimum lock In period\u00a0For SEC Registration From Date Of Business Combination", "documentation": "Minimum lock in period\u00a0for SEC registration from date of business combination." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r91", "r99", "r112", "r150", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r221", "r223", "r243", "r407", "r444", "r445", "r451" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r205", "r206", "r207", "r306", "r434", "r435", "r436", "r447", "r462" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r171", "r192", "r193", "r194", "r195", "r196", "r197", "r237", "r261", "r262", "r263", "r398", "r399", "r401", "r402", "r403" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r82", "r282", "r317", "r337", "r407", "r418", "r430" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r10" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r430", "r459" ] }, "coolu_SharePriceLessThanOrEqualsToUsdEighteenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SharePriceLessThanOrEqualsToUsdEighteenMember", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price Less Than Or Equals To USD Eighteen [Member]", "documentation": "Share Price Less Than Or Equals To USD Eighteen." } } }, "auth_ref": [] }, "coolu_InitialMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "InitialMeasurementMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Initial Measurement [Member]", "documentation": "Initial measurement." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r28" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r236", "r237", "r239", "r240", "r242" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "terseLabel": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r113", "r114", "r254", "r255", "r256", "r257", "r322", "r323", "r324", "r325", "r326", "r347", "r349", "r378" ] }, "coolu_SubsequentMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SubsequentMeasurementMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Measurement [Member]", "documentation": "Subsequent measurement." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationPriceOfAcquisitionExpected": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationPriceOfAcquisitionExpected", "crdr": "credit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Price of Acquisition, Expected", "verboseLabel": "Equity value of expected business acquisition", "documentation": "Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition." } } }, "auth_ref": [ "r429" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodStartLabel": "Beginning balance (Shares)", "periodEndLabel": "Ending balance (Shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r16", "r92", "r112", "r150", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r222", "r223", "r224", "r243", "r407", "r444", "r451", "r452" ] }, "coolu_PublicWarrantsAndPrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "PublicWarrantsAndPrivatePlacementWarrantsMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Public Warrants And Private Placement Warrants [Member]", "documentation": "Public warrants and private placement warrants." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "coolu_AggregateValueOfWarrantsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cga.com/20230930", "localname": "AggregateValueOfWarrantsOutstanding", "crdr": "credit", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Aggregate Value Of Warrants Outstanding", "verboseLabel": "Aggregate value of warrants outstanding", "documentation": "Aggregate value of warrants outstanding." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "verboseLabel": "Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r19", "r76" ] }, "coolu_ClassOfWarrantsRedemptionNoticePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassOfWarrantsRedemptionNoticePeriod", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants Redemption Notice Period", "terseLabel": "Class of warrants, redemption notice period", "documentation": "Class of warrants, redemption notice period." } } }, "auth_ref": [] }, "coolu_ClassOfWarrantsExercisePriceAdjustmentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassOfWarrantsExercisePriceAdjustmentPercentage", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants Exercise Price Adjustment Percentage", "terseLabel": "Class of warrant or right, redemption price adjustment percentage", "documentation": "Class of warrants, exercise price adjustment percentage." } } }, "auth_ref": [] }, "coolu_ClassOfWarrantsRedemptionPricePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "ClassOfWarrantsRedemptionPricePerUnit", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants Redemption Price Per Unit", "terseLabel": "Class of warrants, redemption price per unit", "documentation": "Class of warrants, redemption price per unit." } } }, "auth_ref": [] }, "coolu_FairMarketValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "FairMarketValuePerShare", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Fair Market Value Per Share", "terseLabel": "Fair market value per share", "documentation": "Fair market value per share." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r53", "r54", "r76", "r298", "r371", "r385" ] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Number of Shares Issued in Transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Proceeds from related party debt", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r115", "r116", "r117", "r141", "r266", "r296", "r318", "r321", "r322", "r323", "r324", "r325", "r326", "r329", "r332", "r333", "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r349", "r352", "r353", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r371", "r412" ] }, "coolu_SharePriceMoreThanOrEqualsToUsdEighteenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SharePriceMoreThanOrEqualsToUsdEighteenMember", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price More Than Or Equals To USD Eighteen [Member]", "documentation": "Share Price More Than Or Equals To USD Eighteen." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "auth_ref": [] }, "coolu_SharePriceLessThanOrEqualsToUsdNinePointTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "SharePriceLessThanOrEqualsToUsdNinePointTwoMember", "presentation": [ "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price Less Than Or Equals To USD Nine Point Two [Member]", "documentation": "Share Price Less Than Or Equals To USD Nine Point Two." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r171", "r192", "r197", "r237", "r261", "r401", "r402", "r403" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r79", "r94", "r112", "r144", "r146", "r148", "r150", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r221", "r223", "r243", "r280", "r342", "r407", "r418", "r444", "r445", "r451" ] }, "coolu_MinimumPercentageOfCommonStockToBeHeldAfterConversionOfShares": { "xbrltype": "percentItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MinimumPercentageOfCommonStockToBeHeldAfterConversionOfShares", "presentation": [ "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum Percentage Of Common Stock To Be Held After Conversion Of Shares", "terseLabel": "Minimum percentage of common stock to be held after conversion of shares", "documentation": "Minimum percentage of common stock to be held after conversion of shares." } } }, "auth_ref": [] }, "coolu_StockRedemptionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "StockRedemptionPrice", "presentation": [ "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Redemption Price", "terseLabel": "Stock redemption price", "documentation": "Stock Redemption Price" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r19", "r89", "r103", "r104", "r105", "r115", "r116", "r117", "r119", "r125", "r127", "r141", "r151", "r152", "r190", "r205", "r206", "r207", "r218", "r219", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r291", "r292", "r293", "r306", "r371" ] }, "coolu_TimeOfMeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.cga.com/20230930", "localname": "TimeOfMeasurementAxis", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Time Of Measurement [Axis]", "documentation": "Time of measurement." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r171", "r192", "r193", "r194", "r195", "r196", "r197", "r237", "r263", "r398", "r399", "r401", "r402", "r403" ] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Investments, Fair Value Disclosure", "terseLabel": "Cash and Marketable securities held in Trust Account", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r236" ] }, "coolu_MarketableSecuritiesHeldInTrustAccountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "MarketableSecuritiesHeldInTrustAccountMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Marketable Securities Held In Trust Account [Member]", "terseLabel": "Cash and Marketable Securities Held In Trust Account [Member]", "documentation": "Marketable securities held in trust account." } } }, "auth_ref": [] }, "coolu_AggregateValueOfWarrantsOutstandingPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.cga.com/20230930", "localname": "AggregateValueOfWarrantsOutstandingPerShare", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Aggregate Value Of Warrants Outstanding Per Share", "terseLabel": "Aggregate value of warrants outstanding per share", "documentation": "Aggregate value of warrants outstanding per share." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r89", "r115", "r116", "r117", "r119", "r125", "r127", "r151", "r152", "r205", "r206", "r207", "r218", "r219", "r225", "r227", "r228", "r230", "r232", "r291", "r293", "r306", "r462" ] }, "coolu_WarrantLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "WarrantLiabilitiesMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Warrant Liabilities [Member]", "terseLabel": "Warrant Liabilities [Member]", "documentation": "Warrant liabilities." } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrustCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldInTrustCurrent", "crdr": "debit", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Assets Held-in-trust, Current", "verboseLabel": "Assets held-in-trust, current", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r431" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "coolu_RedemptinThresholdConsecutiveTradingDaysMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RedemptinThresholdConsecutiveTradingDaysMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Redemptin Threshold Consecutive Trading Days [Member]", "documentation": "Redemptin threshold consecutive trading days." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.cga.com/role/CommitmentsAdditionalInformationDetail", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Stock issued during period, stock options exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r53", "r54", "r76", "r201" ] }, "coolu_RedemptionThresholdPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RedemptionThresholdPriceMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Redemption Threshold Price [Member]", "documentation": "Redemption threshold price." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "verboseLabel": "Conversion of Class B ordinary shares to Class A nonredeemable ordinary shares (Shares)", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r18", "r39", "r76", "r172" ] }, "coolu_RedemptionThresholdDaysMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RedemptionThresholdDaysMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Redemption Threshold Days [Member]", "documentation": "Redemption threshold days." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share Price", "terseLabel": "Share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrustNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldInTrustNoncurrent", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets Held-in-trust, Noncurrent", "verboseLabel": "Cash and marketable securities held in Trust Account", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r431" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r89", "r103", "r104", "r105", "r115", "r116", "r117", "r119", "r125", "r127", "r141", "r151", "r152", "r190", "r205", "r206", "r207", "r218", "r219", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r291", "r292", "r293", "r306", "r371" ] }, "coolu_TimeOfMeasurementDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "TimeOfMeasurementDomain", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Time Of Measurement [Domain]", "documentation": "Time of measurement." } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldInTrust", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Assets Held-in-trust", "terseLabel": "Assets held-in-trust", "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations." } } }, "auth_ref": [ "r431" ] }, "coolu_RedemptionPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cga.com/20230930", "localname": "RedemptionPriceMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsDisclosureOfInputsUsedInMeasuringTheFairValueOfWarrantsDetail" ], "lang": { "en-us": { "role": { "label": "Redemption Price [Member]", "documentation": "Redemption price." } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liabilities", "terseLabel": "Change in fair value of warrant liabilities", "verboseLabel": "Change in valuation inputs or other assumptions", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r0", "r4" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "verboseLabel": "Other income (loss)" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockNameDomain", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Name [Domain]", "documentation": "The unique name of a noncash or part noncash stock conversion." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_InvestmentIncomeNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNonoperating", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 4.0 }, "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Income, Nonoperating", "terseLabel": "Earnings and realized gain on marketable securities held in Trust Account", "negatedLabel": "Earnings and realized gain on marketable securities held in Trust Account", "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations." } } }, "auth_ref": [ "r61" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityLineItems", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r93" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r98", "r153", "r154", "r392" ] }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfWarrants", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from issuance of warrants", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)." } } }, "auth_ref": [ "r2" ] }, "us-gaap_TemporaryEquityDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Temporary Equity Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityByClassOfStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityByClassOfStockTable", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, by Class of Stock [Table]", "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable." } } }, "auth_ref": [ "r12", "r35" ] }, "us-gaap_ConversionOfStockDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockDescription", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Description", "verboseLabel": "Conversion of stock, description", "terseLabel": "Conversion of stock, description", "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r198", "r254", "r255", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r322", "r323", "r324", "r325", "r326", "r347", "r349", "r378", "r450" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Basic and Diluted Net Income Per Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r439" ] }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockByUniqueDescriptionAxis", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Conversion Description [Axis]", "documentation": "Information by description of stock conversions." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityParOrStatedValuePerShare", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity par or stated value per share", "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable." } } }, "auth_ref": [ "r12", "r35" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r419" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r420" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.cga.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r235" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r108" ] }, "us-gaap_TemporaryEquitySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesIssued", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity shares issued", "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted net income (loss) per ordinary share", "terseLabel": "Diluted net income (loss) per ordinary share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r106", "r120", "r121", "r122", "r123", "r124", "r132", "r136", "r137", "r138", "r140", "r233", "r234", "r279", "r289", "r394" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r108" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Stock shares issued during the period for services value", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r63", "r64", "r65" ] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Stock issued during period, shares, issued for services", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r420" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r14", "r112", "r150", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r222", "r223", "r224", "r243", "r327", "r395", "r418", "r444", "r451", "r452" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.cga.com/role/FairValueMeasurementsSummaryOfFairValueOfWarrantLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r236", "r237", "r241" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r420" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r421" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r420" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets", "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficit", "http://www.cga.com/role/CoverPage", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.cga.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail", "http://www.cga.com/role/WarrantLiabilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r462" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from issuance of IPO", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r425" ] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cga.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.cga.com/role/ShareholdersDeficitAdditionalInformationDetail", "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfClassAOrdinarySharesDetail" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary equity shares outstanding", "definitionGuidance": "Class\u00a0A ordinary shares subject to possible redemption", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.cga.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r59", "r80", "r287", "r407", "r433", "r440", "r449" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.cga.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.cga.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r46", "r393" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.cga.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_CommonStockConversionBasis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockConversionBasis", "presentation": [ "http://www.cga.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Conversion Basis", "terseLabel": "Stock conversion basis", "documentation": "Description of basis for conversion of convertible common stock." } } }, "auth_ref": [ "r97" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(27)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "45", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481679/480-10-45-2A" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 3.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r419": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r420": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r425": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r426": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r428": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479455/805-10-15-3" }, "r430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 51 0001193125-23-276108-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-276108-xbrl.zip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